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Abstract  
 
The first influenza pandemic of the 21st century was caused by the influenza A (H1N1) 2009 
virus (A(H1N1)pdm09) that emerged from a swine-origin source. Although human infections 
with swine-origin influenza have been reported intermittently in the past decade, none went on 
to cause a pandemic or sustained human-to-human transmission. In previous pandemics, 
specific residues in the receptor binding site of the haemagglutinin (HA) protein of influenza 
have been associated with the ability of the virus to transmit between humans. In this thesis the 
effect of mutations at residue 227 in HA on cell tropism and transmission of A(H1N1)pdm09 is 
described. In A(H1N1)pdm09 and previous seasonal H1N1 viruses this residue is glutamic acid 
(E), whereas in swine influenza it is alanine (A). Using human airway epithelium, a differential 
cell tropism of A(H1N1)pdm09 compared to A(H1N1)pdm09 E227A and swine influenza was 
shown suggesting this residue may alter the sialic acid conformer binding preference of the HA. 
Furthermore, multi-cycle viral growth of both A(H1N1)pdm09 E227A and swine influenza was 
found to be attenuated in comparison to A(H1N1)pdm09 in human airway epithelium. However 
this altered tropism and viral growth in human airway epithelium did not abrogate respiratory 
droplet transmission of A(H1N1)pdm09 E227A in ferrets. This suggests that acquisition of 227E 
was not solely responsible for the ability of A(H1N1)pdm09 to transmit between humans. 
Because the work with the E227A mutant showed that small differences in cell tropism that may 
affect influenza virus transmissibility could be detected in human airway cells, a receptor binding 
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assay was developed for laboratory surveillance using commercial human airway epithelium 
cultures, to screen for zoonotic influenza strains of particular concern for human health.  
To further investigate adaptations by influenza virus for infection of the human host, the cell 
tropism determined by the HA protein of an avian H7N7 and human H7N3 isolate was 
compared. Binding to non-ciliated human airway cells was increased for the human isolate. This 
human case of H7N3 infection yielded two isolates from different sites (eye and throat) from the 
same patient on the same day. A whole genome sequencing assay was designed for H7 
isolates and both eye and throat isolate were fully sequenced. One synonymous nucleotide 
change was found in the NS gene segment and one synonymous and two non-synonymous 
nucleotide changes were found in the PB2 gene segment. Comparison of the non-synonymous 
changes in the protein sequence of PB2 to available avian and human virus PB2 sequences 
revealed that the substitutions in the eye isolate were comparatively uncommon. Interestingly, 
these changes resulted in an increased viral growth in human airway epithelial cells at 32ºC 
when compared to the throat isolate, a phenomenon which was not observed at 37ºC.  
Finally, the use of a lung model maintained by the ex-vivo lung perfusion (EVLP) technique for 
study of virus infection was tested. This technique allows the use of both human and porcine 
lungs up to 24 hours after abstraction and is a potential model for respiratory pathogens and 
novel treatments. Porcine lungs were infected with A(H1N1)pdm09. Physiological and 
virological parameters were measured in two separate experiments and infection was 
demonstrated by increased viral loads in samples obtained at late time points after infection.  
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1 Introduction 
1.1 Taxonomy and nomenclature 
Influenza viruses are members of the family Orthomyxoviridae (from the Greek orthos, „straight, 
correct‟ and myxa, „mucus‟) of which influenza A, B and C constitute three separate genera. 
These genera are distinguishable by antigenic differences in the nucleoprotein (NP) and matrix 
(M) proteins. Genus influenza A virus can be further divided into subtypes based on its surface 
proteins haemagglutinin (HA), of which currently 17 different subtypes are defined, including 
one recently discovered in little yellow-shouldered bats  (Fouchier et al. 2005, Rohm et al. 
1996b, Tong et al. 2012)  and neuraminidase (NA), of which currently 9 different subtypes are 
defined. Theoretically, this would amount to a total of 153 influenza A subtypes. All HA subtypes 
but H17 are found within the wild bird population, which forms the natural reservoir of influenza 
virus. However, only the HA subtypes H1, H2 and H3 as well as NA subtypes N1 and N2 have 
been associated with epidemics of disease in human hosts (Hilleman 2002). Individual influenza 
strains are named according to genera, host of origin (if non-human), geographical origin, strain 
number and year of isolation (WHO 1980). For example, the first pandemic H1N1 2009 
(A(H1N1)pdm09) virus isolated in England was named A/England/195/2009.   
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Figure 1.1 Schematic structure of influenza A particle and RNPs 
a) Three types of proteins – receptor-binding protein HA, receptor-destroying protein NA and ion 
channel M2 – are inserted through the lipid bilayer of the virus. Structural protein M1 is found 
underneath the lipid bilayer and interacts with the RNPs. Image adapted from textbook „Fields 
Virology‟, Chapter 46 „Orthomyxoviruses‟ b) An RNP is formed of one RNA segment (black line) 
encapsidated by NP protein, which is coiled around itself with both ends anchored to a 
polymerase complex consisting of proteins PB1, PB2 and PA. Image adapted from the paper by 
Portela et al. (Portela and Digard 2002). c/d) Immunogold labelling targeting PB1 and PB2 c) 
and PB1 and PA d) on purified RNPs shows binding of the polymerase complex to one side of 
the RNP. Image adapted from the paper by Murti et al. (Murti, Webster and Jones 1988) with 
permission of Elsevier.  
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1.2 The structure of influenza virus 
The genetic information of influenza virus is coded in negative (-) sense, single-stranded RNA 
(vRNA) divided into eight (influenza A and B) or seven (influenza C) segments. For influenza A 
virus, these segments vary from 890 nucleotides (segment 8) to 2341 nucleotides (segment 1 
and 2); laboratory-adapted influenza virus A/Puerto Rico/8/1934 (PR8) has a total genome 
length of 13588 nucleotides (Lamb and Krug 1995). The eight different segments of influenza 
encode a total of 13 proteins. Segment 1 encodes basic polymerase 2 (PB2), segment 2 
encodes basic polymerase 1 (PB1), PB1-F2 and PB1-N40, segment 3 encodes the acidic 
polymerase protein (PA) and the recently discovered PA-X, segment 4 encodes haemagglutinin 
(HA), segment 5 encodes the nucleoprotein (NP), segment 6 encodes the neuraminidase (NA), 
segment 7 encodes the matrix protein (M1) and ion channel protein (M2) and segment 8 
encodes the non-structural protein a (NS1) and the nuclear export protein (NEP or NS2). All 
RNA segments serve as templates for mRNA and antigenome (+) strand synthesis (cRNA). 
Within the virus, the RNA segments are encapsidated by NP protein and folded, resulting in 
helicoidal pseudocircular structures (Figure 1.1b). The packaged RNA segment is associated 
with one heterogeneous polymerase complex, RNA-dependent RNA polymerase (RdRp), 
consisting of polymerase proteins PB1, PB2 and PA, which simultaneously binds both termini of 
the RNA segment (Figure 1.1c/d). The subviral particle containing vRNA, NP proteins and the 
polymerase complex is known as the ribonucleoprotein particle (RNP). Each RNP behaves as 
an individual replication and transcription unit. The RNPs are encapsidated in a shell of M1 
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proteins lined by a lipid bilayer derived from the plasma membrane of the host cell in which the 
virus replicated. This plasma membrane contains three proteins; ion channel M2, receptor-
binding protein HA and receptor-destroying protein NA, of which the latter two can be observed 
as spikes protruding from the viral membrane (Figure 1.1). 
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Figure 1.2 Schematic diagram of the viral life cycle 
Please see text for details on the viral life cycle. Figure adapted from textbook „Fields Virology‟, 
Chapter 45 „Orthomyxoviridae: The Viruses and Their Replication‟.  
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1.3 The replication cycle of influenza A virus 
The HA protein is translated within the host cell as a precursor (HA0). Cleavage of HA0 by host 
proteases upon virion release results in the formation of two subunits, HA1 and HA2, of which 
the former is important in receptor binding, whereas the latter is important in membrane fusion 
upon entry (Steinhauer et al. 1995). HA then binds to the host cell receptor, sialic acid, and the 
virus enters the cell via receptor-mediated endocytosis (Lamb and Krug 1995). The pH within 
these endosomes is particularly low, typically around pH 5-6. This low pH results in a 
conformational change of the HA protein, preserving subunit HA1 but exposing the HA2 subunit 
fusion peptide (Bullough et al. 1994). Consequently, the fusion peptide inserts into the 
membrane of the endosome, thereby fusing the viral and endosomal membrane. The low pH in 
the endosome also opens up the M2 ion channel, which lowers the intra-viral pH. Upon 
acidification of the viral core, the viral RNPs are released from the protein shell formed by M1, 
and enter the host cell‟s cytoplasm (Martin and Helenius 1991a, Martin and Helenius 1991b, 
Zhirnov 1990). Transcription and replication of the influenza viral genome occurs in the nucleus 
rather than in the cytoplasm in contrast to most other RNA viruses, and therefore the RNPs 
require nuclear translocation. The viral proteins within RNPs (PB1, PB2, PA and NP) all have 
nuclear localisation signal (NLS) regions, however the NLS on the NP protein is both sufficient 
and necessary for nuclear import of RNPs using the classical importin α/β route (O'Neill et al. 
1995, O'Neill and Palese 1995, Cros, Garcia-Sastre and Palese 2005). Within the nucleus, 
three different types of RNA are produced during influenza infection; 1) viral messenger RNA  
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(mRNA), 2) positive  sense complementary RNA (cRNA) which serves as a template for 3) 
negative sense viral RNA (vRNA), destined to be incorporated into the eventual progeny virion.  
Cellular mRNA contains a poly-A tail and a 5‟ methylated cap. Influenza virus does not have 
internal capping or methylation mechanisms (Plotch, Tomasz and Krug 1978). Ingeniously, the 
influenza virus RdRp acquires the 5‟ methylated cap of a host cellular mRNA by cleaving 10-13 
nucleotides downstream of the cap structure using PB2 cap-binding and PA endonuclease 
activity (Fodor et al. 2002, Hara et al. 2006, Dias et al. 2009, Blaas, Patzelt and Kuechler 1982). 
This provides the RdRp PB1 subunit with a primer to initiate mRNA synthesis as well as 
ensuring host cell translation by ribosomes of viral mRNAs by including the 5‟ methylated cap. 
Moreover, viral mRNA contains a poly-A tail obtained by stuttering of the RdRp on the poly(U)5-7 
region at the 5‟ end of vRNA (Luo et al. 1991). Therefore, host and viral mRNAs are structurally 
indistinguishable.  
As influenza is a negative sense RNA virus, genome replication is preceded by the production 
of full-length, positive sense cRNA, which is most likely coated with NP protein and associated 
with polymerases during replication to prevent degradation (Vreede and Brownlee 2007). This 
cRNA then functions as a template for negative sense vRNA replication. For replication of both 
cRNA and subsequent vRNA, no primers are necessary and no poly-A tail is made (Deng, 
Vreede and Brownlee 2006). 
Newly synthesized viral proteins PB1, PB2, PA and NP are imported into the nucleus for the 
assembly of viral RNPs (Fodor and Smith 2004, Mukaigawa and Nayak 1991, Neumann, 
Castrucci and Kawaoka 1997). The nascent viral RNPs are then transported out of the nucleus 
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into the cytoplasm. It is hypothesized that the export of viral RNPs is achieved by binding of 
RNPs to the C-terminal part of the M1 protein (Baudin et al. 2001), which subsequently binds 
the viral NEP protein with its N-terminal domain (Akarsu et al. 2003), thereby blocking the N-
terminal NLS found on M1 (Ye, Robinson and Wagner 1995). NEP then binds to nuclear export 
protein Crm1, which binds RanGTP resulting in nuclear export of the viral RNPs complex 
through the nuclear pores (Akarsu et al. 2003).  
After the membrane proteins HA, NA and M2 are synthesized, they are inserted into the plasma 
membrane of the host cell. HA and NA are both preferentially inserted into lipid rafts, whereas 
insertion of the M2 ion channel occurs throughout the entire membrane (Leser and Lamb 2005). 
M1 binds to the plasma membrane where HA and NA are inserted and virions are formed by a 
process called budding, during which the membrane bulges from the cell and is eventually 
pinched off (reviewed in (Nayak et al. 2009)). Recently, a specific role of the M2 protein has 
been suggested for the scission of influenza virions from the host membrane using its 
amphipathic helix to modify membrane curvature (Rossman et al. 2010). 
Finally, NA cleaves sialic acids on the host cell to prevent aggregation at the cell membrane 
(Palese and Compans 1976, Liu et al. 1995) and the newly formed virions are released to infect 
new host cells and repeat the life cycle.  
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1.4 Haemagglutinin, the receptor binding protein of influenza virus 
HA is the most abundant protein on the influenza virion, covering about 80% of the viral surface 
(Lamb and Krug 1995). It plays a major role in three different phases throughout the influenza 
virus life cycle. Firstly, HA is the receptor-binding protein and initiates viral entry. Secondly, 
during endocytosis pH-induced conformational changes within the HA protein expose a small 
peptide which allows fusion of the viral and cellular membrane resulting in the release of the 
viral genome into the host cell. Finally, due to its prominent position on the influenza viral 
surface, HA is the major antigen of influenza viruses. Neutralising antibodies are produced in 
the human host against specific antigenic regions (epitopes) on the HA molecule and epidemics 
are associated with antigenic drift due to mutations within or close to these regions.  
The HA protein is encoded on RNA segment 4 and is named after its ability to agglutinate red 
blood cells by binding to sialic acid residues on the cell surface (Hirst 1941). The genomic 
sequence of HA was the first influenza gene to be fully sequenced (Porter et al. 1979). It 
encodes a signal peptide, receptor-binding region HA1, fusion-mediating region HA2 and the 
basic cleavage site between HA1 and HA2. The structure of the HA protein consist of a small 
hydrophilic domain on the inside of the virion, a small, uncharged hydrophobic peptide which 
spans the membrane, and a large hydrophilic glycosylated domain on the external surface of 
the virion. The latter domain constitutes a long, helical chain composed primarily of HA2 topped 
by a large globular head made exclusively of HA1. This globular head contains the receptor-  
37 
 
binding site (RBS) as well as the antigenic epitopes. The HA1 and HA2 domains are covalently 
linked via a disulfide bond (Wilson, Skehel and Wiley 1981). The HA protein is expressed as a 
homotrimer (Figure 1.3a).  
 
1.4.1 Cleavage of haemagglutinin 
Initially, a precursor of HA (HA0) is synthesised in the host cell via the secretory pathway. HA0 
is glycosylated (Daniels et al. 2003) and trimerized in association with chaperones in the 
endoplasmic reticulum (Copeland et al. 1986, Tatu, Hammond and Helenius 1995, Hebert, 
Foellmer and Helenius 1996). It is then transferred through the Golgi apparatus and integrated 
into lipid rafts in the plasma membrane (Skehel and Wiley 2000).  
Cleavage of the precursor HA0 into HA1 and HA2 is necessary to allow fusion of viral and 
cellular membranes upon host cell entry (Klenk et al. 1975, Lazarowitz and Choppin 1975). 
Cleavage leads to a conformational change in which the fusion peptide (amino acids 1-10 of 
HA2) is inserted into a conserved cavity formed by residues of both HA1 and HA2 located 
adjacent to the cleavage site, most likely attributable to electrostatic forces (Chen et al. 1998). 
Cleavage occurs in two stages. First, an endoprotease cleaves HA at the carboxyl terminus of 
the arginine (R) residue located between HA1 and HA2 comprising the cleavage site, which 
creates the N-terminus of HA2. This is followed by the removal of amino acid R by a 
carboxypeptidase, thereby generating the C-terminus of mature HA1 (Garten and Klenk 1983). 
Cleavage of influenza virus within the human host is generally believed to be completed by 
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Figure 1.3 Receptor binding protein haemagglutinin (HA) 
a) The ribbon presentation of the crystal structure of the uncleaved HA0 trimer of 1918 influenza 
virus adapted from Stevens et al. (Stevens and Wilson 2004) displays the receptor binding site 
(RBS) on the globular head (blue) and the cleavage site (black arrow). HA1 residues of one HA 
unit are coloured red, HA2 residues of one HA unit are coloured green. The orange shades 
represent 1918 influenza virus specific basic patches. b) The RBS pocket was adapted from 
Weis et al. (Weis et al. 1988). The base of the RBS is formed by tyrosine 98 and the aromatic 
ring of tryptophan 153. Residues 134 to 138 (the 130-loop) form the right side of the RBS, 
whereas residues 224 to 228 (part of the 220 loop) form the left side of the RBS. Residues 155, 
183, 190 and 194 form the rear of the RBS. Of these, 190 and 194 are part of the 190 loop 
(Weis et al. 1988). c) Sialic acid is illustrated, showing all interactions with the RBS. Red dot, 
interaction with HA amino acid; Green dot, linkage to glycan; Black arrow, Hydrogen bond; Blue 
arrow, Van der Waals bond; Numbers represent the residue of HA1 with which interactions is 
found.  
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tryptase Clara, a soluble protease excreted by Clara cells located in the human respiratory tract, 
although other proteases can also cleave HA0 (reviewed in (Bertram et al. 2010)).  
When influenza A virus spreads within poultry, occasionally a string of basic amino acids are 
introduced in the cleavage site of HA via either substitution or insertion, thereby creating a 
multibasic cleavage site (Horimoto et al. 1995, Mutinelli et al. 2003, Pasick et al. 2005). Multi-
basic cleavage sites have been associated with high pathogenicity and are recognised by 
endogenous proteases other than tryptase Clara, such as furin. The distribution of these 
proteases plays an important role in the increased pathogenicity of viruses with a multibasic 
cleavage site. Expression of tryptase Clara is restricted to the upper respiratory tract, so HA 
cleavage and subsequently viral replication is normally limited to the respiratory tract (Sakai et 
al. 1993). However, furin is expressed ubiquitously meaning the acquisition of a multi-basic 
cleavage site facilitates expanded cellular tropism and systemic spread of the virus (Walker et 
al. 1994, Stieneke-Grober et al. 1992). Insertion of a multibasic cleavage site into subtype H3N2 
did not result in high pathogenicity in ferrets (Schrauwen et al. 2011), whereas insertion of a 
multibasic cleavage site in H1, H3, H10, H11 and H15 did not convert the low pathogenic 
influenza viruses to high pathogenic influenza viruses when investigated in chickens (Lee et al. 
2009b). This site is therefore not the sole reason for a high pathogenicity profile. Furthermore, 
the virulence of viruses containing a multi-basic cleavage site in HA varies among mammalian 
hosts; whereas the presence of a multibasic-site in A/Vietnam/1203/2004 was associated with 
increased pathogenicity in mice and ferrets, this phenotype was absent in nonhuman primates 
(Suguitan et al. 2012). 
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1.4.2 Receptor binding of HA 
Glycolipids and glycoproteins can be found on the surface of cells in the human body. The 
glycans linked to these structures can carry a specific monosaccharide on the outermost 
capping position; the sialic acid. These are bound by conserved amino-acids in a pocket on the 
globular head of HA; the receptor binding site (RBS). The base of the RBS is formed by tyrosine 
98 and the aromatic ring of tryptophan 153. Residues 134 to 138 (the 130-loop) form the right 
side of the RBS, whereas residues 224 to 228 (part of the 220 loop) form the left side of the 
RBS. Residues 155, 183, 190 and 194 form the rear of the RBS and of these, 190 and 194 are 
part of the 190 loop (Weis et al. 1988) (Figure 1.3b).  
Upon receptor binding, one side of the pyranose ring found in sialic acid faces the base of the 
RBS, and the axial carboxylate, acetamido nitrogen and the 8- and 9-hydroxyl groups face into 
the RBS and form hydrogen bonds. Residues directly involved in receptor binding are 98, 135, 
136, 137, 153, 183, 190 and 194 (Skehel and Wiley 2000) (Figure 1.3c).  
Sialic acid can be linked to galactose at either the carbon-3 or carbon-6 position forming an 
α2,3-linked or α2,6-linked sialic acid respectively (Figure 1.4). The specificity of HA to either of 
these sialic acids forms a governing factor in cell tropism and consequently host specificity. 
Early binding studies with de-sialylated human red blood cells that had been re-sialylated using 
sialyltransferases specific for either α2,3-linked or α2,6-linked sialic acids showed human H3 
influenza viruses have a preference for α2,6-linked sialic acid, whereas avian H3 influenza 
viruses bound α2,3-linked sialic acid (Rogers and Paulson 1983). This preference seems to 
correlate with the expression of sialic acids at the initial site of infection; α2,3-linked sialic acid is 
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Figure 1.4 Two different linkages of sialic acid to galactose 
Sialic acids can be linked to the adjacent sugars via either a) carbon-3 (2,3-linked sialic acid) 
or b) carbon-6 (2,6-linked sialic acid). 2,3-linked sialic acid is commonly used as a receptor 
by avian influenza viruses, whereas 2,6-linked sialic acid is the human influenza virus 
receptor. The α-ketosidic linkage between sialic acid and galactose cleaved by NA is depicted in 
panel a. Image adapted from textbook „Principles of Virology‟ Chapter 5 „Attachment and Entry‟. 
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found abundantly in the avian gut, while α2,6-linked sialic acid is expressed at the apical surface 
of the human airway epithelia (Shinya et al. 2006, van Riel et al. 2010). Furthermore, mucins in 
the sialylated secretions of the human upper respiratory tract, which are important in the initial 
defence against influenza virus, contain mostly α2,3-linked sialic acid (Couceiro, Paulson and 
Baum 1993).  
In 1918, an H1N1 virus caused the first well-documented influenza pandemic of the 20th 
century. Two mutations in the receptor binding site (RBS) of the H1 HA are thought to have 
played a vital role in enabling the transition from birds to man; residue 190 changed to D from E 
which is commonly found in bird viruses, and residue 225 changed to D from G. These residues 
significantly affect the sialic acid preference of the H1 HA protein; human-like D at position 190 
allows for stabilization of the human HA-α2,6 sialic acid receptor interaction (Gamblin et al. 
2004) for which avian-like E is too large (Glaser et al. 2005), whereas avian-like G at position 
225 narrows the receptor binding pocket, which will then not fit α2,6-linked sialic acid (Tse et al. 
2011). Both humanizing changes were experimentally shown to be required for efficient virus 
transmission between ferrets (Tumpey et al. 2007). Similarly, for the influenza A (H3N2) 
subtype, whose HA gene was introduced from an avian source to cause a pandemic in 1968, 
two other residue changes in the HA RBS have been linked to sialic acid preference and 
transmissibility; namely Q226L and G228S (Matrosovich et al. 2000, Vines et al. 1998, Rogers 
et al. 1983, Martin et al. 1998, Roberts et al. 2011, Connor et al. 1994). Changing receptor-
binding preference is thought to be critical in the initiation of a pandemic when the virus 
originates from a non-human host. 
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1.4.3 Membrane fusion mediated by HA 
Upon receptor binding, the influenza virus particle is taken into the host cell by endocytosis and 
exposed to a low pH (pH 5-6) environment. This leads to an irreversible conformational change 
within the HA protein, exposing the fusion peptide and relocating it about 10 nm closer to the 
plasma membrane of the host cell (Bullough et al. 1994). Electron microscopy studies have 
shown that HA2 can be bound to the virion membrane via the N- and C-termini in the absence 
of a target membrane (Wharton et al. 1995). It is therefore hypothesised that during viral entry 
HA2 stays anchored in the viral membrane via its transmembrane domain and is inserted in the 
target membrane via its fusion protein. Subsequent structural rearrangements control the fusion 
of both membranes, revealing the inner virus to the cytoplasm and, in combination with 
acidification of the viral core by ion channel M2, resulting in the transfer of genetic material into 
the host cell (Weissenhorn et al. 1997, Hughson 1997).  
 
1.4.4 Response of the immune system to HA 
The third important role HA plays in the viral life cycle is as the major surface antigenic protein. 
Due to the prominence of HA on the virion‟s surface, neutralising antibodies against HA are 
commonly found in individuals following influenza infection. Five antigenic sites have been 
located on the HA protein of influenza. Three of these sites (A, B and D) are located on the 
globular head, in near proximity to the RBS. A fourth antigenic site (site C) is located 60 Å from 
the distal tip, whereas the location of the fifth antigenic site (site E) is on the lower part of the 
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globular head (Wiley, Wilson and Skehel 1981). Neutralisation of virus infectivity via antibodies 
occurs either due to direct binding to amino acids in the RBS thereby preventing sialic acid 
binding (Bizebard et al. 1995) or binding close to the RBS, preventing receptor binding indirectly 
through steric hindrance by the antibody (Fleury et al. 1999). Antigenic drift, which occurs in 
clusters (Smith et al. 2004), is driven by these neutralising antibodies. Mutations within the 
globular head of HA can directly prevent antibody-binding (Knossow et al. 1984), or can 
introduce a glycosylation site which shields the antigenic site from the antibody (Skehel et al. 
1984). It has recently been proposed that receptor avidity and escape from antibodies are 
correlated. Using lab-adapted A/Puerto Rico/8/1934 (PR8)-immunised mice, PR8 was serially 
passaged and sequenced for antibody escape mutants. Interestingly, the resulting mutant 
viruses were able to escape antibody responses in assays in which virus, cells and antibody 
were used, but the binding of antibody to HA was not altered, suggesting a role for increased 
receptor binding in the evasion of antibody interference. Continued passage in naïve mice led to 
mutant viruses with decreased receptor binding avidity and consequently decreased antibody 
escape. In this model, influenza infection in immune individuals specifically selects single point 
mutant viruses with increased receptor binding avidity and decreased antigenicity, whereas 
subsequent transmission to a non-immune individual selects mutants with decreased receptor 
binding avidity (Hensley et al. 2009) 
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Segment 
Length 
vRNA (nt) 
Length 
mRNA (nt) 
Encoded 
protein 
Length 
protein (aa) 
Molecular weight 
protein (kDa) 
Approximate 
number of 
molecules/virion 
1 2341 2320 PB2 759 85.7 30-60 
2 2341 2320 
PB1 757 86.5 30-60 
PB1-F2 87 13 ND 
PB1-N40 718 NK NK 
3 2233 2211 PA 716 84.2 30-60 
   PA-X 231-251
* 
29 NK 
4 1778 1757 HA 566 61.5 500 
5 1565 1540 NP 498 56.1 1000 
6 1413 1392 NA 454 50.1 100 
7 1027 
1005 M1 252 27.8 3000 
315 M2 97 11.0 20-60 
8 890 
868 NS1 230 26.8 ND 
395 NEP/NS2 121 14.2 130-200 
 
 
 
 
 
 
 
     
Table 1.1 Influenza A virus genome RNA segments and proteins 
Adapted from Fields Virology (Lamb and Krug 1995), based on influenza virus PR8 and Shaw 
et al. (Shaw et al. 2008), based on influenza virus A/WSN/33. NK = Not known, ND = Not 
detected, * Estimation based on (Oh et al. 2009). 
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1.5 The remaining twelve proteins of influenza A virus 
To date, thirteen proteins have been identified which are produced by influenza A virus, 
including structural proteins and immune evasion proteins. RNA segments two, three, seven 
and eight encode multiple proteins, using molecular mechanisms such as mRNA splicing and 
overlapping reading frames (Table 1.1). 
 
1.5.1 Influenza A virus RNA-dependent RNA polymerase 
The heterotrimeric RdRp found attached to every RNP in influenza A virus particles consist of 
PB1, PB2 and PA which have an aggregate molecular mass of 250 kDa. PB1 forms the core of 
the polymerase, PA is bound to PB1‟s N-terminal region via its C-terminal region and PB2 is 
bound to PB1‟s C-terminal region via its N-terminal region (He et al. 2008, Obayashi et al. 
2008). The influenza RdRp does not have proofreading activity and the resulting high mutation 
rate of approximately one error per replicated genome (Drake 1993) plays an important role in 
the continual evolutionary changes observed in influenza virus including adaptation to new 
hosts, evasion of the host immune response and development of antiviral resistance.   
 
1.5.2 Basic polymerase protein 2  
PB2 is encoded on RNA segment 1 of influenza A virus, and forms the polymerase complex 
together with PB1 and PA. The main function of PB2 is so-called “cap-snatching” of host pre-
mRNA, a prerequisite of mRNA transcription (reviewed in (Fechter and Brownlee 2005)). This 
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process can be divided into three different steps. First the RdRp binds to the virion RNA 
promoter formed by the double-stranded RNA panhandle structures produced by circularization 
of the 5‟ and 3‟ ends of vRNA (Flick et al. 1996), followed by binding of the PB2 subunit to the 
cap structure of host mRNAs (Blaas et al. 1982), which is then cleaved off at 10-13 nucleotides 
downstream from the cap structure by endonuclease activity of the PA (Dias et al. 2009).  
PB2 has no significant homology to other proteins and cannot be expressed in a soluble state. 
Therefore, no structural basis for the function of PB2 could initially be investigated. Following 
the development of ESPRIT (Expression of Soluble Proteins by Random Incremental 
Truncation), an automated, library-based method for mapping and soluble expression of protein 
domains from challenging targets, a soluble region within the PB2 protein was identified 
spanning amino acids 241-483 (Guilligay et al. 2008) and including residues 363F and 404F, 
which had been found to be crucial in the cap-binding function of PB2 in earlier research 
(Fechter et al. 2003). Using m7GTP-Sepharose as a replacement of the 5‟ mRNA cap, intrinsic 
cap-binding activity of this peptide was confirmed. Most of the amino acids in contact with 
m7GTP are completely conserved in all influenza strains and point mutations diminish cap-
dependent transcription (Guilligay et al. 2008).  
A second soluble C-terminal domain (amino acids 678-759) of PB2 identified using ESPRIT 
contained a nuclear localization signal (NLS) (736KRKR12KRIR
755, previously thought to be 
monopartite (Mukaigawa and Nayak 1991)) and was found to form a complex with importin α 
(Tarendeau et al. 2007). Previous research on RdRp had already shown that the individual 
polymerase subunits are translated in the cytoplasm, followed by importation into the nucleus to 
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assemble the heterotrimeric polymerase (Smith et al. 1987, Jones, Reay and Philpott 1986, 
Akkina et al. 1987). Importin α is involved in the importation of proteins into the cell nucleus 
(Imamoto et al. 1995) by recognizing and binding the NLS on a cargo protein (Weis, Mattaj and 
Lamond 1995) followed by binding of importin β which subsequently binds to the fibrils of the 
nuclear pore complex and translocates the cargo protein-importin complex (Bayliss, Littlewood 
and Stewart 2000).  
As importin α plays such an important role in the viral life cycle, improving PB2 binding of 
importin α could be an important host adaptation mechanism. In non-influenza related research, 
a correlation has been found between the affinity of proteins for importin α and the import rate 
into the nucleus (Hodel et al. 2006, Hu and Jans 1999). Moreover, in studies using TAP-tagged 
PB2 pull-downs, PB2 proteins of avian influenza origin showed decreased binding to human 
importin α compared to those from human influenza (Resa-Infante et al. 2008), suggesting 
transport of avian-origin PB2 into the nucleus would be decreased in human cells. Furthermore, 
increased binding of mammalian importin α and PB2 was found in a mouse-adapted avian 
H7N7 influenza virus. This adaptation was associated with the D701N mutation in PB2 (Gabriel, 
Herwig and Klenk 2008). Interestingly, it has been observed that in H5N1 viruses isolated from 
infected humans, eleven out of twelve PB2 sequences either contained the D701N mutation, or 
the more studied host-specific PB2 mutation E627K (de Jong et al. 2006), suggesting that the 
presence of either mutation can overcome the avian-mammalian host range restriction. Residue 
627 is located between the cap-binding region and NLS domain and a humanizing mutation at 
this position results in a basic surface patch (Tarendeau et al. 2008), possibly modulating 
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interplay between PB2 and host factors. Indeed, humanizing 627K was also associated with 
increased recruitment of importin α (Hudjetz and Gabriel 2012). However none of these studies 
exclude the role of host factors other than importin α in host adaptation, and research is ongoing 
on this subject.  
 
1.5.3 Basic polymerase protein 1  
PB1 is encoded on RNA segment 2 and forms the core of the polymerase complex, where it is 
found between PB2 and PA (He et al. 2008, Obayashi et al. 2008). Its main function is the 
elongation of RNA (Braam, Ulmanen and Krug 1983) using the SDD amino acid sequence 
located in a conserved motif (motif III) of PB1 (Biswas and Nayak 1994).  
 
1.5.4 Acidic polymerase protein  
PA is the third subunit of the influenza polymerase and is encoded on RNA segment 3. The 
exact role of PA remains unclear, but the protein plays an essential role in endonuclease 
cleavage of host mRNA caps necessary for mRNA synthesis initiation (Fodor et al. 2002, Hara 
et al. 2006, Dias et al. 2009), vRNA synthesis (Kawaguchi, Naito and Nagata 2005) and cRNA 
synthesis (Huarte et al. 2003), packaging of RNA segments (Liang et al. 2012, Regan, Liang 
and Parslow 2006) as well as promoter binding (Kashiwagi et al. 2009). Single mutations in this 
protein can promote the production of defective interfering RNAs, possibly linked to 
destabilisation of the RNA-polymerase complex (Fodor et al. 2003). PA also has proteolytic 
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activity, of which the function in the influenza life cycle is not yet fully understood (Hara et al. 
2001, Perales et al. 2000, Rodriguez, Perez-Gonzalez and Nieto 2007). 
 
1.5.5 Nucleoprotein 
NP is encoded on RNA segment 5 and is the most abundant protein in the RNPs, where it 
encapsidates vRNA by binding along the entire length of the RNA strand at a 24 nucleotide 
interval (Ortega et al. 2000) and interacts with both PB1 and PB2 (Biswas, Boutz and Nayak 
1998). It is further implicated in intracellular trafficking of the viral genome (Digard et al. 1999, 
O'Neill et al. 1995, Wang, Palese and O'Neill 1997), viral RNA replication (reviewed in (Portela 
and Digard 2002)) and the viral switch from transcription to replication by stabilizing cRNA 
(Vreede, Jung and Brownlee 2004, Beaton and Krug 1986, Perez et al. 2010), although the 
polymerase complex might play a role as well (Vreede and Brownlee 2007). 
 
1.5.6 Neuraminidase  
NA is encoded on RNA segment 6 and acts as the receptor-destroying protein, in contrast to 
receptor-binding protein HA. The protein is expressed as a homotetramer on the surface of the 
viral particle and is regarded as the second major surface antigen. Nine different subtypes have 
been identified thus far, which are not serologically cross-reactive (Webster et al. 1992). NA‟s 
main function is cleavage of the α-ketosidic linkage between terminal sialic acid and an adjacent 
sugar residue (Figure 1.4a), using the catalytic site located in the head of the protein. This 
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cleavage activity helps to remove sialic acids linkages between the host cell and HA protein on 
the virus surface as well as virus:virus interactions. This function was elegantly demonstrated by 
infection of cells with neuraminidase-deficient virus (Liu et al. 1995), or using neuraminidase 
inhibitors (Palese and Compans 1976). In both studies, the virus was found to accumulate in 
clusters and chains on the cell surface.  
NA is further thought to be important in the initial infection of the human host. Sialic acids 
displayed on glycosylated mucins present in the mucosal layer in the respiratory tract are the 
first line of defence against influenza virus infection; these sugars capture the virus which is 
then transported out of the body using the mucociliary escalator. NA is thought to cleave these 
sialic acids, thereby creating a pathway through the mucosal layer towards the target respiratory 
cells (Matrosovich et al. 2004b). 
Because HA and NA have such contrasting roles in the viral life cycle but target the same host 
cell molecule, sialic acid, the ratio of expression on the viral surface and activity of the proteins 
needs to be well-balanced (reviewed in (Wagner, Matrosovich and Klenk 2002)). 
The NA enzyme active site is the target of the neuraminidase inhibitor (NAI) antiviral drugs of 
which oseltamivir and zanamivir are currently licensed (Sugrue et al. 2008). Oseltamivir 
resistance linked to the H275Y mutation in NA was found widely in H1N1 viruses isolated in the 
2007-2008 season, increasing to 56% of detected H1N1 influenza viruses in Europe by week 19 
of 2008 (Meijer et al. 2009).  
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1.5.7 Matrix protein  
M1 is one of two proteins encoded on RNA segment 7 and is the most abundant protein in the 
virus particle, produced in the late stages of infection. In the viral particle, M1 forms a coat 
underneath the viral envelope, providing rigidity to the membrane (Lamb and Krug 1995, 
Shishkov et al. 1999) and interacting with both viral RNPs and the cytoplasmic tails of HA and 
NA (Ali et al. 2000, Bui, Whittaker and Helenius 1996, Bui et al. 2000, Baudin et al. 2001, Martin 
and Helenius 1991a). Furthermore, M1 is crucial in viral budding and morphogenesis, as shown 
by infection of cells with influenza virus encoding a nuclear-retained M1 protein resulting in 
reduced particle formation (Whittaker, Kemler and Helenius 1995, Rey and Nayak 1992), 
influenza virus with low expression of M1 and M2 proteins which delays budding (Bourmakina 
and Garcia-Sastre 2005) and influenza virus with mutated M1 protein which significantly 
changes morphology (Burleigh et al. 2005, Elleman and Barclay 2004).  
 
1.5.8 Ion channel protein  
M2 is the second protein encoded on RNA segment 7, specifically derived by alternative 
splicing of mRNA (Lamb, Lai and Choppin 1981), and is the target of antiviral drug amantadine 
(Sugrue et al. 2008). M2 spans the entire viral membrane surface once. Its ion channel function 
was suggested based on its homotetrameric amphiphilic transmembrane region forming an 
alpha helix (Sugrue and Hay 1991) and confirmed by electophysiological experiments using 
oocytes of Xenopus laevis expressing M2 protein (Pinto, Holsinger and Lamb 1992). Finally, the 
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M2 protein has recently been found to play a crucial role in the pinching off of virions using its 
amphipathic helix (Rossman et al. 2010) 
 
1.5.9 Non-structural protein 1 (NS1) 
The non-structural protein 1 (NS1) is encoded on RNA segment 8 and plays an important role in 
the regulation of the immune response as well as cellular host functions. It does this via several 
different mechanisms; NS1 binds dsRNA, thereby preventing detection by pattern recognition 
sensors such as retinoic acid inducible gene I (RIG-I) within the host cell and subsequent 
activation of the dsRNA-dependent response which includes type I interferon production (Wang 
et al. 1999, Min and Krug 2006), NS1 suppresses the RNA silencing-based antiviral response 
(Li et al. 2004), NS1 blocks Protein Kinase R (PKR) activation, a component of the cellular 
antiviral system activated by binding to dsRNA (Li et al. 2006a), NS1 blocks nuclear export of 
poly(A)-containing mRNAs, most likely to allow cap-snatching by PB2 (Qiu and Krug 1994), NS1 
inhibits pre-mRNA splicing of host mRNAs, but not viral NS1 mRNA (Lu, Qian and Krug 1994) 
and finally NS1 activates phosphatidylinositol-3-kinase (PI3K), resulting in enhanced viral 
replication via an as yet unknown mechanism (Hale et al. 2006). 
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1.5.10 Nuclear Export Protein 
NEP (or NS2) is the second protein encoded on RNA segment 8 and is derived from the 
alternative splicing of mRNA. As its name implies, this protein is of importance in the export of 
viral RNPs from the nucleus to the cytoplasm by interaction with cellular nucleoporins (O'Neill, 
Talon and Palese 1998). NEP is also involved in viral assembly through its interaction with the 
M1 protein (O'Neill et al. 1998) and has been implicated in maintaining the balance between 
transcription and replication products of the viral genome independent of its export function 
(Robb et al. 2009). Lastly, NEP has been associated with adaptation of H5 to the human host 
by increasing polymerase activity (Manz et al. 2012).  
 
1.5.11 PB1-F2 
PB1-F2 is a non-essential protein encoded by an alternative open reading frame (+1) on RNA 
segment 2, which was identified serendipitously while searching for CD8+ T-cell reactive 
epitopes (Chen et al. 2001). PB1-F2 is found in the mitochondria, nucleus and cytoplasm and is 
thought to induce apoptosis (Chen et al. 2001, Gibbs et al. 2003, Zamarin et al. 2005). 
Furthermore, this protein has been linked to enhancement of secondary bacterial infection, 
resulting in increased pathogenesis in a mouse model (McAuley et al. 2007) as well as IFN 
suppression (Conenello et al. 2011). However, the importance of PB1-F2 remains controversial 
as not all influenza strains express full-length PB1-F2 (Zell et al. 2007). Furthermore, restoration 
of full-length PB1-F2 in A(H1N1)pdm09 virus does not influence pathogenicity in a ferret or 
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mouse model (Hai et al. 2010) and only moderately enhances pathogenicity in pigs (Pena et al. 
2012). The introduction of 1918 H1N1 PB1-F2 in previous seasonal H1N1 influenza viruses 
delayed proinflammatory responses, but did not cause a difference in pathogenicity in ferrets 
compared to previous wild type seasonal H1N1 (Meunier and von Messling 2012). 
 
1.5.12 PB1-N40  
PB1-N40 is a recently discovered protein expressed during influenza infection, and is encoded 
on RNA segment 2 using start codon 5 in the same open reading frame as PB1, resulting in an 
identical protein except for the lack of the first 39 amino acids (Wise et al. 2009). This truncation 
results in a loss of the primary interaction site with PA, and PB1-N40 is insufficient for influenza 
virus replication (Wise et al. 2009). Due to the recent discovery of PB1-N40, its function remains 
unclear.  
 
1.5.13 PA-X 
The PA-X protein discovery was published in June 2012. PA-X is encoded on RNA segment 3 
and is produced via ribosomal frameshifting at codon 190 due to the presence of motif UCC 
UUU CGU C. This protein contains the N-terminal endonuclease domain of the PA protein with 
a short C-terminal encoded by the +1 ORF. Although limited information is available on the 
function of this protein, a role in the modulation of host-gene expression and host-cell shutoff is 
implicated. PA-X is not required for viral replication (Oh et al. 2009). 
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1.6 Infection and disease in the human host 
Influenza is a serious public health problem affecting 5-15% of the population annually. 
Epidemics are documented practically every year, although severity and extent may vary widely. 
Human-to-human transmission of influenza occurs via the respiratory route. Patients infected 
with influenza virus display a variety of symptoms, often including fever, a sore throat and 
aching muscles but may also be asymptomatic. Annually, influenza virus infections cause 
approximately 3-5 million cases of severe illness and 250,000-500,000 deaths worldwide, 
particularly in higher risk populations including the very young (<5 years), elderly (>65 years) 
and chronically ill patients (WHO Accessed 26-01-2012). Increased severity of disease is often 
associated with pneumonia; either primary viral pneumonia or secondary bacterial pneumonia. 
Secondary bacterial infection is hypothesized to be caused by a change in the indigenous 
microbiota in the upper respiratory tract (URT) as well as an altered immune state during or 
after infection (Snelgrove, Godlee and Hussell 2011, Goulding et al. 2011, Hussell and 
Cavanagh 2009, Ballinger and Standiford 2010, McAuley et al. 2007). Furthermore, NA could 
potentially expose receptors for pathogenic bacterial invaders whilst stripping the lungs of sialic 
acid (McCullers and Bartmess 2003). 
Influenza virus infections impose a substantial economic burden in the form of health care costs 
and lost productivity, estimated to be $87.1 billion yearly in the USA (Molinari et al. 2007). 
Besides annual epidemics, major antigenic changes in the virus can result in periodic, global 
pandemics due to a lack of herd immunity. Estimates put the direct medical costs of a pandemic 
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Figure 1.5 Reassortment of influenza virus 
When two influenza viruses infect one cell, reassortment of the genetic information can occur 
due to the segmented genome of the virus. This phenomenon is called antigenic shift. Image 
adapted from „Fields Virology‟, Chapter 48 „Orthomyxoviruses‟. 
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with an attack rate of 30% at €843 million in the Netherlands alone (Hak, Meijboom and 
Buskens 2006).  
Due to the prominent position of HA and NA on the virion surface (80% and 20% of the viral 
surface on average depending on virus strain (Lamb and Krug 1995)) these proteins constitute 
the major surface antigens of influenza virus. Accumulation of mutations in the viral genome is 
driven by the lack of proofreading of the RdRp which results in the generation of approximately 
one mutation per novel virion (Drake 1993). Mutations in the antigenic sites of HA and NA 
causing minor antigenic changes give significant advantage to viruses evading the host 
response. This process is called antigenic drift and elucidates the ability of influenza to re-infect 
the human host.  
Due to its segmented genome, influenza viruses are capable of a second form of evasion of the 
immune system via major antigenic changes; antigenic shift. This occurs when two different 
influenza viruses infect one cell and during replication exchange segments, thereby creating a 
novel genomic arrangement. For example, an avian HA protein not formerly encountered by the 
immune system of the human host combined with human-adapted internal proteins could form a 
virus capable of replication within the human host which is completely overlooked by the 
immune system. Such viruses are thought to be particularly important in the emergence of 
influenza pandemics (Figure 1.5).  
Two examples of such reassortant viruses causing pandemics occurred in 1957 and 1968, 
when H2N2 and H3N2 respectively caused influenza pandemics. The influenza pandemic 
caused by H2N2 in 1957 is known as the „Asian flu‟ and this virus resulted from a reassortment 
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event between circulating human H1N1 and avian H2N2 viruses. The pandemic virus obtained 
HA, NA and PB1 gene segments from the avian H2N2 virus, while the remaining five segments 
were of human H1N1 origin (Lindstrom, Cox and Klimov 2004, Kawaoka, Krauss and Webster 
1989). The so-called „Hong Kong flu‟, was caused by H3N2 in 1968. As with H2N2, this virus 
arose after reassortment of a circulating human H2N2 virus with an avian H3N2 virus, obtaining 
both HA and PB1 from the avian virus (Lindstrom et al. 2004, Fang et al. 1981, Kawaoka et al. 
1989). The new pandemic virus H3N2 replaced H2N2 as the circulating human seasonal 
influenza strain. 
Not all pandemic viruses are generated via antigenic shift. The most severe influenza pandemic 
in recent documented human history is known as „Spanish flu‟ and claimed the lives of 
approximately 20 to 50 million people in 1918. The general consensus is that this virus, 1918 
H1N1, was entirely of avian origin and changed its receptor binding abilities in order to infect the 
human host and cause human-to-human transmission (Taubenberger et al. 2005, Reid, 
Taubenberger and Fanning 2004). However, recent research has suggested that 1918 H1N1 
was not directly introduced in the human host, but was in fact also a reassortment virus (Smith 
et al. 2009a). If this is indeed the case, then all influenza pandemics in the 20th and 21st century 
were preceded by reassortment of influenza virus.  
1918 H1N1 circulated in the human population until 1957, when it was displaced by H2N2. 
Interestingly, H1N1 was re-introduced into the human population in 1977. This „novel‟ virus was 
genetically identical to the H1N1 virus circulating in 1950 (Nakajima, Desselberger and Palese 
1978). Three possible places for this virus to hide have been suggested; the animal host, the 
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human genome or a frozen source. As no antigenic drift was present in the virus compared to 
isolates from 1950 (Nakajima et al. 1978), and no documented cases of integration of the 
influenza genome in the human genome exist, this reintroduction presumably originates from a 
frozen source. Due to existing immunity in the older population, disease was mainly found in 
younger subjects (Zimmer and Burke 2009). This virus co-circulated with H3N2 until recently, 
when it was replaced by A(H1N1)pdm09. 
Based on the ability of influenza viruses to reassort and the constant detection of influenza virus 
in the avian host, the emergence of another pandemic influenza virus has never been in 
question for most virologists. As such, the more pressing questions were when and where the 
next pandemic virus would arise. In preparation for such an event, the World Health 
Organization (WHO) established the Global Influenza Surveillance and Response System 
(GISRS) in 1952, which is responsible for worldwide surveillance of the human population for 
influenza viruses. Currently, there are 136 National Influenza Centres (NICs) members of 
GISRS located in 107 WHO Member States and these process >1,000,000 samples per year 
(WHO 2012). Another influenza surveillance initiative, overseen by the European Centre for 
Disease Prevention and Control (ECDC), gathers influenza surveillance information from 
European Union (EU) countries. The foundation of these global and regional surveillance 
initiatives are the national influenza surveillance programs which exist all over the world. For 
example, in the UK a virological surveillance scheme is in place that collects and tests samples 
from patients presenting with influenza-like illness (ILI) at one of 100 participating GP Surgeries 
(Fleming et al. 1995). This scheme allows for the rapid detection and monitoring of influenza 
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activity within the community as well as providing both genetic and antigenic information on 
circulating strains within the UK population. 
Surveillance of influenza in the human host resulted in early detection of the first pandemic of 
the 21st century which was caused by an H1N1 virus, A(H1N1)pdm09. On April 21, 2009 the 
Centre for Disease Control and Prevention (CDC) reported two epidemiologically unrelated 
cases of swine-origin influenza infection in California following reports of increased influenza-
like illness in Mexico (CDC 2009). In the following weeks this virus spread globally, causing the 
WHO to declare a pandemic on June 11, 2009. By the time the pandemic had passed in August 
2010, two pandemic waves had been documented in the Northern hemisphere and the virus 
had spread to more than 214 countries, causing over 18,000 confirmed influenza-related deaths 
(WHO 2010). A(H1N1)pdm09 vaccines were not available until October 2009, six months after 
the first cases were reported, and none of the methods undertaken to try and quarantine the 
virus were successful; A(H1N1)pdm09 reached the UK on April 27 2009, only six days after the 
first case report by CDC.  
A(H1N1)pdm09 originates from a swine source and contains a unique gene constellation; the 
NA and M genes originate from Eurasian swine influenza, all other genes originate from triple 
reassortant swine influenza, a virus circulating in the American swine population since 1998 and 
itself containing PB2 and PA from an avian influenza virus, PB1 from a human influenza virus 
and HA, NP, NA, M and NS from classical swine influenza (Vincent et al. 2006, Zhou et al. 
2000). A(H1N1)pdm2009 closest relatives were isolated on average 10 years ago, indicating 
that the virus or a precursor of it had been circulating within the swine population undetected for  
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a prolonged time (Garten et al. 2009). This finding highlights the necessity of surveillance not 
only in the human host but also in the avian and swine population, which has been undertaken 
by the World Organisation for Animal Health (OIE) and the Food and Agriculture Organization 
(FAO). Unfortunately, surveillance in the swine host lags behind surveillance levels in the avian 
host; only 902 full-length HA sequences were deposited in the NCBI Influenza Virus Resource 
Database before April 27, 2009 of which only 742 sequences were unique. However, such 
surveillance is predicted to be an immense undertaking.  
Currently, A(H1N1)pdm09 is co-circulating with H3N2 in the human population; the 2010-2011 
influenza season in the UK was dominated by A(H1N1)pdm09 but during the 2011-2012 
influenza season (with notably low influenza activity) H3N2 has been the dominant virus. The 
majority of the human population has most likely been infected with and produced antibodies 
against A(H1N1)pdm09 (Miller et al. 2010). This brings us back to the central question; when 
and where will the next influenza pandemic arise? 
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1.7 The human pandemic threat from zoonotic influenza viruses 
As explained in section 1.6, previous pandemics were caused by influenza viruses with genes 
originating from avian (1918 H1N1, H2N2 and H3N2) or swine hosts (A(H1N1)pdm09), either 
directly or via reassortment events.  
A large number and variety of different influenza viruses can be found in the avian host (Asplin 
1970, Easterday et al. 1968, Dasen and Laver 1970, Winkler, Trainer and Easterday 1972, 
Downie and Laver 1973, Slemons et al. 1974, Stallknecht and Shane 1988) with aquatic birds 
(the Anseriformes (ducks, geese and swans) and Charadriiformes (gulls, terns and waders)) 
regarded as the primary natural reservoir of influenza virus  (Krauss and Webster 2010, Gorman 
et al. 1991, Gorman et al. 1990a, Gorman et al. 1990b, Okazaki, Kawaoka and Webster 1989, 
Schafer et al. 1993, Kawaoka et al. 1989). Infection and replication of influenza virus takes 
place in the intestinal tract of the avian host and is usually asymptomatic. Transmission of 
influenza virus between birds most likely occurs via water; the virus remains infective in lakes 
for days to weeks depending on water temperature, salinity, pH and viral strain (Stallknecht et 
al. 1990a, Stallknecht et al. 1990b). Migrational behaviour of aquatic birds inadvertently leads to 
extensive spread of influenza virus, which is for example observed in a specific clade of H5N1, 
that has travelled to Europe from Asia via migrational routes (Kilpatrick et al. 2006).  
The first influenza virus isolate was obtained from a swine host in 1931 by Richard Shope, who 
made the pioneering observation that pigs suffered very similar symptoms to humans during the 
Spanish flu in 1918 (Shope 1931). Indeed, 1918 H1N1 was widespread in swine herds then and 
pigs have been known to be infected by both human and avian influenza (reviewed in (Van 
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Reeth 2007)). Due to this ability, the swine host has traditionally been regarded as a potential 
mixing vessel for the generation of novel reassortant influenza viruses.  
History teaches us that both swine and avian hosts have the potential to produce a pandemic 
influenza virus. However, overcoming the species barrier is not straight forward and evolving to 
become a pandemic influenza virus involves much more than just jumping from one host to 
another. Several different factors can play a fundamental role; the virus will need to be able to 
infect appropriate cells in the URT; the initial infection must be followed by replication within the 
cell; replication within the host must lead to a high viral load; virus must be released from the 
host cell; released virus must be found as single particles, and not aggregates; and a high 
amount of virus must be released (Sorrell et al. 2011). This is not an exhaustive list of pandemic 
viral determinants, and several other unknown factors may have a significant role as well, which 
only underlines the complexity of the formation of a new pandemic influenza virus. Nonetheless, 
influenza pandemics occur every few decades and research on these different factors is 
paramount to provide a better understand and possibly prevention of influenza pandemics.  
 
1.7.1 Cell tropism 
A noted difference between avian and human influenza viruses is the receptor binding 
preference, which has been discussed in section 1.4.; avian influenza virus have a higher 
affinity for α2,3-linked sialic acid, which is found abundantly in the avian gut, whereas human 
influenza viruses preferentially bind to α2,6-linked sialic acid which is found in the human URT. 
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α2,3-linked sialic acid is also found in the human lower respiratory tract (LRT) and consequently 
avian viruses can infect the human lungs, but infection of the URT is limited and therefore 
sustained human-to-human transmission does not occur (CDC 1997, Fouchier et al. 2004). It is 
generally assumed that avian influenza virus needs to change its receptor binding preference to 
α2,6-linked sialic acid and decrease its binding to α2,3-linked sialic acid before it can infect the 
appropriate cells in the human URT and obtain pandemic potential. Most likely, this receptor 
binding preference change is more complex than just switching from α2,3-linked sialic acid to 
α2,6-linked sialic acid but involves binding to specific α2,6-linked sialic acids such as longer 
branched and umbrella-like structures, which have been found to be selectively bound by 
human influenza virus (Chandrasekaran et al. 2008).  
Specific mutations in the HA protein have been linked to a change in receptor binding 
preference in earlier pandemic viruses, as discussed in section 1.4. In H2 and H3 influenza 
virus, residues 226 and 228 play an important role, whereas in H1 influenza viruses, residues 
190 and 225 are particularly important. These and other mutations, whether found in natural 
isolates or engineered, in the HA of H5, H7 and H9 avian influenza viruses as researched 
previously, have been linked with a change in receptor binding and thus cell tropism (Ayora-
Talavera et al. 2009, Stevens et al. 2008, Auewarakul et al. 2007, Watanabe et al. 2011, Yang 
et al. 2010, Wan and Perez 2007). However, these changes on their own have not yet led to 
aerosol transmission in the ferret model, a necessary feature of a pandemic influenza virus 
(Chen et al. 2012, Belser et al. 2008, Wan et al. 2008). Therefore these mutations are probably 
necessary, but not sufficient for the establishment of a new pandemic virus. Recent research by 
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Imai et al. conferring aerosol transmission to a reassortant virus containing the HA of H5N1 and 
all other genes of A(H1N1)pdm09 suggests that in addition to receptor binding preference 
changes, the stability of the HA protein in response to pH and heat via mutations in the stalk 
region is also important (Imai et al. 2012).  
 
1.7.2 Replication leading to high viral yields 
Following viral entry into cells of the human URT, replication of the viral genome needs to result 
in viral yields high enough to cause transmission between humans. Adaption-mediating 
mutations in the PB2 gene have been particularly well studied, and have been discussed to 
some extent in section 1.5.2. For example, humanizing mutation D701N in H5N1 was found to 
be a prerequisite of direct contact transmission within a guinea pig model (Gao et al. 2009) and 
avianising mutation K627E was associated with a decrease in transmission efficiency of H5N1 
and H3N2 in a direct contact model of guinea pigs (Steel et al. 2009). These mutations are 
thought to increase the transmission potential of an influenza virus by increasing polymerase 
activity at 32-33°C, the temperature of the human URT (Massin, van der Werf and Naffakh 
2001), ensuring large numbers of released progeny virus are present in aerosols excreted from 
the nose and mouth upon breathing, sneezing and coughing.  
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1.7.3 Release of single particles, not aggregates from the host cell 
It has long been recognized that the balance between HA and NA in respect to receptor binding 
and release is important in viral fitness. A good balance allows viral release from the host cell by 
cleavage of sialic acid by NA (Palese and Compans 1976, Liu et al. 1995), but is also very 
important in the release of single virus particles. HA does not differentiate between sialic acids 
on the host cell and sialic acids on the glycoproteins of influenza virus. Therefore, upon release 
of the virus from the host cell, HA binds to other virions and viral aggregates are formed. 
Cleavage by NA disrupts these interactions and single viral particles instead of viral aggregates 
are released (Rudneva et al. 1993). One study showed that replacing the NA of swine H1N1 
with the NA of a recent A(H1N1)pdm09 with increased relative activity led to the production of 
single particles in MDCK cells, and consequently this virus showed an increase in respiratory 
droplet (RD) transmission in the ferret model (3/3) compared to the wild type (1/3) (Yen et al. 
2011b). Another study showed that the increased activity of NA in A(H1N1)pdm09 was 
correlated with a consistent release of influenza particles in the air – a factor that will 
undoubtedly affect aerosol transmission (Lakdawala et al. 2011).  
 
1.7.4 Release of high viral titres 
Finally, high titres of virus should be released, increasing the chance some of the virions will 
reach the next susceptible host. Evidence for a potential role for the M gene in the release of 
high viral titres can be found in some recent publication studying A(H1N1)pdm09. Chou et al. 
69 
 
investigated transmission of influenza in guinea pigs after infection with reassortant viruses 
containing the NA and M gene of A(H1N1)pdm09 and internal genes of either a swine origin H1 
virus or PR8. It was consistently found that inclusion of the NA gene, but predominantly the M 
gene resulted in an increased viral titre in nasal wash samples obtained from inoculated guinea 
pigs, and consequently an increase in infected sentinels (Chou et al. 2011). Likewise, Yen et al. 
found an increased viral titre in human airway epithelium culture infected with influenza viruses 
containing the Eurasian M gene like A(H1N1)pdm09, compared to those infected with swine 
origin influenza virus without the Eurasian M gene (Yen et al. 2011b). This research suggests a 
role for the M gene in release of virus into the mucus. 
 
1.7.5 Concluding remarks and aims 
The adaptations discussed above may not be the only changes sufficient to cause the next 
pandemic, and changes in any of the other proteins could potentially play an important role as 
well. Other factors such as induction of sneezing and coughing, length of viral shedding and the 
level of immune response could significantly change the outcome. For example, recent research 
correlates the timing of expression of pro-inflammatory molecules in the URT to the point in 
infection when transmission and peak virus shedding occur (Maines et al. 2012). To better 
understand the factors important for transmission, further research is necessary and currently in 
progress, potentially using improved models. Influenza research is currently performed on 
several different models; in vivo, ex vivo and in vitro models are in use. However, no model is 
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perfect and as such there is a constant search for better models. An intriguing example is the 
high-technical solution of using the „lung-on-a-chip‟ model, which has the advantages of using 
highly differentiated cells seeded on an air-liquid interface in a system that mimics the complex 
mechanical and biochemical behaviours of a human lung (Huh et al. 2010). One chapter in this 
thesis will look at the possibility of using a whole porcine lung, which would also have the 
advantage of highly differentiated cells, mechanical and biochemical behaviour of the porcine 
lung, but on top of that the complex 3D structure of the respiratory tract system. 
Here, we try to address some of the questions posed above using pandemic influenza viruses 
and viruses with pandemic potential, tested in different models of infection and transmission; 
 What are the molecular changes in the HA of A(H1N1)pdm09 that explain why this virus 
transmits between humans, whereas earlier swine-origin human isolates do not? 
 Are there any molecular differences between a human and an avian isolate of H7, and 
do differences exist between the human isolates obtained from different anatomical sites 
(the eye and throat of a single patient), which explain the ability to jump species and the 
different infection sites respectively? 
 Can we infect whole porcine lungs with influenza virus and use this as a model of 
influenza virus infection? 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Cell lines 
Name Source Comments 
293T GlaxoSmithKline  
Human Embryonic Kidney 
cells expressing simian virus 
40 (SV40) large T antigen 
HAE 
Raymond Pickles, University of North Carolina 
or 
Epithelix Sàrl 
Primary differentiated human 
airway epithelium cultured at 
air-liquid interface 
IOBA-NHC Virginia Calder, University College London 
Normal human conjunctival 
cell line 
MDCK 
WHO-Collaborating Centre for Reference and 
Research on Influenza, National Institute for 
Medical Research, Mill Hill (Health Protection 
Agency Microbiology Services (HPA MS)) 
or  
GlaxoSmithKline (Imperial College (IC)) 
Madin Darby Canine Kidney 
cell line 
MDCK-
SIAT1 
Mikhail Matrosovich, Philips University Marburg 
MDCK cells expressing 
increased levels of α2,6-linked 
sialic acid (Matrosovich et al. 
2003) 
SF9 Invitrogen 
Spodoptera frugiperda (Fall 
armyworm) cells 
   
Table 2.1 Cell lines used in this project 
 
72 
 
2.1.2 Virus strains 
Name Abbreviation Source Subtype RG* Comments 
A/England/195/09 E195 IC A(H1N1)pdm09 Yes First fully sequenced UK A(H1N1)pdm09 virus 
A/England/195/09 E195c HPA MS A(H1N1)pdm09 No Clinical isolate 
A/England/195/09 E227A E195 E227A This project A(H1N1)pdm09 Yes Mutation in HA protein at position 227 
A/England/195/09 D225G E195 D225G This project A(H1N1)pdm09 Yes Mutation in HA protein at position 225 
A/England/331/10 E331 HPA MS A(H1N1)pdm09 No 
Isolated in December 2010 (third wave of 
A(H1N1)pdm09 pandemic) 
A/England/480/06 E480  HPA MS  H7N3 No Isolated from throat patient  
A/England/481/06 E481  HPA MS H7N3 No Isolated from eye patient  
A/Mallard/Sweden/105/02 M105  HPA MS H7N7 No Isolated from Mallard  
A/Ohio/01/07 Ohio01 This project 
Swine-origin 
H1N1 
Yes 
HA gene: Ohio01 
All other genes: E195 
A/Ohio/01/07 A227E Ohio01 A227E This project 
Swine-origin 
H1N1 
Yes 
Mutation in HA gene at position 227 
HA gene: Ohio01 
All other genes: E195 
      
Table 2.2 Viruses used in this project 
  *RG: Rescued by reverse genetics using 12-plasmid transfection 
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2.1.3 Recombinant proteins 
Name Gene Origin Tags Source Expression model Comments 
E195 HA A/England/195/09 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 insect cells 
 
E195 E227A HA A/England/195/09 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 
Mutated at position 227 
E480 HA A/England/480/06 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 
 
M105 HA A/Mallard/Sweden/105/02 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 
 
Ohio01 HA A/Ohio/01/07 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 
 
Ohio01 A227E HA A/Ohio/01/07 
His  
Human Fc 
This project 
Baculovirus expression 
in SF9 
Mutated at position 227 
       
Table 2.3 Recombinant proteins used in this project 
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2.1.4 Oligonucleotides 
Name Sequence Purpose Designer 
ND-H1swHA-
BAC1-F 
GCG AAT GGC CAT TAT 
GGC CCC GAC ACA TTA 
TGT A 
Amplification of H1 HA  
for baculovirus expression 
This project 
ND-H1swHA-
BAC1-R 
GGA ATA GGC CGA GGC 
GGC CGT AAA TCC TTG 
TT 
Amplification of H1 HA  
for baculovirus expression 
This project 
A227EOhio_
F 
GGT GAG GGA CCA AGA 
AGG GAG AAT GAA C 
Mutagenesis A227E in Ohio01 This project 
A227EOhio_
R 
GTT CAT TCT CCC TTC 
TTG GTC CCT CAC C 
Mutagenesis A227E in Ohio01 This project 
E227AE195_
F 
CCC AAA GTG AGG GAT 
CAA GCA GGG AGA ATG 
AAC TAT TAC 
Mutagenesis E227A in EE195 This project 
E227AE195_
R 
GTA ATA GTT CAT TCT 
CCC TGC TTG ATC CCT 
CAC TTT GGG 
Mutagenesis E227A in E195 This project 
480COseq_F
1 
ATT ATG GCC CCG ACA 
AGA T 
Sequencing codon optimised E480 This project 
480COseq_F
2 
CTG GAA TTC TCC GCT 
GAC C 
Sequencing codon optimised E480 This project 
480COseq_F
3 
CAC CAT CAC CTT CAG 
CTT CA 
Sequencing codon optimised E480 This project 
480COseq_F
4 
ATC AAC TGG ACC CGT 
GAC TC 
Sequencing codon optimised E480 This project 
480COseq_
R1 
GTC TCG GTA GCG TTG 
ACC AC 
Sequencing codon optimised E480 This project 
480COseq_
R2 
TGG TGG ATA CCC CAG 
ATG AT 
Sequencing codon optimised E480 This project 
480COseq_
R3 
TCT GGT GAC GGA AAC 
CGT A 
Sequencing codon optimised E480 This project 
480COseq_
R4 
GTC CTT GTA ACC GGA 
GGA CA 
Sequencing codon optimised E480 This project 
ND_seqHAH
7_F1 
CAG GGG ATA CAA AAT 
GAA CAC 
Sequencing full-length HA of H7 This project 
ND_seqHAH
7_F3_rep 
AGT AAC TTG CCC TTT 
CAG A 
Sequencing full-length HA of H7 This project 
ND_seqHAH
7_R4 
GTG TTT ACT TTA GTC 
CCG TTT G 
Sequencing full-length HA of H7 This project 
Seq.Ohio_E1
95F1 
GCC TGC AGA GAG GAT 
CTC G 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95F2 
CGC AAA TGC MGA CAC 
ATT AT 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95F3 
GAA RGA AGT TCT CGT 
GCT ATG G  
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95F4 
GGC CAT TGC TGG YTT 
YAT T 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95F5 
GAT GGG GTA AAG YTG 
GAA TCA A 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
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Seq.Ohio_E1
95R1 
GTG TCC TTG GGT TGA 
CCA GA 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95R2 
TTY TTC ACA TTT GAG 
TCG TGG 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95R3 
TAG CAC CMT TGG GTG 
TCT G 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95R4 
ACA CTG AGC TCA AYT 
GCT CTC 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Seq.Ohio_E1
95R5 
GCT AAG GGA GAG CTC 
GAT CC 
Sequencing s-o H1N1 and A(H1N1)pdm09 This project 
Bm-PB2-1 
TAT TGG TCT CAG GGA 
GCR AAA GCA GGT C 
WGS H7 gene segment 1, PB2 
Hoffmann(
Hoffmann 
et al. 2001) 
HPB2R421 
GGC CAA AGG TTC CAT 
GTT TTA ACC 
WGS H7 gene segment 1, PB2 
RD(Baillie 
et al. 2012) 
HPB2H7F72
4 
GGG ACC TGC TGG GAA 
CAA ATG 
WGS H7 gene segment 1, PB2 This project 
HPB2R960 
GCA TAT RTC CAC AGC 
TTG TTC TTC 
WGS H7 gene segment 1, PB2 
RD(Baillie 
et al. 2012) 
HPB2R1459 
TCC TCT CAT TGA CAT 
CTC 
WGS H7 gene segment 1, PB2 
RD(Baillie 
et al. 2012) 
PB2-1105F 
TAY GAR GAR TT CAC 
AAT GGT 
WGS H7 gene segment 1, PB2 
RD(Baillie 
et al. 2012) 
HPB2F1441 
GAG ATG TCA ATG AGA 
GGA 
WGS H7 gene segment 1, PB2 
RD(Baillie 
et al. 2012) 
HPB2H7F19
07 
CTT GTG AGA GGC AAC 
TCC CC 
WGS H7 gene segment 1, PB2 This project 
Bm-PB2-
2341R 
ATA TGG TCT CGT ATT 
AGT AGA AAC AAG GTC 
GTT T 
WGS H7 gene segment 1, PB2 
Hoffmann(
Hoffmann 
et al. 2001) 
Bm-PB1-1 
TAT TGG TCT CAG GGA 
GCR AAA GCA GGC A 
WGS H7 gene segment 2, PB1 
Hoffmann(
Hoffmann 
et al. 2001) 
HPB1F370 
CAA ACA AGG GTG GAC 
AAA CT 
WGS H7 gene segment 2, PB1 
RD(Baillie 
et al. 2012) 
HPB1R389 
AGT TTG TCC ACC CTT 
GTT TG 
WGS H7 gene segment 2, PB1 
RD(Baillie 
et al. 2012) 
PB1-1123F 
CAR ATA CCN GCA GAR 
ATG CT 
WGS H7 gene segment 2, PB1 
RD(Baillie 
et al. 2012) 
PB1-1261R 
TTR AAC ATG CCC ATC 
ATC AT 
WGS H7 gene segment 2, PB1 
RD(Baillie 
et al. 2012) 
HPB1H7R16
98 
CGG TAC GTG TAC CTA 
TAA TCC 
WGS H7 gene segment 2, PB1 This project 
HPB1F1711 
AGA GGW GAC ACA CAA 
ATW CA 
WGS H7 gene segment 2, PB1 
RD(Baillie 
et al. 2012) 
Bm-PB1-
2341R 
ATA TGG TCT CGT ATT 
AGT AGA AAC AAG GCA 
TTT 
WGS H7 gene segment 2, PB1 
Hoffmann(
Hoffmann 
et al. 2001) 
Bm-PA-1 
TAT TGG TCT CAG GGA 
GCR AAA GCA GGT AC 
WGS H7 gene segment 3, PA 
Hoffmann(
Hoffmann 
et al. 2001) 
HPAR620 
TCT TCG CCT CTT TCG 
GAC TGA CGA 
WGS H7 gene segment 3, PA 
RD(Baillie 
et al. 2012) 
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PA-745F 
TRC ATT GAG GGC AAG 
CTK TC 
WGS H7 gene segment 3, PA 
RD(Baillie 
et al. 2012) 
HPAH7R984 
CGA TGT TGG GTT CTT 
TCC AAC C 
WGS H7 gene segment 3, PA This project 
HPAF1435 
AAT GCA TCC TGT GCA 
GCA ATG GA 
WGS H7 gene segment 3, PA 
RD(Baillie 
et al. 2012) 
PA-1498R 
TNG TYC TRC AYT TGC 
TTA TCA T 
WGS H7 gene segment 3, PA 
RD(Baillie 
et al. 2012) 
HPAR1824 
GGA CTC RGC TTC AAT 
CAT GCT CTC 
WGS H7 gene segment 3, PA 
RD(Baillie 
et al. 2012) 
Bm-PA-
2233R 
ATA TGG TCT CGT ATT 
AGT AGA AAC AAG GTA 
CTT 
WGS H7 gene segment 3, PA 
Hoffmann(
Hoffmann 
et al. 2001) 
Bm-HA-1 or 
HAFUc 
TAT TCG TCT CAG GGA 
GCA AAA GCA GGG G 
WGS H7 gene segment 4, HA 
Hoffmann(
Hoffmann 
et al. 2001) 
ND_seqHAH
7_F2 
CTA TGC AGA GAT GAA 
ATG G 
WGS H7 gene segment 4, HA This project 
ND_seqHAH
7_F4 
GCT GAR GAA GAT GGC 
ACT G 
WGS H7 gene segment 4, HA This project 
ND_seqHAH
7_R1 
GAT GCC CCG AAG CTA 
AAC CA 
WGS H7 gene segment 4, HA This project 
ND_seqHAH
7_R2 
GRG TGC TTT TGT AAT 
CTG C 
WGS H7 gene segment 4, HA This project 
ND_seqHAH
7_R3_rep 
CAC TCC CGT ATA GCT 
TGG TCT G 
WGS H7 gene segment 4, HA This project 
Bm-NS-890R 
or HARUc or 
NSRUc 
ATA TCG TCT CGT ATT 
AGT AGA AAC AAG GGT 
GTT TT 
WGS H7 gene segment 4, HA and 8, NS 
Hoffmann(
Hoffmann 
et al. 2001) 
NPFUc 
TAT TCG TCT CAG GGA 
GCA AAA GCA GGG TWR 
ATA ATC 
WGS H7 gene segment 5, NP 
RD(Baillie 
et al. 2012) 
HNPH7R594 
CCA TCA CCA TTG TCC 
CGA CTC 
WGS H7 gene segment 5, NP This project 
NPUR664-83 
CGY CCR TTY TCR CCY 
CTC CA 
WGS H7 gene segment 5, NP 
RD(Baillie 
et al. 2012) 
HNPH7F101
7 
GGT ATG GAT GGC ATG 
CCA TTC 
WGS H7 gene segment 5, NP This project 
HNPH7R110
9 
GCA ATT TGA ACT CCT 
CTG GTG G 
WGS H7 gene segment 5, NP This project 
NPRUc 
ATA TCG TCT CGT ATT 
AGT AGA AAC AAG GGT 
AWT TTT 
WGS H7 gene segment 5, NP 
RD(Baillie 
et al. 2012) 
Ba-NA-1 or 
NAFUc 
TAT TGG TCT CAG GGA 
GCA AAA GCA GGA GT 
WGS H7 gene segment 6, NA 
Hoffmann(
Hoffmann 
et al. 2001) 
H7NAF615_s
eq 
CCA TTA AAT CCA TGG 
AGA AAG G 
WGS H7 gene segment 6, N3 This project 
H7NAR664_
seq 
GGG TAC CAT CAA TGC 
ATT GAC 
WGS H7 gene segment 6, N3 This project 
H7NAF1105
_seq 
GTC ACA GAG GGG TGG 
ATT AAC 
WGS H7 gene segment 6, N3 This project 
H7NAR1145
_seq 
CAC TAA TGT TTG TGT 
AAC TG 
WGS H7 gene segment 6, N3 This project 
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Ba-NA1413R 
or NARUc 
ATA TGG TCT CGT ATT 
AGT AGA AAC AAG GAG 
TTT TTT 
WGS H7 gene segment 6, NA 
Hoffmann(
Hoffmann 
et al. 2001) 
MFUc 
TAT TCG TCT CAG GGA 
GCA AAA GCA GGT AGA 
WGS H7 gene segment 7, M 
Hoffmann(
Hoffmann 
et al. 2001) 
HMH7R366 
CGA CCT CCT TAG CTC 
CAT GG 
WGS H7 gene segment 7, M This project 
HMF581 
GCT AAG GCT ATG GAG 
CAA ATG GCT 
WGS H7 gene segment 7, M 
RD(Baillie 
et al. 2012) 
Bm-M-1027R 
or MRUc 
ATA TCG TCT CGT ATT 
AGT AGA AAC AAG GTA 
GTT TTT 
WGS H7 gene segment 7, M 
Hoffmann(
Hoffmann 
et al. 2001) 
Bm-NS-1 
TAT TCG TCT CAG GGA 
GCA AAA GCA GGG TG 
WGS H7 gene segment 8, NS 
Hoffmann(
Hoffmann 
et al. 2001) 
HNSH7F355 
GCC TTA TGG TGA AAA 
TGG ACC  
WGS H7 gene segment 8, NS This project 
HNSH7R474 
TAT TTC GGC CAC AAT 
AGC ACC 
WGS H7 gene segment 8, NS This project 
    
Table 2.4 Oligonucleotides used in this project 
WGS = Whole genome sequencing, s-o = swine-origin 
Wobbles used: R (A+G); W (A+T); M (A+C); Y (C+T); K (G+T); N (A+C+G+T) 
78 
 
2.1.5 Plasmid vectors 
Name Comments Source 
pAc3CFc His SfiI 
Empty baculoviral expression vector 
expressing His-tag and human Fc-tag 
Ian Jones, University 
of Reading 
pAc3CFc His SfiI GFP 
Baculoviral expression vector containing 
GFP gene 
Ian Jones, University 
of Reading 
pAc3CFc His SfiI E195 HA 
Baculoviral expression vector containing 
E195 HA gene 
This project 
pAc3CFc His SfiI E195 
E227A HA 
Baculoviral expression vector containing 
E195 E227A HA gene 
This project 
pAc3CFc His SfiI E480 HA 
Baculoviral expression vector containing 
E480 HA gene, HA is codon-optimised for 
use in insect cells 
This project 
pAc3CFc His SfiI M105 HA 
Baculoviral expression vector containing 
M105 HA gene 
This project 
pAc3CFc His SfiI Ohio01 
A227E HA 
Baculoviral expression vector containing 
Ohio01 A227E HA gene 
This project 
pAc3CFc His SfiI Ohio01 
HA 
Baculoviral expression vector containing 
Ohio01 HA gene 
This project 
pCMV-VictoriaPB2 
Helper plasmid for reverse genetics 
containing segment 1 of A/Victoria/3/75 
Dr. T Zurcher, 
GlaxoSmithKline 
pCMV-VictoriaPB1 
Helper plasmid for reverse genetics 
containing segment 2 of A/Victoria/3/75 
Dr. T Zurcher, 
GlaxoSmithKline 
pCMV-VictoriaPA 
Helper plasmid for reverse genetics 
containing segment 3 of A/Victoria/3/75 
Dr. T Zurcher, 
GlaxoSmithKline 
pCMV-VictoriaNP 
Helper plasmid for reverse genetics 
containing segment 4 of A/Victoria/3/75 
Dr. T Zurcher, 
GlaxoSmithKline 
pPolI 
Reverse genetics plasmid with the human 
PolI promoter site and sequences from the 
hepatitis delta virus ribozyme 
Dr. T Zurcher, 
GlaxoSmithKline 
pPolI-E195PB2 
pPolI vector containing segment 1,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195PB1 
pPolI vector containing segment 2,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195PA 
pPolI vector containing segment 3,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195HA 
pPolI vector containing segment 4,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College and 
this project 
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pPolI-E195NP 
pPolI vector containing segment 5,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195NA 
pPolI vector containing segment 6,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195M 
pPolI vector containing segment 7,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195NS 
pPolI vector containing segment 8,  
cloned from E195 
Dr. Lorian Hartgroves, 
Imperial College 
pPolI-E195 E227A HA 
pPolI vector containing segment 4 cloned 
from E195 mutated at position 722 (AC, 
H1 numbering) 
This project 
pPolI-Ohio01 A227E HA 
pPolI vector containing segment 4 cloned 
from Ohio01 mutated at position 722 (CA, 
H1 numbering) 
This project 
pPolI-Ohio01 HA 
pPolI vector containing segment 4 cloned 
from Ohio01 
This project 
   
Table 2.5 Plasmids used in this project 
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2.1.6 Antibodies and Lectins 
Name Purpose Source 
Primary antibodies 
Anti-HIS tag HRP  Western Blot of recombinant HA Invitrogen Ltd 
Goat anti-human IgG Fc-
specific 
Immunohistochemistry with recombinant HA 
on HAE slides 
Sigma Aldrich Ltd 
Goat anti-human IgG Fc-
specific HRP 
Western Blot of recombinant HA  Sigma Aldrich Ltd 
Mouse anti-influenza A 
NP  
Immunohistochemistry against NP protein AbD Serotec 
Mouse anti-influenza A 
NP  
Immunohistochemistry against NP protein Dhan Samuel, HPA MS 
Rabbit anti-alpha tubulin 
(polyclonal) 
Immunohistochemistry against tubulin AMS Biotechnology 
Rabbit anti-alpha tubulin 
(polyclonal) 
Immunohistochemistry against tubulin Abcam 
Secondary antibodies 
Donkey anti-goat Alexa 
488 
Immunohistochemistry on HAE (HA protein) Invitrogen Ltd 
Donkey anti-rabbit Alexa 
647 
Immunohistochemistry on HAE (HA protein 
and infection) 
Invitrogen Ltd 
Goat anti-mouse Alexa 
488 
Immunohistochemistry on HAE (infection) AbD Serotec 
Streptavidin Alexa 488 Immunohistochemistry  with lectins Invitrogen Ltd 
Streptavidin Alexa 594 Immunohistochemistry  with lectins Invitrogen Ltd 
Streptavidin HRP  Immunohistochemistry  with lectins Life Technologies Inc. 
Lectins 
MAA biotin Detection of α2,3-linked sialic acid TCS Bioscience 
SNA biotin Detection of α2,6-linked sialic acid Vector Laboratories Ltd 
   
Table 2.6 Antibodies used in this project 
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2.1.7 Bacterial and cell culture 
2.1.7.1 Competent cells 
The competent cells (Escherichia coli (E.coli)) used in this study were TOP10 Oneshot TM cells 
(Invitrogen) and XL10 Gold ultracompetent cells (Stratagene).  
 
2.1.7.2 Luria Broth (LB) medium  
1% Oxoid tryptone; 0.5% Oxoid yeast extract; 100 mM NaCl; 5.5 mM glucose; 100 μg/ml 
ampicillin. 
 
2.1.7.3 SOC recovery medium 
2% Oxoid tryptone; 0.5% Oxoid yeast extract; 10 mM NaCl; 2.5 mM KCl; 10 mM MgCl2; 10 mM 
MgSO4.7H2O; 20 mM glucose. 
 
2.1.7.4 NZY+ broth 
1% NZ amine (casein hydrolysate); 0.5% Oxoid yeast extract; 100 mM NaCl; 12.5 mM MgCl2; 
12.5 mM MgSO4; 20 mM glucose. 
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2.1.7.5 MDCK cell medium 
Imperial College: Dulbecco‟s Modified Eagles Media (DMEM, Invitrogen) supplemented with 
10% foetal calf serum (FBS, Biosera); 1% Non-essential amino acids (NEAA, Gibco) 50 U/ml 
Penicillin (Invitrogen); 50 µg/ml Streptomycin (Invitrogen). 
Health Protection Agency: DMEM (Gibco) supplemented with 10% FBS (Invitrogen); 50 µg/ml 
gentamycin (Invitrogen). 
 
2.1.7.6 SIAT cell medium 
DMEM supplemented with 10% FBS; 50 µg/ml gentamycin and 0.4 mg/ml geneticin (Gibco). 
 
2.1.7.7 Spodoptera frugiperda cell medium 
SF900 II medium (Gibco) supplemented with 2% FBS; 2.5 µg/ml Fungizone (Invitrogen); 100 
U/ml Penicillin (Invitrogen); 100 µg/ml Streptomycin (Invitrogen). 
 
2.1.7.8 IOBA-NHC cell medium 
DMEM/F12 (Invitrogen) supplemented with 10% FBS; 50 U/ml Penicillin; 50 µg/ml Streptomycin; 
2.5 µg/ml Fungizone; 2 ng/ml human epidermal growth factor (Sigma); 1 µg/ml bovine pancreas 
insulin (Sigma); 0.1 µg/ml cholera toxin (Sigma); 5 µg/ml hydrocortisone (Sigma). 
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2.1.7.9 293T cell medium 
DMEM supplemented with 10% FBS (Biosera); 1% NEAA; 50 U/ml Penicillin; 50 µg/ml 
Streptomycin. 
 
2.1.7.10 Plaque assay overlay  
1x Earle‟s minimal essential medium (Invitrogen) supplemented with 0.2% w/v Bovine Serum 
Albumin (BSA, Invitrogen); 1 % v/v L-glutamine (Invitrogen); 0.15% v/v NaHCO3 (Invitrogen); 
10mM HEPES (Invitrogen); 0.005% w/v filtered DEAE Dextran (Sigma); 50 U/ml Penicillin; 50 
µg/ml Streptomycin; 0.6% number 3 agarose (Oxoid); 1.6 µg/ml trypsin (Worthingtons).  
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2.2 Methods 
2.2.1 Cell lines 
2.2.1.1 MDCK cells 
MDCK cells were cultured at 37°C in 5% CO2 in DMEM supplemented with 10% FBS, 1% 
NEAA and 50 µg/ml gentamycin or DMEM supplemented with 10% FBS, 50 U/ml penicillin and 
50 µg/ml streptomycin. 
 
2.2.1.2 SIAT cells 
SIAT cells were cultured at 37°C in 5% CO2 in DMEM medium supplemented with 10% FBS, 
1% NEAA, 50 µg/ml gentamycin and 0.4 mg/ml geneticin to maintain stable expression of the 
α2,6-sialyltransferase gene (Matrosovich et al. 2003).   
 
2.2.1.3 Spodoptera frugiperda cells 
Spodoptera frugiperda (SF9) insect cells (Invitrogen) were cultured in suspension at 27°C in 
SF900 II medium supplemented with 2% FBS, 2.5 µg/ml Fungizone, 100 U/ml penicillin and 100 
µg/ml streptomycin at a maximum volume of 30 ml in a 250 ml Corning Erlenmeyer flask 
(Sigma). SF9 cells were diluted every 3-4 days, ensuring cell density did not exceed 107 
cells/ml.  
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2.2.1.4 IOBA-NHC cells 
IOBA-normal human conjunctival tissue (IOBA-NHC) cells, a kind gift from Dr. Virginia Calder 
(UCL), were cultured at 37°C in 5% CO2 in DMEM/F12 medium supplemented with 1 µg/ml 
bovine pancreas insulin, 2 ng/ml human EGF, 0.1 µg/ml cholera toxin, 5 µg/ml hydrocortisone, 
10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin and 2.5 µg/ml Fungizone.  
 
2.2.1.5 293T cells 
293T cells were cultured at 37°C in 5% CO2 in DMEM supplemented with 10% FBS (Biosera), 
1% NEAA, 50 U/ml Penicillin and 50 µg/ml Streptomycin. 
 
2.2.1.6 HAE cultures 
HAE cultures from Epithelix Sàrl were delivered in medium containing agar. Upon arrival, inserts 
were placed in 24-well plates containing 700 µl of pre-warmed (37°C) MucilAirTM medium 
(Epithelix Sàrl). Only the eight wells in the middle of the plate were used, all other wells were 
filled with 1 ml nuclease free water (Severn Biotech) to maintain a high humidity. HAE cultures 
were incubated at 37°C in 5% CO2. Medium was replaced every 2-3 days. 
HAE cultures from Cystic Fibrosis/Pulmonary Research and Treatment Center, Department of 
Microbiology and Immunology, UNC at Chapel Hill were grown in custom made media with 
provision of an air-liquid interface for 4 to 6 weeks to form differentiated, polarized cultures that 
resemble in vivo pseudostratified mucociliary epithelium (Fulcher et al. 2005). 
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2.2.2 Viral methods 
2.2.2.1 Viral cell passage 
A confluent layer of MDCK or SIAT cells in a T25 flask (Nunc) was washed twice with sterile 
PBS (Gibco) after which 5 µl of virus in 1 ml serum-free DMEM was added. The flasks were 
rocked regularly while incubating at 37°C in 5% CO2 for 1 hr. After removal of the inoculum 5 ml 
of serum-free MDCK or SIAT medium (See section 2.1.7) containing 1 µg/ml trypsin 
(Worthington) was added. The cells were incubated until cytopathic effect (CPE) was observed, 
after which the medium was removed and centrifuged at 5000 rpm for 5 mins to remove cell 
debris. Before storage at -80°C, viral titre was determined using HA assay and/or plaque assay.  
 
2.2.2.2 Viral egg passage 
10 days-old embryonated eggs were inoculated allantoically with 100 µl of serially diluted 
influenza virus (10-4 to 10-7) and incubated at 37°C for 48 hrs. Eggs were then placed at 4°C for 
4 hrs. Allantoic fluid was collected and centrifuged at 2000 rpm at 4°C for 10 mins to remove 
debris. Before storage at -80°C, viral titre was determined by HA assay and/or plaque assay.  
 
2.2.2.3 Haemagglutination (HA) assay  
80 µl PBS was added to the first column of a 96-well plate, 50 µl PBS was added to the wells in 
columns 2-12. 20 µl of virus-containing fluid was added to the first column in duplicate, and 
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serially diluted 1:1 up to column 12, leaving 50 µl in every well. PBS was used as a negative 
control. 50 µl 0.5% red blood cells (RBC) was added, using guinea pig, chicken or turkey RBC 
dependent upon the virus subtype. After incubation at 4°C for 1 hr, HA titre was determined as 
the highest dilution that gave full agglutination.  
 
2.2.2.4 Plaque assay 
Preparation of lung tissue for plaque assay was done by weighing the tissue and homogenising 
10% w/v in serum-free DMEM medium in a 50 ml falcon tube. Cell homogenate was centrifuged 
at 500 rpm for 5 min to remove cell debris. Six or 12-well plates with confluent layers of either 
MDCK or SIAT cells were washed twice with sterile PBS, after which six dilutions of 100 µl of 
serially diluted virus or cell supernatant (between 10-1 – 10-8) in virus transport medium (VTM) or 
serum-free medium in duplicate were added. The plates were rocked regularly while incubating 
at 37°C for 1 hr. After removal of the inoculum, 3 ml DMEM containing 1 µg/ml trypsin and 1% 
agarose (MP Biomedicals) (HPA) or plaque overlay medium (IC, section 2.1.7.10) was added. 
After agarose was set, plates were incubated at 37°C in 5% CO2 for three days. Cells were fixed 
with 2 ml/well 5% gluteraldehyde solution (Sigma) for at least 2 hrs, followed by staining with 2 
ml of 5% carbol fuchsin (Fluka) for 30 mins (HPA) or stained with crystal violet (IC, Sigma). To 
determine viral titre, the following formula was used: 
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Equation 2.1 Formula to determine viral titre from plaque assay 
P = plaque forming units per well 
V = volume of virus added per well in µl (e.g. 100) 
D = Dilution of virus (e.g. 10-6) 
 
2.2.2.5 Determining the 50% Tissue Culture Infectious Dose (TCID50) 
MDCK cells were seeded in 96-well plate (90% confluent) and washed with sterile PBS. One 
plate per virus was used. 100 µl serum-free medium was added to column 2-12. 145.4 µl diluted 
virus (dilution of 2½ log) was added to column 1, of which 45.4 µl was added to column 2, up to 
column 11 (serial dilution of ½ log). 45.4 µl was removed from column 11. Column 12 was used 
as negative control. After 1 hr of incubation at 37°C in 5% CO2, cells were washed with PBS. 
150 µl of serum-free medium containing 1 µg/ml trypsin was added to each well and plates were 
incubated at 37°C in 5% CO2 for four days. After aspiration of media, the cells were stained with 
crystal violet and TCID50 was calculated using the Spearman-Karber formula as explained in 
Figure 2.1:  
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)  
 
Equation 2.2 Spearman-Karber formula to calculate TCID50 
Xp = Highest dilution with CPE in all samples 
d = Spacing between dilutions (e.g. 0.5) 
r = Wells with CPE between Xp and lowest dilution with no CPE in all samples 
n = number of wells per dilution (e.g. 8) 
 
 
 
Figure 2.1 Calculation of TCID50 value 
Value for Xp = -3.5; value for d = 0.5; value for r = 21; value for n = 8. TCID50 value is therefore 
   
     =  -3.09375 
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2.2.2.6 Rescue of recombinant influenza virus by 12 plasmid transfection 
293T cells were seeded in 6-well plates overnight to achieve up to 70-80% confluency. 2 hrs 
before transfection, media was replaced with 0.5 ml DMEM with 3% FCS. Twelve reverse 
genetics plasmids (eight pPolI plasmids containing the required viral gene segments, and four 
helper pCMV expression plasmids encoding the polymerase and nucleoprotein of 
A/Victoria/3/75) were aliquoted into eppendorf tubes, each at 0.5 µg apart from pCMV-NP which 
was aliquoted at 1 µg. 200 µl serum-free DMEM was combined with 20 μl Fugene (Roche) and 
incubated at RT for 5 min. DNA was added to the medium/Fugene mixture and incubated for 15 
min at RT. DNA/medium/Fugene mixture was then added drop wise to the 293T cells. 
Transfected 293T cells were incubated overnight at 37°C in 5% CO2. The next day, one 
confluent T75 flask of MDCK cells was resuspended in 25 ml DMEM with 10% FCS. One ml of 
MDCK cell suspension was added to each well of transfected 293T cells and gently pipetted up 
and down. The cell mixture was transferred to a T25 flask together with a further 4 ml of MDCK 
cell suspension. The co-culture was incubated at 37°C in 5% CO2 until the cells were attached 
(6-8 hrs), washed and incubated with 5 ml of fresh serum-free MDCK medium containing 2 
µg/ml trypsin, 50 U/ml penicillin and 50 µg/ml streptomycin. When CPE was observed, the 
medium was harvested and tested for presence of virus by standard plaque assay on a 
confluent monolayer of MDCK cells (see section 2.2.2.4).  
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2.2.2.7 Purification of viral stocks by plaque picking  
Using a sterile aspirator tip, isolated plaques were extracted from plaque plates and incubated 
in sterile PBS containing 0.35% BSA, 50 U/ml penicillin and 50 µg/ml streptomycin at 4°C 
overnight. T75 flasks were seeded with MDCK cells (90% confluent) and washed with sterile 
PBS. Three ml of serum-free medium was mixed with 100 µl of virus diluent, added to MDCK 
cells and incubated for 1 hr at 37°C in 5% CO2. Inoculum was then replaced with 12 ml serum-
free MDCK cell medium with 1 µg/ml trypsin and incubated at 37°C in 5% CO2 until CPE was 
observed. When CPE was observed, the medium was harvested and tested for presence of 
virus by standard plaque assay on a confluent monolayer of MDCK cells (see section 2.2.2.4). 
 
2.2.2.8 Infection and study of viral replication in MDCK and SIAT cells 
MDCK or SIAT cells were seeded on 6-well plates or 24-well plates with a coverslip (90-100% 
confluent) and washed with sterile PBS. Virus inoculum was applied to cells. After 1 hr 
incubation at 37°C in 5% CO2, cells were washed with PBS. Serum-free cell-specific medium 
with 1 µg/ml trypsin was added to each well and plates were incubated at 37°C in 5% CO2 for 
the duration of the experiment. Viral growth kinetics were determined by taking and replacing 
500 µl of serum-free medium. Samples were stored at -80°C prior to analysis. 
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2.2.2.9 Infection and study of viral replication in HAE cultures 
HAE were washed with sterile PBS or MucilAir medium to remove apical secretions. Virus 
inoculum was applied to the apical surface of HAE. After 1 hr of incubation at 33°C or 37°C in 
5% CO2, inoculum was removed and HAE cultures were washed with PBS or MucilAir medium 
and incubated at 33°C or 37°C in 5% CO2 for the duration of the experiment. Viral growth 
kinetics were determined by performing apical washes with 300 µl of serum-free DMEM for 30 
min at 33°C or 37°C in 5% CO2. Washes were then harvested and stored at -80°C prior to 
analysis. 
 
2.2.2.10 Infection and study of viral replication in IOBA-NHC cells 
IOBA-NHC cells were seeded on 6-well plates (90-100% confluent) and washed with sterile 
PBS. Virus inoculum was applied to IOBA-NHC. After 1 hr of incubation at 37°C in 5% CO2, 
cells were washed with PBS. Three ml of serum-free IOBA-NHC medium with 1 µg/ml trypsin 
was added to each well and plates were incubated at 37°C in 5% CO2 for the duration of the 
experiment. Viral growth kinetics were determined by taking and replacing 500 µl of serum-free 
medium. Samples were stored at -80°C prior to analysis. 
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2.2.2.11 Microneutralisation assay for influenza A virus on MDCK cells 
MDCK cells were seeded in 96-well plate (90% confluent) and washed with sterile PBS. Four 
rows of wells per virus were used. Viruses were diluted to 100TCID50 (see section 2.2.2.5). 60 
µl of sterile PBS was added to columns 2-12 of an empty 96-well plate. Serum raised against 
E195 in ferrets was diluted 0-320x and 120 µl was added to all wells in column 1. 60 µl of serum 
from column 1 and serially diluted 1:1 up to column 12, leaving 60 µl in every well. Then 60 µl of 
diluted virus was added to each well and plates were incubated at 37°C in 5% CO2 for 1 hr. 
Hereafter, 100 µl of virus-serum mixture was added to plates containing MDCK cells which were 
incubated at 37°C in 5% CO2 for 1 hr. Inoculum was replaced with 100 µl of serum-free medium 
containing 1 µg/ml trypsin. Plates were incubated at 37°C in 5% CO2 for four days and stained 
with crystal-violet. Wells containing PBS instead of serum were used as positive controls; wells 
containing no virus were used as negative controls. MN value is the highest serum dilution with 
no CPE in any wells (Figure 2.2).  
  
 
Figure 2.2 Calculation of MN value 
The highest serum dilution with no CPE is 1280x (all wells still contain cells), one well with 
serum diluted 2560x has no CPE. The final MN value is 1280x. 
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2.2.3 Molecular techniques 
2.2.3.1 DNA synthesis by GeneArt 
As cloning of the HA of A/England/480/06 (and A/England/481/06) was not successful, this gene 
was codon-optimised for insect cells by GeneArt (Invitrogen). Hereby, the protein sequence of 
the gene stays the same, but the nucleotide sequence is optimised by for example eliminating 
AT- and GC-rich sequences and using codons that are most common in insect cells. 
Furthermore, as the virus A/Ohio/01/2007 was not available, this HA gene was also synthesised 
(but not codon-optimised) by GeneArt.  
 
2.2.3.2 Viral RNA extraction from cell supernatant 
RNA was extracted from 130 µl of cell supernatant using Qiagen Viral RNA mini kit (Qiagen) 
according to manufacturer‟s instructions except for lysis buffer, which was purchased from 
Roche (MagnaPure LC total nucleic acid kit).  
 
2.2.3.3 Viral RNA extraction from porcine lung tissue 
Porcine lung tissue was weighted and RNA was extracted using Qiagen RNAeasy mini kit 
(Qiagen) according to manufacturer‟s instructions.  
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2.2.3.4 cDNA synthesis 
10 µl of extracted viral RNA was incubated at 65°C for 1 min with 1 µl of 10 pmol forward primer 
(Table 2.4) and 1 µl of 25 mM dNTPs (Invitrogen). Then, 4 µl 5x first strand buffer (Invitrogen), 2 
µl 0.1 M DMSO (Invitrogen) and 1 µl RNaseOUT (Invitrogen) were added, followed by 
incubation for 2 min at 42°C. Finally, 1 µl of Superscript reverse transcriptase (Invitrogen) was 
added and the mixture was incubated at 42°C for 50 min followed by 15 min at 72°C to 
inactivate the enzyme.  
 
2.2.3.5 Polymerase Chain Reaction 
All PCR reactions were optimised for MgCl2 concentration and melting temperature. 2-10 µl of 
cDNA was added to 5 µl 10x buffer for KOD DNA polymerase (Novagen), 4 µl forward primer, 4 
µl reverse primer (Table 2.4), 5 µl 2 mM dNTPs (Novagen), 1-5 µl of MgCl2 (Novagen) and 0.4 
µl KOD DNA polymerase (Novagen). Water was added to a final volume of 50 µl. Depending on 
the primer set, reaction times and temperatures varied.   
 
2.2.3.6 Agarose gel electrophoresis 
For visualisation of DNA, 2 µl of DNA was mixed with 2 µl BlueJuice (Invitrogen) and 18 µl 
nuclease free water. For purification of DNA, the entire PCR reaction volume was mixed 9:1 
with BlueJuice. DNA fragments were separated on agarose gels in 1x TBE (Gibco). 
Concentration of agarose gels, running voltage and running time were dependent on the 
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expected size of the DNA band. DNA was visualised by incubating gels in an ethidium bromide-
containing (Invitrogen) bath after electrophoresis and photographed using the Gel Doc 2000 
system (BioRad).  
 
2.2.3.7 DNA purification 
DNA bands of interest were excised from agarose gels and purified using the Qiaquick Gel 
Extraction Kit (Qiagen) according to manufacturer‟s instructions. DNA was measured using the 
Nanodrop (Thermo).  
 
2.2.3.8 Restriction enzyme digestion 
In general, 1 µg of DNA was digested with 1 U of restriction enzyme (New England Biolabs) in 
1x recommended NEB buffer (New England Biolabs) in a final volume of 20 µl. If necessary, 
BSA (New England Biolabs) was added to a final concentration of 100 µg/ml.  
 
2.2.3.9 Ligation into non-commercial plasmids 
Insert and plasmid of interest were mixed in different concentrations (1:1, 1:3 and 1:10) and 
added to 1 µl of T4 ligase (Promega) and 1x T4 buffer (Promega). Nuclease free water was 
added to a final volume of 10 µl and ligation was performed overnight at 16°C. As a negative 
control, plasmid without insert was included.  
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2.2.3.10 Transformation into competent cells 
TOP10 OneShot TM competent cells (Invitrogen) were thawed on ice after which 2 µl of DNA 
was added. Incubation on ice for 10 mins was followed by a heat shock for 30 mins at 42°C. 250 
µl of SOC medium (Invitrogen) was added and the cell mixture was incubated at 37°C for 1 hr at 
200 rpm. 10-100 µl was plated out using appropriate antibiotics (ampicillin (Sigma) 10 µg/µl, 
kanamycin (Sigma) 50 µg/µl or chloramphenicol (Sigma) 68 µg/µl) and incubated overnight at 
37°C.  
 
2.2.3.11 Plasmid isolation 
Bacterial cultures were started from a glycerol stock or a single colony from a plate into LB 
medium containing selective antibiotics (ampicillin 10 µg/µl, kanamycin 50 µg/µl or 
chloramphenicol 68 µg/µl) and grown overnight at 37°C. Three ml of culture media was pelleted 
at 13,000 rpm for 5 min and plasmids were isolated using the Qiaprep Spin Miniprep Kit 
(Qiagen) according to manufacturer‟s instructions. DNA was dissolved in nuclease free water 
and the concentration was measured using Nanodrop (Thermo).  
 
 
2.2.3.12 Site-directed mutagenesis 
Specific mutagenesis primers were designed using primerX (www.bioinformatics.org/primerx) 
and plasmids were mutated using QuickChange site-directed mutagenesis kit (Stratagene) 
according to manufacturer‟s instructions.  
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Figure 2.3 Schema of sequencing strategy of H7 influenza viruses 
Every influenza virus RNA segment was amplified by polymerase chain reaction to produce one 
or two fragments depending on gene segment length. Hereafter, every fragment was 
sequenced using the primers illustrated in this figure. Scale of segments: 1 cm represents 200 
nucleotides. Forward primers are in blue, reverse primers in red.  
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2.2.3.13 Quantitative real-time PCR 
RNA was isolated as described in section 2.2.3.2. Concentration was measured by Nanodrop 
and standardized to 1 µg per reaction. Using the SuperScript III Reverse Transcriptase kit 
(Invitrogen), cDNA was amplified: 1 µl random hexamers, 1 µl 10mM dNTPs, 2.5 µl nuclease-
free water and 8.5 µl RNA was heated at 65°C for 5 min, then incubated on ice for 1 min. To the 
RNA mixture 4 µl 5x First-strand buffer, 1 µl 0.1M DTT, 1 µl RNase OUT and 1 µl Superscript III 
was added and incubated at 50°C for 1 hr followed by enzyme deactivation at 70°C for 15 min. 
TaqMan Fast Universal PCR master mix was used for qRT-PCR on the ABIqPCR system using 
standard curve program. Two µl of cDNA was mixed with 0.5 µl primer MFUc (10 pmol), 0.5 µl 
primer MRUc (10 pmol), 2 µl M Probe, 6.8 µl nuclease-free water and 10 µl TaqMan 2x master 
mix. The standard curve was made using 109-100 copy numbers of pPolI-E195M plasmid.  
 
2.2.3.14 Whole genome sequencing of H7 viruses 
RNA was isolated as described in section 2.2.3.2. cDNA was produced according to section 0 
and PCR was performed according to section 2.2.3.5 using primers specified in Table 2.4. PCR 
products were purified using in-house facilities (HPA) and DNA concentration was measured by 
Nanodrop. DNA was diluted to 30 ng/µl and primers to 10 pmol/µl and sent to GATC Biotech 
(http://www.gatc-biotech.com) for sequencing. Chromatographs were assembled using Seqman 
9.0.5 software by DNASTAR Lasergene. Please see Figure 2.3 for a schematic explanation of 
the alignment of sequence primers. 
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2.2.4 Statistics and Bioinformatics 
2.2.4.1 Statistical analyses 
All statistical analyses were performed using Microsoft Excel 2007 or GraphPad Prism 5. 
Student‟s T-test was performed on unpaired samples; One-way Anova was performed on 
multiple unpaired samples followed by Tukey post test to provide relevant p-values between 
samples. Samples were marked significantly different if the p-value was 0.05 or lower. Area 
under the curve was calculated using GraphPad Prism 5. 
 
2.2.4.2 Multiple protein alignments 
Amino acid sequences were compared using standard settings of Geneious 5.3.6 Blosum62 
(Biomatters Limited) (Drummond AJ 2011).  
 
2.2.4.3 Phylogenetic analysis 
Phylogenetic trees were created using multiple alignment files of Geneious 5.3.6 using standard 
bootstrap settings.  
 
2.2.4.4 Modelling of HA protein of E195 and mutants 
The crystal structure of A(H1N1)pdm09 HA protein A/California/04/2009 (Protein Data Bank ID 
code 3LZG) was used as a template for homology modeling of HA of E195 using SwissProt 
(Bairoch et al. 2004) (http://web.expasy.org/docs/swiss-prot_guideline.html). Yasara force field 
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minimization server (Krieger et al. 2009) (http://www.yasara.org/minimizationserver.htm) was 
used to calculate energy minimization values. Molecular surfaces images were created using 
Autodock (Park, Lee and Lee 2006) (http://autodock.scripps.edu/) and coloured per amino acid. 
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2.2.5 Recombinant baculovirus techniques and protein production 
2.2.5.1 Bacmid preparation 
E.coli containing bacmid (a kind gift from Professor Ian Jones, University of Reading) was 
cultured overnight at 37°C in LB medium containing 50 µg/ml kanamycin and 68 µg/ml 
chloramphenicol. Bacmid DNA was isolated using the BacMAX Kit (Cambio Ltd) according to 
manufacturer‟s instructions. Bacmid DNA concentration was measured using the Nanodrop. To 
linearise bacmid DNA, 1 µg of bacmid was digested with 3 U of Bsu361 (New England Biolabs) 
in 1x NEBuffer 3 (New England Biolabs) and 100 ng/µl BSA (New England Biolabs) at 37°C for 
2 hrs. An extra 3 U of Bsu361 was added followed by a further incubation at 37°C for 2 hrs. 
Bsu361 was heat inactivated by incubation at 80°C for 20 min. Linearised bacmid DNA was 
stored at -20°C. 
 
2.2.5.2 Construction of P0 generation virus 
418 ng linearised bacmid was added to 418 ng transfer vector in a total volume of 12 µl. 
Lipofectin (Invitrogen) was mixed 2:1 with nuclease free water. Bacmid and lipofectin mix were 
mixed 1:1 and incubated at RT for 30 min. 5 x 105 SF9 cells per well were seeded in a 6-well 
plate (50% confluent). After 30 min, cells were washed twice with serum-free media. 1 ml 
serum-free media containing the lipid/DNA complexes (24 µl) was added to the cells and the 
sealed plate was incubated overnight at 27°C. Serum-free media was replaced with 2 ml normal 
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insect media (See section 2.1.7.7) and the sealed plate was incubated at 27°C for 3-7 days. As 
a positive control, transfer vector containing a gene construct for GFP was transfected 
simultaneously. Protein production was inspected microscopically; when >40% of the cells were 
GFP positive, cells were scraped from the well and centrifuged at 13,000 rpm for 2 min. 
Supernatant was aspirated and stored in aliquots at 4°C in the dark.  
 
2.2.5.3 Construction of P1 generation virus 
15 * 106 SF9 cells were seeded in a T150 flat tissue culture flask. After 30 min, media was 
removed leaving 2 ml medium remaining. 0.5 ml P0 generation virus was added. After 
incubation at 27°C for 1 hr inoculum was replaced with 10 ml insect media and cells were 
incubated for a further 3-5 days at 27°C. When the cells showed CPE, they were harvested and 
after centrifugation at 13,000 rpm for 2 min supernatant was stored at 4°C in the dark.  
 
2.2.5.4 Small scale protein production 
Whilst constructing P1 generation virus, HA production by SF9 cells was tested on a small scale. 
5 x 105 SF9 cells per well were seeded in a 6-well plate (50% confluent). After 30 min, cells 
were washed twice with SFM and 0.5 ml of P0 generation virus was added. After 1 hr incubation 
at 27°C media containing virus was replaced with 2 ml normal insect media. The sealed plate 
was incubated at 27°C for 3-4 days, after which cells were harvested and centrifuged 2 min at 
13,000 rpm. Supernatant was analysed by Western Blot (WB) (see section 2.2.5.6).  
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2.2.5.5 Large scale protein production 
In a 500 ml Corning Erlenmeyer flask, 500 µl P1 generation baculovirus was added to 6 x 10
7 
SF9 cells in a total volume of 5 ml. After 2 hrs of incubation at 27°C while shaking at 225 rpm, 
45 ml insect media was added. The cells were incubated for 6-7 days at 27°C in suspension 
and pelleted by centrifugation at 4000 rpm for 10 min at 4°C. Supernatant was further 
concentrated by centrifuging at 3500 rpm for 1.5 hrs at 4°C using vivaspin columns (Sartorius). 
 
2.2.5.6 Western Blot 
10.2 µl protein was added to 1.6 µl reducing agent (Invitrogen) plus 4 µl loading buffer 
(Invitrogen) and incubated at 100°C in a water bath for 5 min. 15 µl of sample was added to a 
10% Bis/Tris gel (Invitrogen) next to 5 µl NuPage Magic Marker (Invitrogen). Gels were run at 
125 V for 80 min and transferred onto a protein membrane with the iBlotTM Gel Transfer system 
(Invitrogen). Using Ponceau S (Fluka), proteins on the membrane were localised. After blocking 
the membrane for 1 hr at RT with 10% milk (Marvel) in PBS containing 0.05% Tween, the first 
antibody at an appropriate dilution in 10% milk/PBST was added (Table 2.6) and incubated for 1 
hr at RT. The membrane was then washed 5x, 3x for 10 sec and 2x for 5 min. Secondary 
antibody at an appropriate dilution in 10% milk/PBST (Table 2.6) was added and incubated for 1 
hr at RT. After a washing step as above, the blot was developed using western blotting 
detection reagents (Amersham) according to the manufacturer‟s instructions.  
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2.2.6 Immunohistochemistry 
2.2.6.1 Lectin staining 
Cells (MDCK, SIAT or IOBA-NHC) were seeded on coverslips in a 24-well plate and left 
overnight at 37°C to adhere. After blocking the cells for 1 hr at RT with 3% BSA in PBS 
containing 0.05% Tween (PBST), the biotin-conjugated lectins SNA (Sambucus Nigra lectin, 
binds to α-2,6 sialic acid) (Vector Laboratories) or MAA (Maackia amurensis, binds to α-2,3 
sialic acid) (TCS Bioscience) diluted 1:200 in PBST with 1% BSA were incubated with the cells 
for 1 hr at RT. Cells were washed 3x 5 min with PBST and incubated with streptavidin 
conjugated with Alexa 594 (Invitrogen) 1:1000 in PBST with 1% BSA for 1 hr at RT. After 
repeating the wash step, the coverslips were mounted in 5 µl mowiol (Invitrogen). Images were 
taken on the Nikon Eclipse Ti. 
 
2.2.6.2 Detection of infection of mammalian cells with influenza virus using immuno-
fluorescence 
Cells (MDCK, SIAT or IOBA-NHC) were seeded on coverslips in a 24-well plate and left 
overnight at 37°C to adhere. After washing the cells twice with PBS, cells were infected with a 
low MOI (between 0.1 and 0.5) by incubating them with inoculum for 1 hr at RT (See section 
2.2.2.8 and 2.2.2.10). After replacing the inoculum with serum-free cell-specific medium (See 
section 2.1.7), cells were incubated at 37°C for 16 hrs followed by fixation with ice-cold 
methanol:acetone 1:1. Cells were blocked for 1 hr at RT with 3% BSA in PBST, followed by 
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incubation with anti-NP antibody raised in mice 1:400 in PBST with 1% BSA for 1 hr at RT. To 
remove excess antibody, cells were washed 3x 5 min with PBST and incubated with anti-mouse 
antibody raised in goat conjugated with Alexa 488 (AbD Serotec) 1:500 in PBST with 1% BSA 
for 1 hr at RT. After repeating the wash step, the coverslips were mounted in 5 µl mowiol. 
Images were taken on the Nikon Eclipse Ti. 
 
2.2.6.3 Detection of infection of HAE cultures with influenza virus 
HAE cultures were infected according to section 2.2.2.9 and fixed with 4% paraformaldehyde 
with 0.25M HEPES (Invitrogen) for 15 min at RT on both apical and basal surfaces. After a 
wash step (3x) with PBS containing 0.2% fish gelatin (Sigma), 0.02% sodium azide (Sigma) and 
0.02% saponin (Sigma) (PGAS), cells were quenched and permeabilized using 50 mM NH4Cl 
and 0.2% Saponin for 10 min at RT. Cells were then washed again 3x with PGAS and blocked 
for 1 hr at RT with PGAS, followed by incubation with anti-NP antibody raised in mice 1:400 and 
rabbit anti-tubulin 1:200 in PGAS 1 hr at RT. To remove excess antibody, cells were washed 3x 
with PGAS and incubated with anti-mouse antibody raised in goat conjugated with Alexa 488 
(AbD Serotec) 1:500 and anti-rabbit antibody raised in goat in PGAS for 30 min at RT. After 
repeating the wash step, HAE cultures were cut out of the culture rings and mounted in 5 µl 
mowiol with the apical surface facing upwards. Images were collected on the Zeiss Axiovert 
200. 
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2.2.6.4 Detection of infection of porcine lung tissue with influenza virus 
Lung tissue samples were fixed in 10% formalin saline for 24 hrs, embedded in wax and cut at 5 
µm. Tissue sections were deparaffinised by immersing the slides 2x5 min in xylene. By 
immersing the slides in 100% ethanol, 90% ethanol, 70% ethanol and placing under running tap 
water respectively the tissue sections were rehydrated. Further work was performed in a 
humidity chamber. After blocking for 1 hr at RT with 3% BSA in PBS, 200 µl of anti-NP antibody 
raised in mice 1:400 in 3% BSA in PBS was incubated on the cells for 1 hr at RT. To remove 
excess antibody, cells were washed 3x with PBS and incubated with anti-mouse antibody raised 
in goat conjugated with Alexa 488 (AbD Serotec) 1:500. After repeating the wash step, lung 
tissue was mounted in 5 µl mowiol. Images were collected on the Zeiss Axiovert. 
 
2.2.6.5 HA binding assay on HAE culture sections 
The concentrated HA proteins of interest were mixed with PBS to a final volume of 200 µl 
(dilution depended on Western Blot result) and pre-complexed with 0.67 µl anti-human antibody 
raised in goat (Sigma), 2 mg BSA and 5 µl rabbit anti-acetylated anti-tubulin (AMS 
Biotechnology). This was mixed overnight at 4°C on a rotating wheel. Paraffin embedded 
sections of cultured human airway epithelium or normal human tracheal sections were obtained 
from Professor Ray Pickles at the University of North Carolina. Tissue sections were 
deparaffinised by immersing the slides 2x5 min in xylene. By immersing the slides in 100% 
ethanol, 90% ethanol, 70% ethanol and placing under running tap water respectively the tissue 
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sections were rehydrated. Further work was performed in a humidity chamber. After blocking for 
1 hr at RT with 3% BSA in PBST, 200 µl of the HA mixture was incubated on the cells for 1 hr at 
RT. To remove excess antibody, slides were washed 3x5 min with PBST, followed by incubation 
with anti-goat antibody raised in donkey conjugated with Alexa 488 (Invitrogen) 1:1000 and 
donkey anti-rabbit Alexa 647 (Invitrogen) in PBST with 1% BSA. Cells were washed 3x5 min 
with PBST and viewed under a confocal microscope. Images were collected on a Zeiss Pascal 
LSM5 laser scanning microscope.  
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Figure 2.4 Cage setup for transmission experiments with ferrets 
Donor animals were infected with influenza A virus. Twenty-four hrs later, sentinels were 
introduced; the respiratory droplet sentinel was separated from the donor animal by two 
perforated walls containing 5 mm holes which were 25 mm from each other, whereas the 
contact sentinel was placed in the same cage as the donor animal. Twenty-four hrs later, the 
contact sentinel was placed in an adjacent cage to ensure the respiratory droplet sentinel would 
not receive a double dose of influenza A virus. 
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2.2.7 Influenza virus transmission in the ferret model 
2.2.7.1 Set-up ferret transmission experiments 
Twenty to twenty-six week old female ferrets (Mustela putorius furo) weighing between 900–
1250 g were used. After acclimatisation, sera were obtained and tested by MN assay (see 
section 0) for antibodies against E195. All ferrets were negative for influenza antibodies at the 
start of the experiments. Strict procedures were followed to prevent cross-contamination 
between animals during all procedures. Twenty-four hrs after inoculation of the donor ferrets, 
sentinels were introduced either as contacts or respiratory sentinels. Contact sentinels were 
placed in the same cage as donor animals for 24 hrs, and were then transferred to adjacent 
cages. Respiratory sentinels were placed in adjacent cages with a perforated separation. Airflow 
was monitored to create optimal conditions for transmission (Figure 2.4). When animals were 
handled or daily husbandry chores were performed, a strict order was used to ensure no cross 
contamination would occur; aerosol sentinels, then contact sentinels, then donor animals were 
treated. If influenza infection was suspected in an aerosol or contact sentinel, these animals 
would be treated last in their respective group (e.g. a suspected infected aerosol sentinel would 
be the last aerosol sentinel to be treated). Daily nasal washing was performed and donor ferrets 
were observed for 1 hr per day. At the end of the experiment, terminal blood samples were 
collected for seroconversion determination. 
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2.2.7.2 Inoculation of ferrets with influenza A virus 
For inoculation, ferrets were lightly anaesthetised with ketamine (22 mg/kg) and xylazine (0.9 
mg/kg) and inoculated intranasally with virus diluted in PBS, 0.1 ml per nostril.  
 
 
2.2.7.3 Nasal washing and weighing of ferrets 
All animals were weighed daily using a veterinary weigh scale and nasal washed consciously, 
by instilling 2 ml PBS into the nostrils. Expectorate was collected in modified 250 ml centrifuge 
tubes. BSA (0.3%), antibiotics (1%) and antifungal agent (1%) were added to nasal wash 
expectorate before viral titre was determined by standard plaque assay on MDCK cells 
monolayers (see section 2.2.2.4). The limit of virus detection in plaque assays was 10 PFU/ml.  
 
2.2.7.4 Observation donor animals 
During the first 12 days of the experiment, all donor animals were observed from 10am until 
11am. The observer would enter the room at 9.45am and note temperature and humidity. After 
allowing the ferrets to settle down for 15 min, all coughs, sneezes and sneeze fits were reported 
during 1 hr. Furthermore, every 15 min the activity of every animal was scored; one point was 
awarded if the animal was asleep, two points if it was awake but not active and three points if it 
was active. Behaviour was also noted, e.g. sleeping, washing and eating. Finally, any 
remarkable observations were noted, e.g. difficulty breathing.  
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2.2.8 Ex-vivo porcine lung perfusion and infection methods 
2.2.8.1 Setup ex-vivo porcine lung perfusion 
Both lungs were extracted from a 5-month old pig by Dr. Alastair Proudfoot, Brompton hospital 
and transported on wet ice, after which the lungs were coupled to the EVLP system developed 
by the Department of Cardiothoraric Surgery at the University Hospital of Lund, Sweden (Steen 
et al. 2003). Cannulae were placed in the pulmonary artery and vein after which the lungs were 
perfused with high oncotic pressure perfusate called Steen solution (Steen et al. 2003) with or 
without red blood cells from porcine origin, which was circulated via a centrifugal pump. The 
trachea was attached to a ventilator protected by a filter which ventilates the porcine lungs. This 
closed system allows for ventilation of the lungs and was expected to maintain them for 
approximately 12-18 hrs. The lungs were kept in an unsealed dome (Xvivo Perfusion) to provide 
an environment with a high humidity. Physiological parameters are measured using specialized 
equipment installed within the circuit.  
 
2.2.8.2 Infection of ex-vivo porcine lungs 
Influenza virus was diluted in serum-free medium. Using a tube connected to a fibre-optic 
bronchoscope, lobes were sought out and (mock-)infected with 10 ml serum-free medium or 10 
ml diluted virus per lobe segment. This was repeated for 3-5 lobe segments per lung. One lung 
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was infected with influenza virus; the other lung was used as a control. After infection, the 
bronchoscope was removed and cleaned with 70% ethanol. 
 
2.2.8.3 Sampling ex-vivo porcine lungs 
Tissue samples were taken at different time points from both the uninfected and infected whole 
porcine lung. The lungs were deflated by inactivating the ventilator. Samples were taken using 
biopsy equipment, which first staples the lung and then cuts the tissue on the outer side of the 
staple line. This ensures that the lung stays sealed and consequently no virus escapes. Tissue 
samples were then divided into different parts and either snap-frozen in liquid nitrogen or fixed 
in 4% paraformaldehyde. Frozen samples were stored at -80°C. Fixed samples were stored at 
RT. During the experiment, samples of 0.5 ml were taken of the perfusate via a tap installed in 
the reservoir. Part of the fixed lung tissue was embedded in wax and cut at 5 µm. 
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3 Cell tropism and in vitro replication of A(H1N1)pdm09 with altered HA 
genes  
3.1 Introduction 
The influenza A (H1N1) virus which caused the first pandemic of the 21st century 
(A(H1N1)pdm09) is known to originate from a swine source (Garten et al. 2009). The ability of 
swine influenza virus to transmit to humans was first demonstrated by Wentworth et al., who 
reported on an accidental transmission of influenza from experimentally infected pigs to two out 
of four laboratory personnel (Wentworth et al. 1997). To investigate the likelihood of contracting 
a swine-origin influenza infection in people regularly exposed to swine, such as farmers, in 
comparison to non-swine exposed individuals, a 2-year prospective study looked at antibody 
levels against swine influenza in both groups. They reported an odds ratio of 54.9 of swine 
influenza infections in farmers, showing that farmers are much more likely to contract swine 
influenza at some point during their working life (Gray et al. 2007). Shinde et al. described the 
clinical features of eleven separate cases that were reported to the CDC between December 
2005 and February 2009, in which all patients were infected with swine-origin influenza viruses, 
mostly after coming into close proximity with pigs (Shinde et al. 2009). The symptoms 
associated with infection by swine influenza were similar to those reported for human adapted 
strains including fever, cough and headaches. Similarly, Yassine et al. reported an outbreak of 
swine influenza at an Ohio county fair, where 26 people went on to develop mild respiratory 
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symptoms (Yassine et al. 2009). These studies show the ability of swine influenza viruses to 
infect humans, but also emphasize the necessity of close contact between pigs and humans, 
and suggest a poor ability of these viruses to transmit between humans. Indeed, no or only 
limited human-to-human transmission of swine influenza virus had been reported (Shinde et al. 
2009) and until the recent pandemic with A(H1N1)pdm09 swine were not considered the most 
likely source of the next influenza pandemic. A recent ferret transmission study of a human 
isolate from the Ohio county outbreak, A/Ohio/02/2007 (Ohio02), showed that, in line with the 
observations in the above studies, efficient transmission was detected following direct contact 
between ferrets, but transmission by RD exposure did not occur (Belser et al. 2011a). 
In an attempt to find differences in receptor binding preference which could explain the ability of 
A(H1N1)pdm09 to transmit between humans, glycan array studies comparing the carbohydrate 
specificity of the HA of swine-origin viruses involved in dead-end zoonoses with that of 
A(H1N1)pdm09 HAs were performed by several groups. An obvious ligand difference was not 
identified by these studies, which may be because these arrays do not completely represent the 
glycans expressed in the upper respiratory tract (Chen et al. 2011, Bradley et al. 2011, Childs et 
al. 2009). The exact configuration of the sialic acids bound by human and avian influenza 
viruses has not yet been fully defined and it is becoming apparent that the composition and 
configuration of the glycan chain, in addition to the terminal sialic acid linkage, may also be 
important for receptor specificity.  Diverse preferences shown by different influenza viruses for 
modifications such as fucosylation, sulfation and sialylation linkage of the terminal trisaccharide 
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have been reported (Stevens et al. 2006a). Mass-spectrometry of the glycome of human 
bronchial epithelial cells revealed the presence of long α2,6-linked sialic acids, which formed a 
so-called „umbrella-like‟ glycan topology, in contrast with the „cone-like‟ glycan topology formed 
by α2,3-linked sialic acid and short α2,6-linked sialic acid. These findings illustrate the extent of 
structural diversity amongst cell surface sugars. Both α2,3-linked sialic acid and short α2,6-
linked sialic acid were bound by avian influenza HA, whereas the ability to bind to long α2,6-
linked sialic acid structures was specific for human influenza HAs (Chandrasekaran et al. 2008). 
Although these studies bring us closer to identifying the exact sialic acids used for influenza 
virus receptor binding, until these biological glycans can be studied on glycan arrays, 
conclusions derived from these experiments must be taken with precaution.  
Due to the incomplete surveillance of influenza in swine in the decades before the start of the 
pandemic, it has not been possible to identify the exact origin of A(H1N1)pdm09 (Smith et al. 
2009b, Vijaykrishna et al. 2011) and it is therefore challenging to identify which specific 
mutations allowed A(H1N1)pdm09 to transmit efficiently enough between humans to start a 
pandemic. Interestingly the HA of the classical swine H1N1 viruses from which A(H1N1)pdm09 
originates already contained the human-like amino acids 190D and 225D (which were 
associated with the start of the 1918 H1N1 pandemic) but the classical swine H1N1 viruses did 
not transmit between humans. We hypothesise therefore that other, yet unknown, amino acid 
changes unique to the HA of the A(H1N1)pdm09 played a crucial role in the ability of the virus to 
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cause an influenza pandemic. In this chapter we aimed to identify such mutation(s) and their 
effect on receptor binding and growth within relevant cell cultures.  
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3.2 Results 
3.2.1 Evolution of residue 219 and 227 in the receptor binding protein HA of 
H1N1 influenza A virus 
To investigate the molecular determinants of the ability of A(H1N1)pdm09 to transmit between 
humans (Maines et al. 2009, Munster et al. 2009, Itoh et al. 2009), compared to earlier swine-
origin zoonotic viruses that failed to cause human-to-human transmission (Shinde et al. 2009, 
Yassine et al. 2009), 173 full-length HA sequences of H1N1 swine influenza viruses isolated 
before January 2009 in North America were compared to a randomly selected panel of 1397 
sequences from human former seasonal H1N1 viruses, isolated between 1918 and 2008, and 
1605 A(H1N1)pdm09 isolates, as well as five published HA sequences of H1 swine-origin dead-
end zoonotic viruses (Shinde et al. 2009), all selected using the NCBI influenza database(Cypel 
et al. 2008)(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et 
al. 2008) . The majority of recent human seasonal H1 viruses and A(H1N1)pdm09, both of 
which transmit efficiently between humans, contain E at residue 227. In contrast, the majority 
(>95%) of HA sequences of North American classical swine influenza and zoonotic viruses 
investigated contained A at position 227 (Table 3.1, Figure 3.1).  
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Isolate name Host 
Human-to-
human 
transmission 
Residue at 
219 227 
A/SC/1/1918 Pandemic Human Y A A 
A/England/654/07 Seasonal Human Y K E 
A/England/26/08 Seasonal Human Y K E 
A/California/07/09 Pandemic Human Y I E 
A/England/195/09 Pandemic Human Y I E 
A/Ohio/01/07 Dead-end zoonose Swine/Human N T A 
A/Wisconsin/87/05 Dead-end zoonose Swine/Human N T A 
A/Swine/Alberta/56626/03 Classical swine Swine N T A 
A/Swine/Ontario/23866/04 Classical swine Swine N T A 
 
 
     
Table 3.1 Glutamic acid at position 227 is associated with human to human 
transmission. 
Sequence comparison of amino acid 227 and 219 (H3 numbering) of HA protein of H1N1 
viruses, showing prototypic examples of previous seasonal H1N1, A(H1N1)pdm09, classical 
swine influenza and dead-end swine zoonoses. 
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Residue 227 is found in the RBS of H1 HA (Figure 3.2), and substitution A227E at this position 
may have a potential role in changes in receptor binding specificity. However, the earliest H1N1 
viruses, such as the 1918 virus, contained A at position 227 and yet were clearly transmissible 
between humans. This contradiction may be explained by the additional influence of amino acid 
219 which is A in 1918 H1 but lysine (K) in the later seasonal human H1N1 viruses with 227E 
and is isoleucine (I) in the HA of A(H1N1)pdm09. Cooperation between residue 219 and 227 
has been suggested to influence the orientation of residue 186, which forms an interaction 
network with residues 187 and 189. This network then influences the orientation of residue 190 
(Maines et al. 2009), which plays a vital role in receptor binding preference of H1 HA (Glaser et 
al. 2005, Tumpey et al. 2007). Thus 1918 HA can tolerate the 227A and still bind efficiently to 
α2,6-linked sialic acid because it has a compensatory A at position 219, whereas classical 
swine flu viruses have threonine (T) at this position and require mutation at 227 to 
accommodate the α2,6-linked sialic acid. 
Most swine H1N1 virus sequences examined contained A at position 227 (>95%). In contrast, 
three swine influenza viruses isolated in 2005 and 2007 contained E at position 227. However, 
phylogenetic analysis of the HA sequences of these viruses showed a clustering with swine 
influenza viruses from the δ-cluster (Figure 3.3). This cluster is associated with two separate 
introductions of human H1N2 and H1N1 into the swine population (Vincent et al. 2009, Karasin, 
Carman and Olsen 2006). Moreover, these viruses also contained the human-like amino acid 
lysine (K) at position 219 reinforcing the concept that they were human derived viruses and 
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Figure 3.1 Distribution of amino acids at position 227 in North American swine H1 HA 
Presence of alanine (A), glutamic acid (E) and other amino acids at position 227 in 173 full-
length HA sequences of pre 2009 North-American swine H1 influenza. Sequences were 
downloaded from the NCBI influenza database on 16th March 2011 using the following search 
criteria: Type A; Host Swine; Region North America; Subtype H1N1; Collection Date Before 
01-01-2009; Full-length only 
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not swine-origin influenza virus. This could explain why these viruses contain 227E. One HA 
derived from a swine-origin dead-end zoonosis, containing E at position 227, also clustered with 
the δ-cluster and is therefore hypothesized to represent a zoonotic infection (swine to human) of 
human-origin H1.  
Interestingly, the HA of a typical A(H1N1)pdm09 isolate used in this study, A/England/195/2009, 
clustered with classic swine influenza, just like A/California/04/2009, another A(H1N1)pdm09 
isolate, did (Garten et al. 2009), within the γ-cluster (Figure 3.3).  
Analysis of sequences showed that in the 1980s residue 219 in classical swine H1N1 changed 
from A to T, potentially changing the interaction network around the receptor binding site and 
possibly the receptor binding preference (Figure 3.4). Interestingly, A(H1N1)pdm09 does not 
contain T at position 219, but I. This amino acid is only rarely found at this position in either 
human or swine H1 HA, and is thought to be suboptimal for receptor binding (Maines et al. 
2009, de Vries et al. 2011). No human cases of influenza virus infection containing T at position 
219 have been reported. 
Finally, residue 219 and 227 in H1 influenza virus isolated from Eurasian pigs before 2009 was 
investigated. After collapsing identical sequences, 343 full-length HA sequences were found in 
the NCBI influenza database on 12th November 2012 (Type A; Host Swine; Region Asia, 
Europe; Subtype H1N*; Collection Date Before 01-01-2009; Full-length only). The majority of 
sequences contained A at position 227 (261 sequences, 76%), but 58 sequences (17%) 
contained E at this position. Interestingly, most of the sequences containing 227E were found to 
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Figure 3.2 Molecular surface of HA protein of wild type E195  
The crystal structure of A(H1N1)pdm09 HA protein A/California/04/2009 (Protein Data Bank ID 
code 3LZG) was used as a template for homology modelling of HA of E195. Yasara 
(http://www.yasara.org/minimizationserver.htm) was used to calculate energy minimization 
values. Molecular surfaces images were created using Autodock (http://autodock.scripps.edu/) 
and coloured per amino acid. 
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Figure 3.3 Phylogenetic tree of HA sequences based on nucleotide sequences of swine 
H1 influenza virus 
Four clusters of related viruses as suggested by Vincent et al. are indicated by bars on the right 
side of the phylogenetic tree. HA sequences analysed were chosen from phylogenetic trees 
from Vincent et al. (Vincent et al. 2009) (black), and supplemented with zoonotic events from 
swine to human hosts containing amino acid 227A (green) or 227E (red), swine influenza virus 
containing amino acid 227E (blue) and A(H1N1)pdm09 (orange). Diamonds indicate viruses 
included in Figure 3.1. Scale indicates number of changes per site. Phylogenetic analysis was 
conducted in Geneious 5.4.5 (Drummond AJ 2011) and performed using standard settings. 
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Figure 3.4 Distribution of amino acids at position 219 in North American swine H1 HA  
Presence of A, E and other amino acids at position 219 in 173 full-length HA sequences of pre 
2009 North-American swine H1 influenza. Sequences were downloaded from the NCBI 
influenza database on 16th March 2011 using the following search criteria: Type A; Host Swine; 
Region North America; Subtype H1N1; Collection Date Before 01-01-2009; Full-length only 
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contain 219K (40 sequences, 69%) and are hypothesised to be introduced into the swine 
population from a human source. Twenty sequences (6%) contained 227T. Both amino acids A 
and T were commonly found at position 219 (165 and 104 sequences respectively, 48% and 
30% respectively). Amino acid I was not found at position 219.  
In summary, these data indicate that the HA of A(H1N1)pdm09 is unique amongst swine 
influenza H1 HAs, combining a human virus like amino acid at residue 227 (E) with an unique I 
at residue 219 in the RBS. 
Having identified residue 227 as a candidate substitution which may have played a key role in 
the ability of A(H1N1)pdm09 to transmit between humans, we then looked more closely at the 
evolution of residue 227 in human influenza H1N1 using both alignments as well as 
phylogenetic trees based on protein sequences of former seasonal H1N1 isolated in different 
decades. HA protein sequences containing at least residues 219 and 227 were selected from 
the NCBI influenza database (Cypel et al. 2008)(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et 
al. 2008)(Cypel et al. 2008)(Cypel et al. 2008)and stratified per decade. Identical sequences 
were collapsed. Isolates from the Fort Dix outbreak (Gaydos et al. 1977a, Gaydos et al. 1977b, 
Hodder et al. 1977, Top and Russell 1977, Gaydos et al. 2006), swine-origin zoonotic infections 
and laboratory isolates were not included.  
A different evolution of residue 227 in human influenza virus is observed compared to swine 
influenza isolates. Whereas in swine influenza viruses residue 227 is consistently A, human 
influenza viruses show changes in this residue from A in the period 1918-1970s, to E in the 
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Figure 3.5 Proposal of genetic evolution of human H1N1 
All subsets of human H1N1 influenza viruses detailed in Table 3.2, divided based on amino 
acids at position 219 and 227, are represented per decade. The most likely candidate 
hypothesized to be the progenitor for the next generation of virus is depicted by the start of the 
arrow. The thickness of the arrows and corresponding percentages show relative distribution of 
219-227 amino acid profile. Dashed arrows depict the reintroduction of H1N1 in the 1970s. The 
N-number on the left-hand side indicates the number of sequences analysed per decade. Boxes 
are coloured based on amino acid at position 227; Red: 227A, Blue: 227E, Green: 227P, 
Yellow: 227H, Purple: 227T, Orange: 227S, Black: 227K, Grey: 227R. Sequences were 
downloaded from the NCBI influenza database on 4th July 2011 using the following search 
criteria: Type A; Host Human; Region Worldwide; Subtype H1N1; Collection Date Before 01-01-
2000; Containing amino acids 219 and 227; Collapse identical sequences; Isolates from the 
Fort Dix outbreak, swine-origin zoonotic infections and laboratory isolates were excluded  
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period 1970s to date. This change seems to go hand in hand with changes in residue 219; in 
the 1970s all isolates with the K substitution at residue 219 also had the E substitution at 
residue 227. Interestingly, the combination of A at both position 219 and 227 is only found in 
1918 isolates, and not in any later human isolates, suggesting this amino acid combination is 
not optimal for infection of the human host. Although other amino acids than A and E are found 
sporadically at position 227, these strains do not seem to perpetuate (summarized in Table 3.2). 
Figure 3.5 is a hypothesized proposal of the evolutionary path H1N1 influenza has undertaken 
in humans since 1918. All isolates are divided by their amino acids at position 219 and 227. This 
figure shows that early in the 20th century, most human viruses contained 219E and 227A, 
which was slowly replaced by 219K variants. Influenza A (H1N1) then completely disappeared 
in 1957, with the emergence of the new H2N2 pandemic virus (reviewed in (Lagace-Wiens, 
Rubinstein and Gumel 2010)). The first viruses isolated after the reintroduction of H1N1 in 1977 
contained 219E and 227A, but these residues rapidly changed to 219K and 227E. No human 
strains with 219T were found. These findings strengthen the hypothesis that residues 219 and 
227 are interconnected, and that the combination of 219A and 227A or 219T and 227A found in 
swine, is not associated with human-to-human transmission. 
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Year 219;  
amino acid (%) 
227;  
amino acid (%) 
# of  
seq 
1918 A (100) A (100) 5 
30s E (66.7), A (33.3) A (55.6), P (22.2), T (11.1), H (11.1) 9 
30s 219A A (100) P (66.7), H (33.3) 3 
30s 219E E (100) A (83.3), T (16.7) 6 
40s E (95), G (5) A (100) 20 
50s K (52.2), E (47.8) A (43.5), P (39.1), S (17.4)  23 
50s 219E E (100) A (90.9), P (9.1) 11 
50s 219K K (100) P (66.7), S (33.3) 12 
70s E (55.6), K (44.4) E (55.6), A (38.9), K (5.6) 18 
70s 219E E (100) A (70.0), E (20.0), K (10.0) 10 
70s 219K K (100) E (100) 8 
80s K (95.4), E (3.1), I (1.5) E (96.9), A (3.1) 65 
90s K (98.4), A (0.8), E (0.8) E (97.7), A (0.8), H (0.8), R (0.8) 128 
 
 
   
Table 3.2 Evolution of amino acid 219 and 227 in human H1N1 
Summary of findings of multiple alignments of human H1N1, stratified per decade. For isolates 
from 1930s, 1950s and 1970s a second stratification is used to highlight the separation of amino 
acids at residue 227 in conjunction with the amino acid at position 219. Sequences were 
downloaded from the NCBI influenza database on 4th July 2011 using the following search 
criteria: Type A; Host Human; Region Worldwide; Subtype H1N1; Collection Date Before 01-01-
2000; Containing amino acids 219 and 227; Collapse identical sequences; Isolates from the Fort 
Dix outbreak, swine-origin zoonotic infections and lab isolates were excluded. 
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Recombinant HA protein Viral Origin Mutation Tag 
E195 A/England/195/09 - Human-Fc, His 
E195 E227A A/England/195/09 E227A Human-Fc, His 
Ohio01 A/Ohio/01/07 - Human-Fc, His 
Ohio01 A227E A/Ohio/01/07 A227E Human-Fc, His 
    
Table 3.3  Recombinant HA proteins produced as part of this study 
 
 
 
 
Virus Origin backbone Origin HA gene Mutation in HA gene  
(H3 numbering) 
E195 A/England/195/09 A/England/195/09 - 
E195 E227A A/England/195/09 A/England/195/09 E227A 
Ohio01 A/England/195/09 A/Ohio/01/07 - 
Ohio01 A227E A/England/195/09 A/Ohio/01/07 A227E 
    
Table 3.4 Recombinant influenza viruses produced by reverse genetics using the 
genetic backbone based on A/England/195/2009 as part of this study. 
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3.2.2 Binding of recombinant H1 HA proteins on HAE and human trachea 
The initial site of human infection by influenza virus is the respiratory tract. The human 
respiratory tract is lined with a ciliated epithelium, interspersed with non-ciliated goblet cells that 
secrete mucus. The combination of these two cell types enables the respiratory tract to create a 
mucus layer which is able to trap inhaled particles and subsequently excrete them. It is 
important to consider the different roles of cells in the human airway epithelium during infection 
to better understand influenza disease. Human airway epithelial (HAE) cell cultures are highly 
differentiated epithelial cultures grown in an air-liquid interface made from human primary cells 
which can be sourced from the nasal cavity, trachea or bronchus. HAE cultures are capable of 
producing mucus and contain beating cilia, tight junctions and several different cells typical of 
the upper respiratory tract; basal cells, goblet cells and ciliated cells. These cultures are thought 
to be the best available in vitro model of the human respiratory tract, as they represent 
differentiated cells normally found in the respiratory tract and contain naturally occurring 
glycans, in contrast to the previously discussed glycan arrays.  
Published work using the HAE culture model found that α2,3-linked sialic acid was found 
exclusively on ciliated cells and consequently avian viruses infected these cells predominantly. 
In contrast, human transmissible influenza viruses displayed a preference for non-ciliated cells 
which expressed α2,6-linked sialic acid (Ayora-Talavera et al. 2009, Shelton et al. 2011, 
Thompson et al. 2006, Matrosovich et al. 2007, Matrosovich et al. 2004a). In our laboratory 
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Figure 3.6 Cloning scheme of HA protein for baculoviral expression 
Expression of recombinant HA proteins was accomplished by cloning the HA gene excluding 
the signal peptide (SP), transmembrane domain (TM) and cytoplasmic tail (CT) a), and 
introducing Sfi1 restriction sites on either site of the partial HA sequence b). The resulting 
product was then ligated into the pAc3CFc His Sfi1 vector c).  
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Ayora-Talavera et al. developed a method to investigate the binding of recombinant HA proteins 
to HAE sections (as described in Materials and Methods) (Ayora-Talavera et al. 2009, Shelton 
et al. 2011). We then compared HA binding to influenza infection, and found the binding of 
recombinant HA proteins to different cell types in the HAE cultures was representative of the 
tropism displayed by influenza virus encoding the same HA (Shelton et al. 2011).  
In order to investigate the effect of the specific amino acid at position 227 in HA on cell tropism 
of influenza virus, HA proteins of influenza viruses of interest were expressed in SF9 insect 
cells. First, cDNA of the HA protein sequences were amplified using primers containing the Sfi1 
restriction site, excluding the transmembrane domain and cytoplasmic tail. The PCR product 
was then cloned into the correct reading frame of the pAc3CFc His Sfi1 expression vector using 
the Sfi1 restriction sites. This vector also contains a human Fc tag for dimerisation of the 
protein, a 6x His tag for detection and a baculovirus gp67 signal peptide to force secretion of the 
protein (See Figure 3.6 for cloning scheme). The E227A mutation at residue 227 could then be 
introduced using the QuickChange site-directed mutagenesis kit (Stratagene). Co-transfection 
of this vector with bacmid DNA into SF9 insect cells resulted in expression of soluble 
recombinant HA protein. Detection of binding was facilitated using the human Fc tag (Shelton et 
al. 2011). A/England/195/2009 (E195, Genbank accession number GQ166661) was chosen as 
a prototypic A(H1N1)pdm09 virus and a single residue variant, E227A, was created in addition 
to the parental sequence.  
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Figure 3.7 Western blot of recombinant HA proteins expressed in SF9 cells 
Protein levels of 1) E195, 2) E195 E227A, 3) Ohio01, 4) Ohio01 A227E. Proteins were run on a 
10% Bis/Tris gel and stained with anti-human Fc. 
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The HA of a swine-origin dead-end zoonosis virus A/Ohio/01/2007 (Ohio01, Genbank accession 
number FJ986620) was expressed similarly. Ohio01 is a swine influenza virus that infected a 
36-year old male but did not transmit between humans. Ohio02, which was shown by Belser et 
al. not to transmit via RD in the ferret model (Belser et al. 2011a), is a virus isolated from the 
patient‟s daughter. It is believed that both of these transmission events originate from the same 
source and do not represent a case of human-to-human transmission. This is evident by an 
identical HA sequence as well as the same date of onset of symptoms (Shinde et al. 2009). 
Both Ohio01 and Ohio02 contain internal gene segments from the triple-reassortment internal 
gene (TRIG) constellation, which predominates in North-American pigs (Olsen 2002, Vincent et 
al. 2008), combined with the H1 HA from classical swine influenza which contains A at position 
227 and T at position 219. Again, a single residue variant, Ohio01 A227E, which was a 
recombinant HA protein mutated to contain the human-like E at position 227 was expressed. A 
list of all recombinant HA proteins produced can be found in Table 3.3. Protein production was 
confirmed with Western Blot against the human-Fc tag and all four HA proteins were found to be 
expressed at similar levels and of a similar molecular weight (Figure 3.7).  
These different recombinant H1 HA proteins were used to investigate whether the cell type in 
HAE cultures that the HA protein preferentially bound to varied according to the amino acid at 
position 227, which would give an indication of whether the 227E substitution in A(H1N1)pdm09 
was responsible for any change in the cell tropism linked to the outbreak. An equal amount of 
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Figure 3.8 Binding of different recombinant H1 HA proteins to HAE sections 
HAE culture sections were probed with HA-Fc recombinant proteins from human or swine origin 
influenza virus. Ciliated cells were identified using anti-acetylated α-tubulin (red) and HA-Fc 
proteins were identified using anti-human Fc antibody (green). Images are representative of 
multiple probed sections. Both ciliated (white arrow) and non-ciliated (yellow arrow) cells were 
found in HAE sections. a) E195; b) E195 E227A; c) Ohio01; d) Ohio01 A227E 
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HA protein was incubated on fixed sections of HAE cultures for all three HA proteins. Dilutions 
were based on the strength of WB bands. The HA proteins with lowest concentration (E195 
E227A and Ohio A227E) were diluted 2-fold and dilutions of E195 HA and Ohio HA were 
prepared such that a similar HA protein concentration would be achieved (4-fold dilution). In 
preliminary experiments, further dilution of HA protein provided no significant difference in HA 
binding profiles (data not shown). Ciliated cells in the formalin fixed HAE sections were 
identified using anti-acetylated α-tubulin antibody (red) and HA protein binding to specific cells 
was detected by anti-human Fc antibody (green) as an Fc-tag was present at the C-terminus of 
all the HA proteins (Figure 3.8). HA protein of wild type E195 showed a preference for non-
ciliated cells, 79.7% of the bound cells were non-ciliated (Figure 3.8a). In total HA protein of 
E195 bound to 29.5% of available cells. In comparison to E195 HA, the HA protein of wild type 
Ohio01 bound to a higher proportion of ciliated cells (61.3% of cells bound were non-ciliated) 
(Figure 3.8c) and a lower percentage of total cells (16.3%). The single mutation at residue 227 
in E195 from E to A doubled the percentage of ciliated cells bound, reducing the proportion of 
non-ciliated cells bound from 79.7% (E195) to 55.0% (E195 E227A) (Figure 3.8b) but at the 
same time increased the percentage of total cells bound to 45.7%. In fact, the number of non-
ciliated cells bound by HA protein of E195 and E195 E227A was very similar (47 and 44 cells 
respectively) but the number of ciliated cells bound by E195 E227A HA protein was tripled 
compared to the number of ciliated cells bound by E195 HA protein (36 and 12 cells 
respectively). Surprisingly, mutation of residue 227 in Ohio01 from A to human-like 
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Figure 3.9 Quantification of recombinant HA protein binding to HAE sections 
The percentages of non-ciliated and ciliated cells was quantified by blind counting >200 cells 
per sample. 
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signature E completely abrogated binding to HAE sections (Figure 3.8d) even though the 
western blot showed that the protein was produced and was stable. Although the sequence of 
the HA gene in the baculovirus transfer vector was verified it is not possible to exclude 
mutations within the eventual P0 or P1 baculovirus constructs.  
Quantification of the binding profiles was obtained by blind counting 5-10 different fields 
containing around 200 cells in total for each HA (Figure 3.9). Using these quantifications, the 
relative ratio of non-ciliated/ciliated cells bound by the recombinant proteins was calculated, 
which was higher for E195 HA (3.9) than for E195 E227A HA (1.2) which was similar to Ohio01 
HA (1.6)  (Table 3.5).  
Using the same recombinant HA protein binding assay, the receptor binding of all four HA 
proteins on formalin fixed ex vivo sections of human trachea was investigated. Ciliated cells 
were identified using anti-acetylated α-tubulin antibody (red) and cells bound by HA protein 
were detected by anti-human Fc antibody (green). Again, HA protein of wild type E195 showed 
a preference for non-ciliated cells, 79.8% of the bound cells were non-ciliated (Figure 3.10a). 
HA protein of Ohio01 showed more binding to ciliated cells and less to non-ciliated cells (66.2% 
of cells bound were non-ciliated) (Figure 3.10c), although the difference was less pronounced 
than in HAE cultures (Figure 3.8c). The single mutation at residue 227 in E195 from E to A 
reduced the proportion of non-ciliated cells bound to 71.1% and again increased the total 
number of cells bound, although not as dramatically as in HAE culture (Figure 3.10b). In fact, 
the percentage of bound cells of all HA proteins was similar on human trachea; E195 
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Figure 3.10 Binding of different recombinant H1 HA proteins to human trachea sections 
Ex vivo human trachea sections were probed with HA-Fc recombinant proteins from human or 
swine origin influenza virus. Ciliated cells were identified using anti-acetylated α-tubulin (red) 
and HA-Fc proteins were identified using anti-human Fc antibody (green). Images are 
representative of multiple probed sections. Both ciliated (white arrow) and non-ciliated (yellow 
arrow) cells were found in HAE sections. a) E195; b) E195 E227A; c) Ohio01; d) Ohio01 A227E 
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bound to 49.4%, Ohio01 bound to 55.1% and E195 E227A bound to 57.5% of total cells. Once 
more, mutation of residue 227 in Ohio01 from A to human-like signature E completely abrogated 
binding to the human trachea sections (Figure 3.10d). The binding profiles were quantified by 
blind counting 5-10 different fields containing around 200 cells in total for each HA (Figure 3.11). 
From this quantification, the relative ratio of non-ciliated/ciliated cells bound by the recombinant 
proteins was calculated, which was higher for E195 (3.9) than E195 E227A (2.5) or Ohio01 (2.0) 
HA proteins (Table 3.5). Although the differences in ratios of ciliated to non-ciliated cells bound 
were more pronounced for HAE cultures than for ex vivo tracheal sections, the overall trend was 
maintained as in every experiment the ratio of E195 was higher than that of E195 E227A and 
Ohio01. This shows that E195 showed a cell tropism more akin to the fully adapted human HAs 
previously studied in this system, such as H3 HA, than to the avian viral HAs such as H5. 
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Figure 3.11 Quantification of recombinant HA protein binding to human trachea sections 
The percentages of non-ciliated and ciliated cells was quantified by blind counting >200 cells 
per sample.  
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3.2.3 Infection of HAE by recombinant influenza viruses with E195, E195 E227A 
or Ohio01 HA 
Work in our laboratory has previously showed that the binding profile of HA proteins to HAE 
sections mirrored the infection profile observed in HAE cultures for a variety of wild type HA 
proteins derived from human and avian influenza viruses (Shelton et al. 2011). To confirm the 
results obtained with HAE sections bound by H1 HA proteins of human and swine origin 
(Section 3.2.2), reverse genetics was used to create isogenic viruses based on the E195 
backbone but containing HA genes of wild-type E195, E195 E227A, Ohio01 or Ohio A227E 
(Table 3.4) (Elleman and Barclay 2004, Fodor et al. 1999). The viruses were rescued in MDCK 
cells. Even though Ohio A227E HA protein was unable to bind cells on fixed HAE cultures, this 
virus did rescue in MDCK cells. Because of doubt about the functionality of the Ohio A227E HA 
protein it was decided not to use the Ohio A227E virus in the infection assay, as the 
complementary recombinant protein binding data was not available  to confirm a correlation. It is 
possible that the sialic acid receptors in HAE cultures are more restrictive than sialic acid 
receptors expressed on MDCK cells, which would then allow for rescue of Ohio A227E in this 
system but would restrict growth in HAE cultures.  
Using a multiplicity of infection (MOI) of 0.1, HAE cultures were infected with virus (E195, E195 
E227A or Ohio01) and fixed 16 hrs post infection (h.p.i.). Ciliated cells were identified using anti-
acetylated α-tubulin (red) and infected cells were identified using anti-NP antibody (green). 
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Figure 3.12 Infection of HAE cell cultures with recombinant H1N1 influenza viruses 
HAE cultures were infected with isogenic viruses based on the E195 backbone but containing 
HA genes of wild-type E195, E195 E227A or Ohio01. Ciliated cells were identified using anti-
acetylated α-tubulin (red) and virus-infected cells were identified using anti-NP antibody (green). 
Images are representative of multiple probed sections. Both ciliated (white arrow) and non-
ciliated (yellow arrow) cells were found in HAE sections. a) E195; b) E195 E227A; c) Ohio01.  
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The cell types infected by the recombinant viruses that varied only in their HA genes mirrored 
the results obtained in the recombinant HA binding assay on HAE sections. E195 preferentially 
infected non-ciliated cells (60.0% cells infected were non-ciliated) (Figure 3.12a), whereas the 
single HA amino acid substitution at residue 227 from E to A decreased the proportion of non-
ciliated cells infected by E195 E227A to 41.4% (Figure 3.12b). Virus with Ohio01 HA infected a 
similar percentage of non-ciliated cells (43.6%) as the E195 E227A mutant virus (Figure 3.12c). 
Both E195 and E195 E227A viruses infected 10% of total cells (10.4% and 10.7% respectively), 
whereas virus with Ohio01 HA actually infected twice as many cells (20.3%). Cell tropism was 
quantified by blind counting around 200 cells per HAE section in 8-10 fields for each virus 
(Figure 3.13). Using these quantifications, the relative non-ciliated/ciliated infected cells ratio 
could be calculated, which was considerably higher for E195 (1.5) than E195 E227A (0.7) or 
Ohio01 (0.8) viruses (Table 3.5). 
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Figure 3.13 Quantification of viral infection of HAE cultures 
The percentages of non-ciliated and ciliated cells was quantified by blind counting >200 cells 
per sample.  
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Recombinant HA/Virus Human trachea HAE 
HA binding HA binding Viral infection 
E195 3.9 3.9 1.5 
E195 E227A 2.5 1.2 0.7 
Ohio01 2.0 1.6 0.8 
    
 
Table 3.5 Ratios of non-ciliated/ciliated cell binding or infection 
Ciliated or non-ciliated infected or bound cells were counted on human trachea and HAE (≥ 200 
cells/section) and ratios were calculated by dividing the number of non-ciliated cells bound or 
infected by the number of ciliated cells bound or infected. 
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 Area Under Curve (Total PFU) 
Time interval E195 E195 E227A Ohio01 
0-48 h.p.i. 1.636 x 10
9 
2.454 x 10
9
 1.130 x 10
9
 
0-72 h.p.i. 3.856 x 10
9
 5.934 x 10
9
 3.050 x 10
9
 
 
 
Figure 3.14 Multi-cycle growth curves of E195, E195 E227A and Ohio01 recombinant 
viruses in MDCK cells 
Comparison of multi-cycle virus growth in MDCK cells inoculated with isogenic viruses based on 
the E195 genetic backbone but containing different HA genes; either wild-type E195, E195 
E227A or Ohio01 at MOI of 0.001. a) Viral titres were determined by standard plaque assay on 
MDCK cells. Data shown represent the mean and standard deviation of 4 replicates. Statistical 
differences between wild type E195 and E195 E227A or Ohio01 were determined using one-
way ANOVA. ** = p<0.01. b) Area under the curve was calculated using Graphpad Prism 4 
Software and presented for each virus in total PFU released between 0-48 h.p.i. and 0-72 h.p.i. 
Significant differences could not be calculated with the current experimental setup. 
 
a. 
b. 
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3.2.4 Replication of recombinant influenza viruses with HA genes of E195, E195 
E227A and Ohio01 in MDCK cells and HAE cultures 
It was previously shown that virus with avian-like sialic acid binding by HA was attenuated for 
multicycle replication in HAE cultures (Scull et al. 2009). Based on the results obtained from the 
HA binding assay on HAE sections and recombinant virus infection of HAE cultures, it was 
hypothesized that the viruses containing swine-like signature amino acid A at residue 227 would 
also be attenuated compared to wild-type E195 in highly differentiated HAE cultures, but not 
monolayer MDCK cells which display abundant sialic acids of both linkages and can be readily 
infected by both swine and human influenza viruses. Confluent monolayers of MDCK cells were 
infected with each virus at an MOI of 0.001 at 33˚C, the proposed temperature of the upper 
respiratory tract (Scull et al. 2009), and samples of supernatant containing released virus were 
taken at different time points up to 72 h.p.i. As expected, all viruses grew with similar kinetics. 
No significant differences were found between viral titres of wild-type E195 and E195 E227A. 
Recombinant virus with Ohio01 HA did show a small but statistically significant attenuation at 12 
h.p.i (Figure 3.14). It is possible that this is caused by a mismatch between Ohio HA and E195 
NA (Yen et al. 2011b). 
HAE cultures were then infected with an MOI of 0.001, apical samples were taken at different 
time points up to 48 h.p.i. In contrast with the results from MDCK cells, wild-type E195 grew to 
significantly higher viral titres than E195 E227A at 33 ˚C at both 12 and 24 h.p.i. (Figure 3.15). 
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 Area Under Curve (Total PFU) 
Time interval E195 E195 E227A 
0-36 h.p.i 1.456 x 10
9 
3.935 x 10
8 
0-48 h.p.i 3.040 x 10
9 
9.503 x 10
8
 
 
Figure 3.15 Multi-cycle growth curves of E195 and E195 E227A recombinant viruses in 
HAE cultures 
Comparison of multi-cycle virus growth in HAE cultures inoculated with isogenic viruses based 
on the E195 backbone but containing HA genes of either wild-type E195 or E195 E227A at MOI 
of 0.001. a) Viral titres were determined by standard viral plaque assay on MDCK cells. Data 
shown represent the mean and standard deviation of 3 replicate cultures. Statistical differences 
between wild type E195 and E195 E227A were determined using one-way ANOVA. * = p<0.05 
b) Area under the curve was calculated using Graphpad Prism 4 Software and presented for 
each virus in total PFU released between 0-36 h.p.i. and 0-48 h.p.i. Significant differences could 
not be calculated with the current experimental setup. 
a. 
b. 
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In addition Ohio01 HA virus grew to lower viral titres than E195 at 33˚C in HAE at each time 
point after 36 h.p.i. although the difference was not statistically significant (Figure 3.16).   
154 
 
 
 
 
 Area Under Curve (Total PFU) 
E195 1.515 x 10
8 
E195 E227A 1.035 x 10
7 
 
Figure 3.16 Multi-cycle viral growth curves of E195 and Ohio01 recombinant viruses in 
HAE cultures 
Comparison of multi-cycle virus growth in HAE cultures inoculated with isogenic viruses based 
on the E195 backbone but containing HA genes of either wild-type E195 or Ohio01 at MOI of 
0.001. a) Viral titres were determined by standard plaque assay on MDCK cells. Data shown 
represent the mean and standard deviation of 3 replicate cultures. Statistical differences 
between wild type E195 and Ohio01 were determined using one-way ANOVA. b) Area under 
the curve was calculated using Graphpad Prism 4 Software and presented for each virus in total 
PFU released. Significant differences could not be calculated with the current experimental 
setup. 
b. 
a. 
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3.2.5 Microneutralisation of E195, E195 E227A and Ohio recombinant viruses 
with E195 antiserum 
The efficacy of pre-existing natural immunity or vaccine induced protection for prevention of 
infection with influenza viruses in humans is mostly monitored by antibodies directed against the 
highly abundant viral exposed surface protein HA protein (Nayak et al. 2010). The ability of 
influenza virus to re-infect humans is associated with variations in antigenic sites of the HA 
protein (Wiley et al. 1981, Caton et al. 1982, Gerhard et al. 1981, Smith et al. 2004), enabling 
the virus to escape the humoral immune system by antigenic drift (Schmolke and Garcia-Sastre 
2010), driven by the selective pressure of neutralizing antibodies in combination with the error-
prone RNA-dependent RNA polymerase (Parvin et al. 1986).  
Residue 227 is located very close to one antigenic site (Ca2) as identified in A/Puerto Rico/8/34 
by Caton et al. (Caton et al. 1982). To test whether mutations at residue 227 affected the 
antigenicity of the viruses Ohio01 HA or Eng195 E227A, their neutralization by antibodies raised 
against E195 was tested in microneutralisation assays. 
The 50% tissue culture infective dose (TCID50) of each recombinant virus; wild-type E195, 
E195 E227A, Ohio01 and Ohio01 A227E was determined on MDCK cells seeded in 96-well 
plates. All viruses were then diluted to 100 TCID50 and incubated with serially diluted ferret 
serum raised against E195, followed by incubation on MDCK cells seeded in 96-well plates. All 
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Virus E195 E195 E227A Ohio01 Ohio01 A227E 
MN titre exp. 1  6400 3200 4480 16640 
MN titre exp. 2 20480 4480 5760 35840 
Average 16640 3840 5120 26240 
 
 
 
 
    
Table 3.6 Microneutralisation of H1N1 viruses with ferret post-infection antiserum raised 
against E195. 
Viruses were incubated with serial dilutions of anti-E195 antiserum for one hr at 37°C, followed 
by incubation on MDCK cells for one hr at 37°C. The 96-well plates were stained with crystal-
violet after incubation for 4 days at 37°C. Data shown represent the mean of 4 replicate 
cultures. The average represents the average of both experiments.  
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viruses were neutralized by ferret serum raised against E195, including Ohio01 and Ohio01 
A227E. There were no major differences in microneutralisation titre between any of the viruses 
examined. Viruses containing A at residue 227 (E195 E227A and Ohio01) showed a small 
decrease in microneutralisation titre compared to viruses containing E at this position (wild-type 
E195 and Ohio01 A227E) but variation between assays performed at different times was too 
large to conclude this was a genuine effect (Table 3.6).  
Interestingly, serum raised in ferrets against E195 wild type neutralised Ohio01, reaffirming the 
close relationship of these two viruses. 
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3.3 Discussion 
In this chapter hypothetical changes in the HA sequence were investigated which enabled the 
virus to transmit between humans. HA multiple sequence alignments found that amino acid 227 
in previous seasonal H1N1 viruses is usually E, whereas in swine influenza it is usually A, 
suggesting that the specific amino acid at this key position in the virus RBS might serve to 
optimize the interaction between virus and the human host at the point of entry. To investigate 
this, the swine-like amino acid A was introduced in the HA of E195 (E195 E227A) which was 
then expressed as recombinant protein or whole virus. E195 virus containing the HA gene of 
swine influenza virus Ohio01 was rescued. Finally, Ohio01 recombinant protein was produced. 
In HAE cultures, E195 was shown to bind (HA protein) and infect (reverse genetic virus) more 
non-ciliated cells than E195 E227A and Ohio01 and multi-cycle viral growth of both E195 E227A 
and Ohio01 was found to be attenuated in comparison to E195 in HAE cultures. 
When H1N1 was reintroduced in 1977 the amino acids 219K and 227E were fixed soon after. 
However, A(H1N1)pdm09 contained 227E in combination with 219I, an amino acid only found 
twice in swine isolates and once in human isolates at this position. This dissimilarity, as well as 
the more prevalent changes of amino acids at residue 219 compared to 227 as shown in Figure 
3.1, Figure 3.4 and Figure 3.5, led us to focus in this study on residue 227 which seemed to be 
less tolerant of substitutions and therefore of greater importance in a switch in receptor 
preference compared to position 219. Nonetheless, amino acid substitution 219K in 
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A(H1N1)pdm09 influenza virus A/California/04/2009 has been found to result in increased HA 
binding and RD transmission in a ferret model (Jayaraman et al. 2011). 
We first compared the cell tropism of the HA protein of a prototypic A(H1N1)pdm09 strain E195 
with the HA mutant E195 E227A and the dead end zoonotic virus Ohio01 in HAE cultures.  Both 
E195 E227A and Ohio01 were found to bind a higher proportion of ciliated cells than wild type 
E195 virus indicating a shift in receptor preference towards α2,3-linked sialic acid binding. 
Published work using the HAE culture model has indicated that α2,3-linked sialic acid is found 
exclusively on ciliated cells and consequently avian influenza viruses bind and infect these cells 
predominantly in contrast to human transmissible viruses that preferentially bind and infect non-
ciliated cell types (Thompson et al. 2006, Ayora-Talavera et al. 2009, Shelton et al. 2011, 
Matrosovich et al. 2007, Matrosovich et al. 2004a). The relevance of these binding profiles has 
yet to be directly correlated with transmissibility of influenza viruses but the tendency of viruses 
that are unable to transmit between humans to infect only ciliated cells (Matrosovich et al. 2007, 
Shelton et al. 2011) suggests an entry preference that could be the foundation of transmission. 
Therefore by infecting an increased proportion of ciliated cells and a decreased number of non-
ciliated cells in the HAE system, the likelihood or efficiency of transmission in vivo might 
decrease.  
An interesting example of the interconnectivity of cell tropism and transmission can be found in 
a set of H3N2 reverse genetic viruses mutated in their RBS. After mutation of the human H3N2 
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virus A/Hong Kong/1/68 at residues 226 and 228, the infected non-ciliated/ciliated ratio was 
changed from approximately 3 to <0.05 (Matrosovich et al. 2007).  
Our laboratory previously showed that the spread of the human influenza A (H3N2) virus; 
A/Victoria/3/75, in HAE was profoundly attenuated by the introduction of avian-like amino acid 
substitutions L226Q and S228G into the HA RBS, (Scull et al. 2009). The same mutations 
completely abolished transmission of A/Victoria/3/75, in the ferret model (Roberts et al. 2011). 
Based on these findings, the results of the multi-cycle growth curves performed in HAE in this 
study suggest that E195 E227A would be less able to transmit in a ferret model. 
In generating the opposite „humanizing„ mutation in the Ohio 01 HA protein (227E), we were 
surprised to find that it abrogated HA binding to the HAE in our system (Figure 3.8d and Figure 
3.10d). This might suggest that only a limited number of swine influenza viruses can 
accommodate the humanizing mutations. Interestingly the same mutation was tolerated in the 
context of an infectious virus with Ohio01 HA containing the A227E mutation. As can be 
observed in Figure 3.8b, mutating E195 at residue 227 to A greatly increased the HA binding to 
the HAE section. Similarly, introducing Ohio01 to contain E at 227 could lead to a decrease in 
sialic acid binding. It may be that the loss of sialic acid affinity linked to E at 227 in Ohio01 
results in an HA with undetectable binding to epithelial sialic acid in these conditions. In 
contrast, the multivalency of Ohio01 A227E recombinant virus increases avidity, allowing the 
virus to bind sialic acid and to be a viable virus.  
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For all other HA mutations recombinant viruses were rescued as expected and their tropism 
reflected that of the HA proteins. This suggests that HA protein binding profiles were not altered 
by tissue processing or fixation methods. The results with the virus infections were always 
somewhat less clear cut than with HA. This phenomenon has been observed before (Shelton et 
al. 2011).  
Binding of HA protein to HAE sections also provided a more stringent result than binding to 
human trachea sections. It is possible that sialic acid distribution on epithelial cells in HAE 
sections is more discriminative compared to sialic acid distribution in the human trachea. This 
makes HAE sections a much better tool to determine sialic acid preference than sections of the 
human trachea. 
Maines et al. suggested that residue 227, which is found in the RBS of HA, in combination with 
residue 219 stabilizes the orientation of amino acid 190 (Maines et al. 2009, Soundararajan et 
al. 2009) which, in turn, is important in the receptor binding preference of HA (Tumpey et al. 
2007). They proposed that the combination of 227E with 219I found in the HA of 
A(H1N1)pdm09 viruses destabilizes this network and this may explain the lower α2,6-linked 
sialic acid binding of A(H1N1)pdm09 HA as compared with that of 1918 HA (Maines et al. 
2009). Theoretical modelling of the A(H1N1)pdm09 HA led Soundararajan et al. to hypothesize 
that residue 227 stabilized the orientation of 222K (Soundararajan et al. 2009), itself a 
component of a “lysine fence” that acts to anchor α2,6-linked glycans. This interaction and the 
importance of the lysine fence remain to be proven experimentally. 
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Jayaraman et al. corrected the interaction network between 227 and 219 in A(H1N1)pdm09 by 
changing residue 219 to the amino acid found in seasonal H1N1 in human isolates (lysine, K), 
thereby creating a theoretically more stable ionic network. This mutant showed both increased 
binding to α2,6-linked sialic acid and increased RD transmission in a ferret model. A second 
mutant, with the hydrophobic network corrected by changing three residues E227A, S186P and 
A189T, also showed increased α2,6-linked sialic acid binding compared to wild type, although 
no data on its transmissibility in animal models is available (Jayaraman et al. 2011). Although 
these studies suggest mutational pathways by which A(H1N1)pdm09 would increase its binding 
affinity to human receptors, it is interesting that these substitutions have not yet emerged during 
the virus transmission through human hosts (Baillie et al. 2012). It is likely that yet unknown 
mutations will be able to increase α2,6-linked sialic acid affinity. The recent pandemic allows 
scientists to record mutations in the HA protein and changes in α2,6-linked sialic acid affinity in 
real-time, providing the perfect opportunity to gain more insight into the evolution of HA in a new 
host. 
De Vries et al. investigated the importance of residue 227 in binding sialic acid by comparing 
binding of fetuin, which contains α2,3-linked sialic acid and α2,6-linked sialic acid in an 
approximate 2:1 ratio,  to different HA proteins. HA proteins of swine influenza showed greater 
binding to fetuin compared to A(H1N1)pdm09 HA. By creating chimeric proteins with regions of 
swine influenza HA or A(H1N1)pdm09 HA, as well as by single-residue mutations it was found 
that introducing only E227A in A(H1N1)pdm09 increased fetuin binding and conversely 
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introducing A227E in swine HA decreased fetuin binding. This clearly demonstrates that residue 
227 alone is capable of changing the receptor binding profile of HA (de Vries et al. 2011). In  the 
present study, an increased binding intensity to HAE was observed for E195 E227A HA (Figure 
3.8b), which could be due to a correction of the hydrophobic network between 219 and 227 
(Maines et al. 2009) similar to the increased binding of the same HA to fetuin reported by de 
Vries et al. (de Vries et al. 2011). 
Yewdell has suggested that the neutralization capacity of an antibody depends on the affinity of 
HA for sialic acid receptors (Hensley et al. 2009). We were therefore interested to see whether 
we could detect difference in neutralization of viruses that differ only in this receptor binding 
capacity. The antigenicity of E195, E195 E227A, Ohio and Ohio A227E was investigated using 
antiserum raised against E195 in ferrets. Although residue 227 is found close to a known 
antigenic site of HA (Caton et al. 1982), no change in antigenicity was found when comparing 
E195 to E195 E227A. Further research using monoclonal antibodies would completely exclude 
a possible role of residue 227 in sensitivity to antibodies. Interestingly, both Ohio and Ohio 
A227E were sensitive to antibodies against E195, providing further evidence of the close 
relatedness of E195 and Ohio, which is also observed in the phylogenetic tree (Figure 3.3).  
We established potential correlates of human to human transmission, by defining the ratios of 
non-ciliated/ciliated cell binding in the HAE cell model. We and others (Ayora-Talavera et al. 
2009, Shelton et al. 2011, Matrosovich et al. 2004a) have observed that human influenza virus 
preferably bound or infected non-ciliated cells, whereas avian viruses bound or infected ciliated 
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cells. This ratio (to be found in Table 3.5) can potentially predict the ability of a virus to transmit 
between humans; the virus needs to be able to infect a certain percentage of non-ciliated cells 
to transmit to another human host.  
Future research to establish these correlations and to further determine whether the 
hypothesized mutation at position 227 in the HA protein of A(H1N1)pdm09 was beneficial in the 
start of the pandemic should be done using transmission models, e.g. ferrets. 
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4 Transmission studies of wild type E195 and E195 E227A in ferrets 
4.1 Introduction 
In Chapter 3 the changes in cell tropism and viral growth resulting from a mutation in residue 
227 of HA from E to swine-like A (E227A) in A(H1N1)pdm09 virus (E195 E227A) were 
discussed. These results, showing a more human-like cell tropism and increased viral titres with 
E rather than A at position 227, suggested that this residue was important for A(H1N1)pdm09 
virus in gaining the ability to transmit from human-to-human, an essential feature of a pandemic 
virus. To further investigate the importance of residue 227 in transmission, we examined the 
ability of E195 E227A to transmit within the ferret (Mustela putorius furo) model. Several 
different models are currently available to investigate infection and transmission of influenza 
virus, which are extensively reviewed by Belser et al. (Belser, Katz and Tumpey 2011b, Belser 
et al. 2009b). Traditionally the mouse model has been used to study pathogenesis of influenza 
virus, due to advantages such as low cost and readily available reagents which allow the study 
of for example cytokines (Conn et al. 1995, Hennet et al. 1992). Furthermore, the mouse model 
permits examination of the role of single genes in influenza infection due to the availability of 
transgenic mice (Belser et al. 2009b). However, due to an absence of α2,6-linked sialic acid in 
the respiratory tract of mice (Ibricevic et al. 2006) adaptation of human influenza strains is 
necessary to establish an infection in this model. Moreover, mice do not present with the same 
clinical signs as humans; fever, nasal secretions or coughing and sneezing are not detected in 
the mouse model (Belser et al. 2011b). Lastly, this model is not suitable to test the transmission 
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potential of influenza viruses and the organism has to be euthanized to determine viral titres 
(Belser et al. 2009b).  
A relatively new model to study transmission (either via contact or via respiratory droplets) of 
influenza in small mammals, the guinea pig, has been developed by the Palese laboratory 
(Lowen et al. 2006). This model does not require prior adaptation of human influenza strains. 
Like humans, guinea pigs express α2,6-linked sialic acid in the upper respiratory tract (Sun et al. 
2010) which may explain the ability of human influenza virus to transmit between donor and 
sentinel guinea pigs. However, like mice, guinea pigs lack many clinical signs observed in 
humans during influenza infection and they are a poor model of pathogenesis; highly virulent or 
pathogenic influenza strains such as the 1918  and H5N1 viruses which caused high mortality in 
humans, left guinea pigs almost unaffected (Van Hoeven et al. 2009a).  
Non-human primates have been used to study influenza infection, as these mammals are 
closely related to humans. Features such as the complex immune response to influenza 
infection can be more relevantly studied in primates than in smaller mammals (Kobasa et al. 
2007) and this model has been applied to the study of highly pathogenic influenza strains 
(Kobasa et al. 2007, Rimmelzwaan et al. 2001). Naturally, experimental procedures using non-
human primates are costly and ethical considerations as well as the large size of the animals 
and the need for specialist facilities have limited the number of experiments performed with this 
model.  
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Pigs have been recognised as a host for influenza virus since 1931 (Shope 1931) and therefore 
form an obvious transmission model. Indeed, replication of avian influenza virus (Hinshaw et al. 
1981) as well as human and swine influenza strains (Landolt et al. 2003) can be studied within 
the swine host without prior adaptation. Furthermore, transmission experiments between pigs 
have been successful (Brookes et al. 2010). Finally, the pig model can be used to study vaccine 
efficacy or cytokine production (Van Reeth, Van Gucht and Pensaert 2002). However, pigs are 
relatively difficult to handle due to their size, and costing is greatly increased when the use of 
„high health status herd‟ pigs (pigs tested against e.g. swine influenza) is required.  
A low-cost alternative to the above models is the cotton rat. This model supports replication of 
influenza virus without prior adaptation and virus can be recovered from nasal washes. 
However, it is thought that transmission studies cannot be performed in this model due to a lack 
of the sneeze reflex (Eichelberger 2007), although guinea pigs do not have the sneeze reflex 
either.  
In comparison to all the above models, the ferret model has several obvious advantages for 
study of influenza pathogenesis and transmission. In ferrets, the anatomical distribution of sialic 
acid in the respiratory tract is similar to that observed in humans; α2,6-linked sialic acid is found 
in abundance in the upper respiratory tract, whereas α2,3-linked sialic acid is mostly detected in 
the lungs (Shinya et al. 2006, Kirkeby, Martel and Aasted 2009). A recent study further defines 
the location of α2,6-linked sialic acids recognised by humanised influenza viruses to 
submucosal glands in the lung hilar region in ferrets and compares these tissues to the more 
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prominent goblet cells in human tissue (Jayaraman et al. 2012). Furthermore, ferrets are 
naturally susceptible to influenza infection (Swenson et al. 2010) and human influenza viruses 
are able to replicate efficiently in the respiratory tract without prior adaptation (Maines et al. 
2009, Munster et al. 2009, Itoh et al. 2009, Kim et al. 2009). Upon infection, ferrets display 
clinical symptoms such as fever, nasal secretions, coughing, sneezing, anorexia and lethargy 
which can all be observed in human patients (Belser et al. 2011b). Furthermore, transmission of 
influenza virus in the ferret model has been established in both a contact model, where an 
infected donor animal is co-housed with a naïve sentinel animal, as well as a RD model, where 
an infected donor animal is housed next to a naïve sentinel animal and direct contact is 
prohibited (Maines et al. 2006, Herlocher et al. 2001, Yen et al. 2007). The combination of these 
factors makes the ferret model understandably the best model to study influenza infection. 
Ferret transmission experiments can be performed in two different ways. Firstly, the ability of the 
virus to transmit via contact is investigated by co-housing an influenza virus-inoculated ferret 
with a sentinel ferret. Secondly, the ability of the virus to transmit via respiratory droplets is 
investigated by housing an influenza virus-inoculated ferret next to a sentinel ferret. The cages 
are placed in close proximity (25 mm distance in our set-up) and contain perforated side walls (5 
mm holes in our set-up) to allow for air exchange from donor animal towards aerosol sentinel 
but prevent direct contact between the ferrets. An interesting example of the difference between 
these two measurements was demonstrated by Belser et al. (Belser et al. 2011a). Two different 
swine-origin triple reassortant viruses isolated from sporadic human cases not associated with 
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transmission between humans were investigated (A/Ohio/02/2007 and A/Texas/14/2008). Both 
of these viruses were able to transmit via contact, but not via RD transmission. In comparison, 
A(H1N1)pdm09 transmitted to all contact sentinel ferrets, and 6 out of 9 RD sentinel ferrets. 
This suggests that although viruses that are transmitted via contact transmission might be 
closer to causing a pandemic in the human host, RD transmission is a necessity.  
Numerous ferret transmission studies with different influenza virus strains have been performed, 
and show an excellent predictive value. Human influenza viruses which evidently are able to 
transmit between humans are found to be transmitted between ferrets (Herlocher et al. 2001, 
Herlocher et al. 2004, Roberts et al. 2011). In contrast, avian influenza viruses such as H5, H7 
and H9 are not transmitted between ferrets, which reflects the inability of avian influenza viruses 
to cause human-to-human transmission (Wan et al. 2008, Yen et al. 2007, Peiris 2009, Belser et 
al. 2007). An outbreak of H7N7 in poultry in the Netherlands was linked to 89 human cases with 
reported human-to-human transmission to three household contacts (Du Ry van Beest Holle et 
al. 2005). Consequently, contact transmission studies with this virus revealed transmission in 
2/3 contact sentinels but no virus was detected in RD sentinels (Belser et al. 2008).  
Predictions based on single-point mutations regarding transmissibility of an influenza virus, such 
as the hypothesis discussed in this chapter, have been investigated previously. Often in the 
ferret model transmission of viruses that have been generated by reverse genetics has been 
monitored both via contact and respiratory droplet. The first study of this kind compared the 
transmission of 1918 virus with transmission of the parental virus mutated at residue 190 
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(D190E) and 225 (D225G) of the HA protein. These two mutations conferred the virus to a more 
avian-like receptor binding preference (Glaser et al. 2005, Stevens et al. 2006a). RD 
transmission of both viruses was assessed by housing a donor animal next to a naïve ferret. 
Wild type 1918 virus was detected in nasal washes from 3/3 sentinels, but 0/3 sentinels 
exposed to mutant 1918 D190E D225G had viral titres in nasal washes (Tumpey et al. 2007).  
Substitutions in the HA protein of H3 influenza virus at position 226 and 228 have been shown 
to change receptor binding preference (Connor et al. 1994, Rogers et al. 1983, Vines et al. 
1998), as well as cell tropism (Matrosovich et al. 2007). Recent studies showed that mutating an 
H3 virus to contain the more avian-like amino acid substitutions L226Q and S228G completely 
abrogated transmission in a ferret model even when the animals where in direct contact with 
each other during the exposure period (Roberts et al. 2011). The same effect was found in 
H2N2 viruses isolated during the 1957/58 pandemic; H2N2 with the human residues 226L and 
228S transmitted to 3/3 RD sentinels, whereas H2N2 with the avian residues 226Q and 228G 
transmitted to 1/3 RD sentinels and this transmission event was associated with a Q226L 
mutation in the HA protein (Pappas et al. 2010).  
We hypothesise that the E227A mutation in E195 abrogates or attenuates host-to-host 
transmission and aim to investigate this hypothesis using the above described ferret 
transmission model. Due to the increased binding to ciliated cells, it is further hypothesised that 
E195 E227A-infected ferrets display a more severe disease. This will be investigated by close 
observation of ferrets inoculated with either wild type E195 or E195 E227A.  
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4.2 Results 
4.2.1 Transmission of E195 and E195 E227A in a ferret model 
The ferret model is generally accepted as the most relevant system for investigation of human-
to-human transmission of influenza viruses as the distribution of sialic acid in the respiratory 
tract of humans and ferrets is comparable and ferrets display clinical signs typical of the 
symptoms of human disease (Shinya et al. 2006, Langlois 2005, Kirkeby et al. 2009, Reuman, 
Keely and Schiff 1989). An experimental set-up was devised whereby we were able to measure 
both direct contact transmission, via the co-housing of an inoculated donor ferret with a naive 
contact sentinel ferret, and RD transmission by placing a sentinel animal in a cage adjacent to 
the same donor animal, with the RD sentinel separated by a perforated plastic barrier which 
completely prevented contact (Figure 4.1).  
In preliminary studies we found that, like many other A(H1N1)pdm09 viruses studied in this 
manner (Maines et al. 2009, Munster et al. 2009, Itoh et al. 2009), E195 transmitted to all 
contact ferrets in a co-housed model and to two of three sentinel ferrets housed in adjacent 
cages by RD transmission (data not shown). In the current study, we confirmed the RD 
transmission of wild type E195 virus. Three ferrets were inoculated intranasally with 103 PFU 
E195 in 200 µl under light anaesthetic. This is a lower inoculum than generally used by others in 
the field in a smaller volume. Twenty-four hrs post inoculation (p.i.) an RD sentinel was 
introduced to the cage adjacent to the donor animal and infectious viral shedding by both on 
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Figure 4.1 Diagram of cage setup transmission experiments 
The placement of the different animals in the cages is depicted per timeframe. Every square 
represents one cage; the dotted line represents the perforated division between two cages. In 
the first 24 hrs after inoculation, the donor animal was placed in one cage. 24 hrs post-
inoculation, a contact sentinel was introduced in the same cage, whereas a respiratory droplet 
sentinel was introduced in an adjacent cage. The perforated separation walls (5 mm holes) 
between the cages containing donor and respiratory droplet sentinel animal were 25 mm apart. 
48 hrs post-inoculation, the contact sentinel was moved to a separate cage to ensure the 
respiratory droplet sentinel was only exposed to one infected animal. The photo shows four 
cages which were occupied by two donor and contact sentinel pairs during the experiment. 
 
airflow 
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Figure 4.2 Nasal washing ferrets 
a/b) Both nostrils of the ferret were washed with a total of 1 ml of sterile PBS. c/d) The 
expectorate was collected in modified 250 ml centrifuge tubes.  
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Figure 4.3 Transmission of wild type E195 to respiratory droplet sentinels 
Viral titres in nasal wash samples of ferret pairs. Each pair contained one donor ferret (solid 
lines) and one respiratory droplet sentinel ferret (dotted lines). Donors were inoculated with 103 
PFU E195 virus. Samples were taken daily and viral titres were determined by standard plaque 
assay on MDCK cells. Please see Table 4.1 for exact numbers on days of shedding, peak titre 
and area under the curve. 
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donors and respiratory sentinels was monitored by daily nasal washing (Figure 4.2) and virus 
titration MDCK cells. All donors inoculated with E195 became positive for infectious virus in 
nasal wash on day 1 p.i. Viral shedding was detected in nasal washes from RD sentinels 
starting on day 3, 4 and 6 p.i. 
Peak E195 viral titres reached by RD sentinels (average of 9.7 x 105 PFU/ml) were comparable 
to peak viral titres reached by donors (average of 1.9 x 106 PFU/ml) and viral shedding was 
detected for 4 and 6 days (Figure 4.3) in line with inoculated donors that all shed infectious virus 
from the nose for 6 days. Thus it is likely that under these conditions ferrets would be able to 
support a chain of transmission of E195 by respiratory droplet. 
Next we assessed transmission of the E195 virus with the mutation engineered in the HA 
receptor binding site at position 227 from E to A (E227A). Five donor ferrets were inoculated 
with 104 PFU of E195 E227A via the intranasal route. A higher dose was used for this virus in 
order to assure robust infection of the donor animals given the modest attenuation of replication 
in the HAE cultures (see section 3.2.4). Twenty-four hrs p.i. two contact sentinel ferrets were 
introduced to two out of five inoculated donors to assess contact transmission and placed in an 
adjacent cage after a further 24 hrs. A RD sentinel was exposed to four out of five inoculated 
donors in adjacent cages to determine if efficient RD transmission was achieved by this virus 
(see diagram in Figure 4.1).  
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Figure 4.4 Transmission of E195 E227A to contact and respiratory droplet sentinels 
Viral titres in nasal wash samples of ferret sets. Each pair contained one donor ferret (solid 
lines) and one respiratory droplet sentinel ferret (dotted lines) and/or contact sentinel (dashed 
lines). Donors were inoculated with 104 PFU E195 E227A. Samples were taken daily and viral 
titres were determined by standard plaque assay on MDCK cells. Please see Table 4.1 for 
exact numbers on days of shedding, peak titre and area under the curve. Contact sentinels; 
group c and d; respiratory droplet sentinels; group a, b, c and e; * = Mutated virus E195 A227T 
obtained from nasal wash 
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Duration of shedding 
(days) 
Peak titre 
(PFU/ml) 
Area Under Curve (AUC) 
(Total PFU shed) 
 E195 
E195 
E227A 
E195 
E195 
E227A 
E195 
E195 
E227A 
Donors 
6 
6 
6 
6 
6 
5 
5 
3.1 x 10
6 
1.6 x 10
6 
9.5 x 10
5 
4.0 x 10
6 
3.1 x 10
5 
1.4 x 10
6 
3.5 x 10
7 
3.2  x 10
6
 
1.6 x 10
6
 
1.5 x 10
6
 
4.2 x 10
6
 
4.4 x 10
5
 
1.4 x 10
6 
3.5 x 10
7
 
Average 6 5.5 
1.9 x 10
6 
(± 1.1 x 10
6
) 
1 x 10
7 
(± 1.7 x 10
7
) 
2.1 x 10
6 
(± 9.8 x 10
5
) 
1 x 10
7 
(± 1.7 x 10
7
) 
 
Respiratory 
Droplets 
6 
6 
4 
5 
5 
2 
2 
3.6 x 10
5 
1.4 x 10
6 
1.2 x 10
6 
1.7 x 10
7 
5.5 x 10
6 
1.4 x 10
4 
3.8 x 10
3 
4.4 x 10
5
 
4 x 10
6
 
1.9 x 10
6
 
1.8 x 10
7
 
6.5 x 10
6
 
2.3 x 10
4 
3.9 x 10
3
 
Average 5.3 3.5 
9.8 x 10
5
 
(± 5.5 x 10
5
) 
5.6 x 10
6
 
(± 8 x10
6
) 
2.1 x 10
6 
(± 1.8 x 10
6
) 
6 x 10
6
 
(± 8 x 10
6
) 
       
       
Table 4.1 Summary of results transmission experiments 
Duration of shedding, peak titre and AUC were compared between ferrets directly inoculated or 
infected by respiratory droplet contact with wild type E195 or E195 E227A. Averages are 
displayed in bold with standard deviation indicated in brackets.  None of the groups were 
significantly different as determined by Student‟s t-test.  
 
179 
 
All of the donors inoculated with E195 E227A became positive for infectious virus in nasal wash 
on day one (3/5) or two (2/5) p.i. (Figure 4.4). Viral titres shed were greater than from ferrets 
infected with wild type E195 virus (mean peak titre of E195 E227A virus shed was 8.2 x 106 
PFU/ml). This is potentially caused by the higher inoculum dose used for E195 E227A (104 
PFU/ferret) compared to E195 (103 PFU/ferret). Shedding duration was similar to that of the wild 
type E195 virus (5-6 days).  
Both contact sentinels were robustly infected (average peak shedding of 1.8 x 105 PFU/ml) with 
no difference in duration of shedding (6 days in both contacts) in comparison to the duration of 
shedding in inoculated donors of both the wild type E195 and E195 227A viruses. 
Infectious virus was detected in at least two consecutive daily nasal washes for all four RD 
sentinels (4/4). Virus shedding in nasal washes from the RD sentinels exposed to E195 E227A 
occurred at a range of times after first exposure and to various titres. Two respiratory sentinel 
animals shed robust peak virus titres (1.7 x 107 and 5.5 x 106 PFU/ml) with duration of 5 days 
comparable to wild type E195 RD transmission. The other two respiratory sentinel animals 
showed a reduced duration of shedding (2 days) and considerably lower peak viral titre (1.4 x 
104 and 3.8 x 103 PFU/ml) (Figure 4.4). However, none of the observed differences were found 
to be significant. 
Table 4.1 shows a summary of the transmission experiments. 
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Figure 4.5 Activity chart of E195 and E195 E227A inoculated ferrets 
Donor animals were observed daily for one hour before nasal washing during the first 12 days 
of the experiment. Activity was scored every 15 min, awarding one point if the animal was 
asleep, two points if it was awake but not active and three points if it was active. a) E195 
inoculated animals; b) E195 E227A inoculated animals; c) average of activity per day for E195 
inoculated animals (blue) and E195 E227A inoculated animals (red). Statistical differences 
between wild type E195 and E195 E227A were determined using Student‟s t-test. ** = p<0.01 
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4.2.2 Symptoms and behaviour of ferrets during infection with E195 or E195 
E227A 
As described in Chapter 3, it was observed that recombinant E195 E227A HA bound more 
intensively to cells in the HAE cultures than E195 HA (Figure 3.8). This observation in 
combination with the increase in ciliated cell binding and infection of ciliated cells by E195 
E227A compared to wild type E195 suggests a more avian-like binding profile. It is therefore 
possible that the virus is capable of penetration deeper into the respiratory tract of the ferret, 
which in turn could lead to higher pathogenesis. Furthermore, as is hypothesised by Liu et al. 
(Liu et al. 2010), the increased infection of ciliated cells could have a marked effect on the 
mucociliary clearance function of the upper respiratory tract and thereby increase the severity of 
disease. To investigate the clinical signs associated with infection, three donor animals were 
observed daily for one hour in the morning for the first 12 days of each experiment.  
Activity was scored every 15 min on a 3-point scale; 1 point when the animal was asleep, 2 
points if the animal was awake but inactive, 3 points if the animal was awake and active. This 
allowed for a maximum score of 12 points per day. During the hour, every single sneeze and 
cough was scored and sneeze fits were scored separately, recording both the number of 
sneeze fits and the number of sneezes per fit. The body weight of every animal was recorded 
daily before nasal washes were taken. 
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Figure 4.6 Number of sneezes and coughs of ferrets during infection with wild type 
E195 or E195 E227A 
Donor animals were observed daily for one hr before nasal washing during the first 12 days of 
the experiment; a) total number of sneezes (includes all sneezes in sneezing fits); b) number of 
coughs; E195 inoculated animals (N=3) (blue) and E195 E227A inoculated animals (N=3) (red). 
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All ferrets showed decreased activity during infection. Both groups of donor animals were active 
at the start of the experiment before inoculation at day 0. The first dip in activity for all animals 
infected with E195 was observed at day 3 (average score; 5.3), with a second dip observed at 
day 7 (average score; 5) and the last dip at day 9 (average score; 4) (Figure 4.5a.). Donor 
animals inoculated with E195 E227A also experienced three dips in activity, their first dip was 
slightly earlier on day 2 (average score; 6), with a similar dip observed at day 7 as in E195 
inoculated animals (average score; 5) and the last dip at day 10 (average score; 7.7) (Figure 
4.5b). The only significant difference found in activity was at day 9 when ferrets infected with 
wild type E195 were relatively inactive compared to ferrets inoculated with E195 E227A (Figure 
4.5c).  
No difference was found when comparing the number of coughs of ferrets inoculated with wild 
type E195 or E195 E227A (Figure 4.6b). However, it was observed that animals inoculated with 
wild type E195 were sneezing more than animals inoculated with E195 E227A at days 4 to 7, 
whereas the ferrets inoculated with E195 E227A had an increase in the number of sneezes on 
days 9 to 11 (Figure 4.6a). Interestingly, this correlates with the days when the paired RD 
sentinels became positive; the RD sentinel paired with a donor that had increased number of 
sneezes from 0 to 42 on day 9 did not show virus in the nasal wash until day 9, whereas the RD 
sentinel paired with a donor showing an increased number of sneezes from 26 to 117 on day 10 
did not show virus in the nasal wash until day 12. It should be noted however that at these later 
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Figure 4.7 Relative body weight of ferrets during infection with either wild type E195 or 
E195 E227A 
The body weight of all animals was recorded daily just before nasal washing; a) Wild type E195; 
b) E195 E227A; c) Average body weight of donor animal inoculated with wild type E195 (blue 
solid line) or E195 E227A (red solid line), respiratory droplet sentinels infected with wild type 
E195 (blue dotted line) and E195 E227A (red dotted line) and contact sentinels infected with 
E195 E227A (red dashed line). No uninfected animals were monitored. Statistical differences 
between donors inoculated with wild type E195 or E195 E227A were determined using a 
Student‟s t-test. * = p<0.05 
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time points no virus could be found in the nasal wash of the donors (Figure 4.4).  
The body weight of every ferret was measured daily to monitor the progression of infection and 
health of the animal. There was greater variation in body weight of ferrets infected with E195 
E227A (Figure 4.7b) compared to body weight of ferrets infected with wild type E195 (Figure 
4.7a). Furthermore, when the average body weight of ferrets were compared by virus (wild type 
E195 or E195 E227A) and origin (donor, RD or contact) it was observed that donors inoculated 
with E195 E227A had a lower average body weight than donors inoculated with wild type E195 
(Figure 4.7c). No significant differences were observed between the RD sentinels infected with 
wild type E195 or E195 E227A. RD and contact sentinels were less affected by weight loss than 
donors. This difference was significant between donors and sentinels infected with E195 E227A 
from 6 days p.i. onwards (Figure 4.7c). It should be noted that the donor animals obtained a 
very different dose of virus than the sentinel animals, which likely explains this difference.  
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Figure 4.8 Molecular characterization of virus shed by a donor and respiratory droplet 
pair 
Influenza virus in the nasal wash of ferrets was plaque purified from a MDCK cell monolayer 
and passaged once in MDCK cells. Viral RNA was extracted from the supernatant using a 
QIAamp Viral RNA mini kit (Qiagen), and a 1341 nt DNA fragment (HA 42-1382) was amplified 
by RT-PCR and sequenced using the Sanger method. Nucleotide sequence and corresponding 
amino acids from HA nucleotides 709 to 726 including residue 227 are shown for two different 
sequenced plaques of a donor (E195 E227A) and a respiratory droplet sentinel (E195 A227T). 
187 
 
4.2.3 Molecular changes in the HA protein of virus shed by respiratory droplet 
sentinels  
The HA gene of influenza viruses shed by all four donor and RD sentinel pairs in the 
transmission experiment with E195 E227A were sequenced by plaque-purifying five plaques per 
ferret, using nasal wash obtained on the first day of positivity from aerosol sentinels and the last 
day of positivity from donor animals. Although most ferrets (7/8) shed E195 E227A virus 
identical to the inoculum virus, one RD sentinel was found to have shed a virus containing a 
mutation at the residue of interest from A to T (A227T) (Figure 4.4). The HA gene sequenced 
from five different plaque picks from the nasal wash of this virus on day 12 consistently 
contained the A227T mutation. No other mutations were found in the HA protein (Figure 4.8). It 
should be noted that this mutation was not found in influenza virus shed by the donor animal 
and the viral titre shed by the RD sentinel on day 13 was too low to check for mutational 
changes.  
To investigate the consequence of the A227T amino acid substitution to the HA receptor binding 
site structure, the molecular surface of all three E195 variants was investigated. The crystal 
structure of the HA of A/California/04/2009 (Cal04), another prototypic A(H1N1)pdm09 virus, 
has been solved by Xu et al. (PDB 3LZG) (Xu et al. 2010). The protein database file (PDB) was 
used as a template to mutate all amino acids to the wild type E195 (4 changes), E195 E227A or 
E195 A227T (5 changes) amino acids in Swiss Prot. The resulting PDF files were then force 
field minimized using free online software program Yasara, which was expected to reveal a 
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Figure 4.9 Molecular surface of RBS of wild type E195, E195 E227A and E195 A227T 
PDB 3LZG (A/California/04/09) was used as a template to mutate all amino acids to the wild 
type E195 (4 changes), E195 E227A and E195 A227T (5 changes) amino acids in Swiss Prot 
(http://www.uniprot.org/). Yasara was used for force field minimization 
(http://www.yasara.org/minimizationserver.htm). The molecular surface was calculated using 
Autodock (http://autodock.scripps.edu/) and coloured per amino acid in RasMol code. White 
arrow = residue 227. 
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more realistic view of the positioning of the different amino acids. The molecular surface was 
calculated and images were created using Autodock and coloured per amino acid. 
The RBS pocket of E195 E227A is more open than the RBS pocket of both wild type E195 and 
E195 A227T; amino acid 145 is pointing towards the outside of the pocket, whereas it is pointing 
inwards in both wild type E195 and E195 A227T. Furthermore, amino acid 136 is bulging into 
the pocket, which is not seen in both wild type E195 and E195 A227T. Overall, E195 E227A 
looks different from wild type E195 and E195 A227T, which are more similar. This suggests that 
the shape of the RBS pocket of wild type E195 is preferred for transmissibility in ferrets and the 
correcting mutation at position 227 from A to T has restored this structural feature (Figure 4.9).  
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4.2.4 Differential plaque phenotype of virus shed by donor animals and 
respiratory droplet sentinels 
After nasal washes were obtained from the ferrets, viral titre was determined on a monolayer of 
MDCK cells. During these titrations, differences in the plaque phenotypes were observed. To 
further investigate these differences, nasal washes from two donor ferrets and two RD sentinels 
infected with E195 as well as the nasal washes from four donor ferrets and four RD sentinels 
infected with E195 E227A were diluted to 300 PFU/ml and plaque assays were performed using 
MDCK cells in a 6-well plate. The radii of eleven to fifty-seven plaques per virus were single-
blinded measured using a ruler, excluding plaques at the edges of the wells. Values were 
recorded in 0.5mm increments. The results were first stratified by their origin; one group was 
formed by all donors, one group was formed by all RD sentinels excluding the mutated E195 
A227T virus and the last group consisted of just E195 A227T. All these groups were significantly 
different; viruses isolated from the nasal washes obtained from RD sentinels had a lower 
median radius than donor animals, whereas the mutated E195 A227T showed a higher median 
radius (Figure 4.10a). Secondly, the results were further stratified by virus, forming five different 
groups. The only two groups that were still significantly different from the others were the RD 
sentinels infected with E195 E227A and E195 A227T (Figure 4.10b). Lastly, the results were 
stratified per ferret. The most interesting observation from this graph is the lack of plaque 
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Figure 4.10 Plaque size phenotype of influenza virus isolated from nasal washes 
obtained from ferrets infected with wild type E195, E195 E227A or E195 A227T 
Plaque assays were performed using MDCK cells and the radius of the plaques formed by wild 
type E195, E195 E227A or E195 A227T viruses were single-blinded measured using a ruler, 
recording results in 0.5mm increments. Plaque size phenotypes of; a) Results stratified by 
origin; b) Results further stratified per virus; c) Results per ferret, colour coded per pair. Graphs 
were produced using Graphpad Prism 5.01 software. Statistical differences between wild type 
E195 and E195 E227A and E195 A227T were determined using ANOVA one-way test. * = 
p<0.05, ** = p<0.01. Due to complication of significance of panel c, results can be found in 
Table 4.2. 
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Figure 4.11 Plaque morphology phenotype of influenza virus isolated from nasal 
washes obtained from ferrets infected with wild type E195, E195 E227A or E195 A227T 
All isolates were titred on MDCK cells and stained after 3 days. A representative example of 
plaque phenotype is shown for every ferret. All pairs are colour-coded per pair as in Figure 4.10; 
red and blue = E195; orange, purple and yellow = E195 E227A; green = E195 E227A (donor) 
and E195 A227T (RD).  
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formation by the viruses isolated from two RD sentinels, explaining the low average radius 
observed in Figure 4.10a and b. Again it is observed that the mutated virus E195 A227T has an 
increased radius compared to most other viruses, although it is now only significant in a few 
cases (Figure 4.10c, Figure 4.11 and Table 4.2). 
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Table 4.2 Statistical differences between plaque sizes of influenza virus from different 
origins.  
The significance was determined by ANOVA one-way and Tukey‟s test, p<0.05 was noted (X). 
The different donor and RD sentinel ferret pairs are coloured as in Figure 4.10. 
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4.3 Discussion 
In this chapter, the transmissibility of a prototypic A(H1N1)pdm09 virus wild type E195 and 
mutant E195 E227A was investigated in the ferret model. We showed that the subtle switch 
detected in HAE binding and infection caused by mutation E227A did not abrogate the 
transmissibility of the virus in the ferret model used here, suggesting that more dramatic 
changes in sialic acid specificity than are conferred by the E227A mutation lie behind the 
acquisition of transmissible phenotype shown by pandemic virus. Nonetheless, selective 
pressure on the virus to adjust this residue was likely; one aerosol sentinel was found to be 
infected with E195 E227A virus which was mutated at position 227 (A to T). No differences in 
severity of disease were found between wild type E195 and E195 E227A-infected ferrets.  
A recent study showed that a natural isolate of A/Ohio/02/07, a virus with an identical HA 
sequence to Ohio01, was able to transmit between co-housed ferrets, but not by RD 
transmission (Belser et al. 2011a). Similar to these results, RG virus E195 E227A virus was 
shed robustly from donor animals and transmitted readily to 100% contact animals (Figure 4.4). 
However, unlike natural isolate A/Ohio/02/07 (Belser et al. 2011a), the E195 E227A mutant 
virus also transmitted to all of the exposed sentinels through the RD route, although it can be 
argued transmission was slightly attenuated. It is possible that other genetic difference in either 
the HA gene or other genes of A/Ohio/02/07 preclude the transmissibility through the air. 
The HA proteins of Ohio01/02 and E195 have an overall identity of 93.7%, differing in 36 amino 
acids. When the residues of the RBS were compared (the 130-loop (residues 134-138), 190-
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helix (residues 188-194), 220-loop (residues 221-228) and highly conserved residues (98Y, 
153W, 183H and 195Y), H3 numbering) only residue 227 was different, suggesting the other 
amino acids do not directly affect receptor binding. The multi-cycle replication kinetics in HAE of 
the E195 point mutant E227A and of the 7:1 HA reassortant virus Ohio01 were similar (Section 
3.2.4), suggesting that the other 35 amino acid differences in Ohio01 HA did also not 
significantly affect virus replication in this system.  
A/Ohio/01 and A/Ohio/02 wild type viruses differ further from A(H1N1)pdm09 viruses in the 
origin of their NA and M gene segments; whereas A(H1N1)pdm09 acquired its NA and M genes 
from an Eurasian source, Ohio01 and Ohio02 contain the typical TRIG constellation and their 
NA and M gene originate from classical swine influenza (Zhou et al. 1999, Ma et al. 2010). It is 
not clear from Belser‟s study whether lack of RD transmission of Ohio02 was due to the NA and 
M genes in the Ohio02 virus. If this caused the lack of RD transmission, this would not be 
mirrored using the 7:1 reassortment virus Ohio01, as this virus contains the NA and M genes 
from an Eurasian source (identical to E195 NA and M genes). The importance of the NA and M 
genes has been suggested in the literature. Yen et al. (Yen et al. 2011a, Yen et al. 2011b) 
investigated the transmissibility of different human and swine-origin influenza viruses, including 
one virus isolated in 2004 (A/swine/HK/915/04, sw915) which contained all gene segments of 
the TRIG virus, but for the M gene which was of Eurasian origin. This virus is therefore similar to 
A(H1N1)pdm09, but does not contain the Eurasian NA gene. In ferret transmission experiments 
sw915 transmitted to 1/5 RD sentinels, whereas other swine-origin influenza viruses did not 
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transmit through the air. Introduction of the Eurasian NA gene in sw915 allows for transmission 
to 3/3 RD sentinels (Yen et al. 2011a, Yen et al. 2011b). These findings are confirmed in the 
guinea pig model (Chou et al. 2011). Furthermore, a recent study showed that the Eurasian NA 
gene is important in the quantity of release of infectious A(H1N1)pdm09;  viruses containing the 
Eurasian-origin NA and M gene segments released influenza viral RNA-containing particles into 
the air consistently and this correlated with increased NA activity of these viruses (Lakdawala et 
al. 2011). 
Although the sample size was small (n=4) it was observed that in two of the RD sentinels 
exposed to E195 E227A virus, infection was delayed and peak titres were distinctively lower 
(Figure 4.4). In one of these animals the transmitted virus was found to contain a T at the site of 
manipulation, A227T. Five out of five plaques picked from the nasal wash of this sentinel 
contained the A227T mutation, yet this mutation was not present in any of five plaques picked 
from virus shed from the paired donor animal, suggesting that it had been selected for at the 
transmission bottleneck or within the sentinel animal after transmission. Although T is not a 
charged residue like E, they are both polar amino acids. T at position 227 is occasionally 
observed in HA sequences of swine or human H1N1 influenza isolates, but not in human 
isolates of H5 or H3 influenza virus. To investigate the relevance of mutation A227T, the 
molecular surface of wild type E195, E195 E227A and E195 A227T was compared (Figure 4.9). 
One of the most apparent differences besides residue 227 is the differential orientation of 
residue 145 in E195 E227A compared to wild type E195. Leucine at position 145 in E195 
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E227A seems to bend away from the receptor binding pocket creating a more open RBS than 
what is observed in wild type E195. Secondly, residue 136, part of the 130 loop which forms one 
side of the RBS (Gamblin et al. 2004), bulges into the RBS. The size of the RBS is measured 
between the 130 and 220 loop, and therefore the RBS of E195 E227A virus could be smaller 
due to the position of residue 136. Avian HAs are thought to have a smaller RBS than human 
HAs, as the relatively large α2,6-linked sialic acid needs a larger pocket to be able to bind the 
receptor (Stevens et al. 2004, Ha et al. 2001). Furthermore, residue 136 is important in receptor 
binding (Ha et al. 2001) and the changed position of this residue could alter the binding profile of 
A(H1N1)pdm09. Both the changes in the positions of residue 136 and 145 seem to be reversed 
by mutation into T at position 227. Overall, the molecular surface of the wild type E195 RBS 
resembles the RBS of E195 A227T, whereas the RBS of E195 E227A is unique. Although it is 
very difficult to make conclusions based on molecular surface images, this seems to suggest 
the slightly wider RBS observed in wild type E195 is preferable for transmission in ferrets, hence 
the mutation from A to T in E195 E227A, reversing the RBS pocket size. Further studies are 
needed to investigate the significance of T at position 227.  
Two aerosol sentinels infected with E195 E227A or E195 A227T showed a reduced shedding 
profile combined with a shortened length of shedding (Figure 4.4). It is conceivable that 
although obviously initial transmission from donor to aerosol sentinel occurred, transmission of 
influenza virus from the primary aerosol sentinel animal to a second aerosol sentinel will be 
impaired due to the decrease in amount of infectious virus shed by the primary aerosol sentinel. 
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To investigate this possibility, so-called transmission chains could be used, in which the primary 
aerosol sentinel becomes the donor, and a secondary aerosol sentinel is introduced. Exposure 
of a new aerosol sentinel could be repeated over several rounds, and would provide additional 
information on the ability of the virus to spread within a population.  
Importantly, the other two animals who acquired E227A virus through the RD route showed a 
shedding profile likely to support a chain of transmission. When variables such as days of 
shedding, peak titre and area under the curve (AUC) were compared between the groups, no 
significant difference could be observed.  
It was observed that average peak titre and total amount of virus shed by the ferrets inoculated 
with E195 E227A was higher than those inoculated with E195. The former were inoculated with 
a 10x higher viral dose, which might have caused this difference. It is possible that this had 
aided the transmission of E195 E227A, and a more severe attenuation would have been found if 
the ferrets were all infected with the same lower dose (103 PFU/ferret). 
The increase in ciliated cell binding and infection of E195 E227A compared to wild type E195 
suggests a more avian-like binding profile, which could mean that the virus is capable of 
penetration deeper into the respiratory tract of the ferret or switches tropism to ciliated cell 
types, which in turn could lead to higher pathogenesis through defective clearance of virus and 
cell debris (Liu et al. 2010). A difference in tissue tropism favouring the LRT was for example 
observed when the binding profile to human respiratory tract tissue of a prototypic wild type 
A(H1N1)pdm09 and A(H1N1)pdm09 D225G were compared by Chutinimitkul et al. 
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(Chutinimitkul et al. 2010). The G225D mutation is known to shift the viral binding profile to 
include more α2,6-linked sialic acid and infect more non-ciliated cells (Liu et al. 2010), and has 
been identified as one of the necessary molecular changes in the HA protein of H1N1, just 
before or during the emergence of the devastating 1918 virus (Tumpey et al. 2007, Stevens et 
al. 2006a). In these studies, Chutinimitkul et al. found that binding of A(H1N1)pdm09 D225G 
was more prominent on type II pneumocytes and alveolar macrophages than binding of wild 
type A(H1N1)pdm09, suggesting an increase potential for LRT infection (Chutinimitkul et al. 
2010). These findings could explain the association of this mutation with a higher morbidity and 
mortality in humans (Kilander et al. 2010). It should however be noted that in this study no 
difference in either pathogenesis or tissue tropism was found in a ferret transmission experiment 
(Chutinimitkul et al. 2010).  
Avian H5N1 influenza  viruses  have also been associated with a LRT infection, and 
consequently a significant increase in pathogenicity in ferrets (Zitzow et al. 2002). For these 
reasons, we closely observed the symptoms displayed by both the donor ferrets infected with 
E195 E227A, as well as the donor ferrets infected with wild type E195. However, no obvious 
differences were found between the activity profiles, number of sneezes and coughs or the 
weights of wild type E195 infected ferrets compared to E195 E227A infected ferrets. This further 
underlines our earlier conclusion that no significant difference is caused by the mutation E227A 
in the infection of ferrets. A difference could be found in the weight of the donor ferrets versus 
the RD and contact sentinels; the donor ferrets lost more weight on average than the sentinel 
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animals did. This is quite likely caused by the relatively large amount of virus which is used to 
infect the donors, 103 and 104 PFU/animal for wild type E195 and E195 E227A respectively. It is 
very unlikely that the sentinel animals were infected with a similar dose; the ID50 of influenza 
virus is estimated to be as low as 1.1 PFU (Roberts et al. 2011, Gustin et al. 2011). This 
relatively high dose of virus could have triggered a larger response of the immune system, 
consequently having a greater impact on the weight of the donor animals. Nonetheless, total 
PFU shed (AUC) was very similar for donor and RD sentinel animals. There were no uninfected 
animals included in this experiment, and therefore no negative control was available. As such, it 
is possible that infected animals gained less weight than an uninfected animal would have 
gained and it is therefore not possible to claim influenza infection had no effect on body weight. 
Two out of four RD sentinels exposed to E195 E227A did not become positive for virus in their 
nasal wash until day 9 and day 12 (Figure 4.4), which is counterintuitive as no virus was 
detected in the nasal wash of the paired donor animals after day 6. Similar late shedding events 
have been reported by our group (Roberts et al. 2012, in press) and others (Pappas et al. 2010, 
Wan et al. 2008). It is not clear what causes this increase in the incubation period. 
A sharp tail in the trajectory of infectious virus in the nasal wash of all ferrets was noted (Figure 
4.3, Figure 4.4) in contrast to other transmission studies (Brookes et al. 2010, Koster et al. 
2012). This phenomenon is suspected to be caused by the assay used to detect virus in nasal 
wash; whereas in this study plaque assays were used, in the other studies qRT-PCR was used. 
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This hypothesis is strengthened by a similar fast decline in virus from nasal wash in other 
studies detecting infectious virus instead of viral RNA (Munster et al. 2009, Belser et al. 2011a). 
The plaque size of a virus is linked to the ability of the virus to spread from cell to cell; a small 
plaque size is associated with limitations in spread, whereas a large plaque shows an increase 
in viral spread. The mechanisms underlying the cell-to-cell spread of influenza are poorly 
understood, but thought to be important for virulence (Doceul et al. 2010). Our analysis showed 
a significant difference in plaque size of E195 E227A compared to wild type E195, which was 
smaller in plaque size, as well as E195 A227T, which was larger in plaque size than wild type 
E195. This suggests the A227T mutation improved the fitness of the virus. However, as E195 
E227A was still able to transmit between ferrets via respiratory droplets, this mutation was not 
necessary to allow the virus to transmit. More experiments will be necessary to determine the 
difference in fitness the A227T mutation made.  
Based on the experiment described above, we conclude that the acquisition of the A227E 
mutation in a precursor of the 2009 pandemic virus is unlikely on its own to account for the 
emergence of human transmissibility phenotype. Future work should be aimed at investigating 
the potential of a transmission chain with E195 E227A compared to wild type E195. Here, 
infected aerosol sentinels would function as a donor to a second aerosol sentinel, which would 
function as a donor animal once infected, and so forth.  
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5 Differential cell tropism and in vitro replication of human and avian H7 
virus  
5.1 Introduction 
The first description of avian influenza dates back to 1878 in Italy, and was then termed 
classical fowl plague (Perroncito 1878). It was not until 1950 that the cause of classical fowl 
plague was found to be influenza A virus (Krauss and Webster 2010). No real attention was 
paid to this discovery until after the H2N2 pandemic in 1957. In an effort to identify the source of 
H2N2, the antigenic relationship between human influenza virus and influenza virus from other 
sources was investigated. Cross-reactivity of antisera raised against the 1957 pandemic strain 
with an avian influenza virus isolated from turkeys provided the first link between avian and 
human influenza and highlighted birds as a possible reservoir of influenza A virus (Pereira, 
Tumova and Webster 1967). We now know that these viruses both possess N2 neuraminidase. 
This finding spiked an interest in influenza virus infection of birds, and consequently influenza 
virus was found in a wide variety of birds, specifically aquatic waterfowl such as wild ducks 
(Asplin 1970, Easterday et al. 1968, Dasen and Laver 1970, Winkler et al. 1972, Downie and 
Laver 1973, Slemons et al. 1974, Stallknecht and Shane 1988). Phylogenetic analysis revealed 
that all influenza viruses from different hosts originated from an avian source and that the 
primary reservoir of influenza A virus are the aquatic bird orders; the Anseriformes (ducks, 
geese and swans) and Charadriiformes (gulls, terns and waders) (Krauss and Webster 2010, 
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Gorman et al. 1991, Gorman et al. 1990a, Gorman et al. 1990b, Okazaki et al. 1989, Schafer et 
al. 1993, Kawaoka et al. 1989). Longitudinal surveillance studies found almost all influenza A 
subtypes in American and Eurasian birds (Aymard-Henry et al. 1973, Krauss et al. 2007, Krauss 
et al. 2004, Obenauer et al. 2006, Sharp et al. 1993, Krauss and Webster 2010, Olsen et al. 
2006, Munster et al. 2007, Wallensten et al. 2007) with the exception of H14 and H15 which are 
exclusively found in birds in Eurasia (Krauss and Webster 2010).  
Avian influenza causes an asymptomatic to mild disease in its natural host, but can cause a 
range of symptoms in poultry where it is defined as low (LPAI) or highly pathogenic avian 
influenza (HPAI). LPAI causes a localised infection of mucosal surfaces on the digestive and 
respiratory tract and is characterized by low mortality and mild clinical signs. In contrast, highly 
pathogenic avian influenza (HPAI) is a systematic disease characterized by high mortality rate 
which may be as high as 100% (Suarez 2010). In nature the HPAI phenotype has been 
restricted to subtypes H5 and H7 hitherto, but subtypes H2, H4, H6, H8, H9 and H14 were 
shown capable of acquiring the HPAI phenotype using in vitro  and in vivo studies (Munster et 
al. 2010, Soda et al. 2011, Lee et al. 2009b). Insertion of a multibasic cleavage site into H3N2 
did not result in increased pathogenicity in ferrets (Schrauwen et al. 2011), whereas insertion of 
a multibasic cleavage site in H1, H3, H10, H11 and H15 did not convert the low pathogenic 
influenza viruses to high pathogenic influenza viruses when investigated in chickens (Lee et al. 
2009b). 
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Although 16 different HA subtypes are found in aquatic birds, retrospective seroepidemiological 
and virological studies of influenza pandemics that occurred in humans before isolation of the 
first influenza virus in 1933 (Smith, Andrewes and Laidlaw 1933) suggest these pandemics were 
caused by H2 and H3 (Davenport et al. 1964, Davenport et al. 1969, Marine and Workman 
1969, Marine, Workman and Webster 1969, Masurel 1969, Mulder and Masurel 1958, Shope 
1936). This led to the concept of a limited number of influenza subtypes able to replicate in the 
human host, and the consequent recycling of H1, H2 and H3. Avian influenza viruses of other 
subtypes were therefore not perceived as a threat. This presumption changed when in May 
1997 a 3-year-old boy in Hong Kong was hospitalised and eventually died of HPAI H5N1 
infection (Subbarao et al. 1998, Claas et al. 1998) and six months later, another 17 cases were 
diagnosed with HPAI H5N1 resulting in a further five fatalities (Chan 2002). Epidemiologic and 
molecular evidence suggests poultry as the source of the HPAI H5N1 virus (Shortridge 1999). 
Since then many human infections with H5N1 influenza virus have been documented in various 
locations worldwide, with a reported 60% fatality rate (Table 5.1) (WHO Accessed 26-01-2012).  
Although H5N1 forms the obvious avian influenza pandemic threat, other potential pandemic 
viruses including H7 and H9 subtypes should not be overlooked. H7 has been found worldwide 
in wild waterfowl and poultry (Stegeman et al. 2004, Rohm et al. 1996a, Selleck et al. 2003, Li et 
al. 2006b, Abbas et al. 2010, Pasick et al. 2005, Berhane et al. 2009, Ferro et al. 2010, Baumer 
et al. 2010).  
208 
 
 
 
Table 5.1 Cumulative number of human cases of H5N1 avian influenza infection reported to World Health 
Organization, 2003-June 2012  
Table amended from WHO website (WHO Accessed 26-01-2012). 
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A clear phylo-geographic pattern has been observed in the H7 subtype; distinct genetic lineages 
are found in North-America and Eurasia (Lebarbenchon and Stallknecht 2011, Banks et al. 
2000).  
Outbreaks caused by H7 subtypes in poultry include HPAI H7N3 in Pakistan in 1994 (Naeem 
and Hussain 1995), in Chile in 2002 (Rojas et al. 2002) and in Canada in 2004 (Bowes et al. 
2004, Hirst et al. 2004); LPAI H7N3 in England in 2006 (Nguyen-Van-Tam et al. 2006); HPAI 
H7N1 in Italy in 1999 (Mutinelli et al. 2003) and HPAI H7N7 in the Netherlands in 2003 
(Stegeman et al. 2004, Fouchier et al. 2004, Koopmans et al. 2004). Several of these outbreaks 
have resulted in human infections. In 1996, the first human-origin H7 influenza virus strain was 
isolated from a 43-year-old female patient who had cleaned a duck house one day before she 
developed conjunctivitis (Kurtz et al. 1996). This incident was the first described natural event 
involving transmission of an avian H7 directly to a human from a presumed avian source. The 
H7N7 outbreak in poultry in the Netherlands in 2003 resulted in a record number of human 
cases identified by RT-PCR (89) including one fatal case (Koopmans et al. 2004). Furthermore, 
serological analysis of serum samples from persons directly exposed to poultry and persons 
exposed to H7-positive cases revealed A(H7) specific antibodies in 49% and 64% of samples 
respectively (Meijer et al. 2006). H7N3 in Canada in 2004 led to two human cases (Hirst et al. 
2004, Tweed et al. 2004) and a poultry worker in England contracted H7N3 in 2006 (Nguyen-
Van-Tam et al. 2006). These incidences of human infection highlight the potential of H7 
influenza virus to jump the host species barrier. Furthermore, evidence of anti-H7 antibodies 
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was found in 3.8% of serum samples obtained from poultry workers active between 1999 and 
2003 in Italy (Puzelli et al. 2005). Nonetheless, antibodies do not necessarily reflect an active 
infection with influenza; the immune system could have responded solely to exposure to the 
virus, for example via chicken dust during their work with poultry. This is occasionally observed 
during influenza transmission experiments in ferrets; although no infectious virus is detected in 
obtained nasal washes, ferrets do seroconvert to the influenza virus tested (Maines et al. 2011).  
Human infections with the H5 subtype often cause severe disease and have a reported ~60% 
fatality rate (WHO Accessed 26-01-2012), although this is thought to be an overestimation as 
only hospitalized cases are included. In contrast, infection with the H7 subtype causes milder 
influenza-like symptoms and serologic evidence even suggests many infections are 
asymptomatic (Meijer et al. 2006, Puzelli et al. 2005). The single reported fatal case caused by 
H7 infection in the Netherlands was associated with 14 amino acid substitutions found in five 
different genes (Fouchier et al. 2004). The pathogenesis of H7 influenza virus infection in 
humans is unique in that in addition to causing only a mild influenza-like illness in most cases, 
conjunctivitis is typically reported and virus can be isolated from ocular samples (Fouchier et al. 
2004, Nguyen-Van-Tam et al. 2006, Wong and Yuen 2006). In contrast with the cells lining the 
human respiratory tract, corneal, conjunctival and lacrimal duct epithelial cells of the human eye 
express abundant α2,3-linked sialic acid on their surface (Paulsen et al. 1998, Royle et al. 
2008). Furthermore, whereas mucins in the sialylated secretions of the upper respiratory tract, 
which are important in initial defense against influenza virus, contain mostly α2,3-linked sialic 
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acid, ocular secretions contain mostly α2,6-linked sialic acid (Couceiro et al. 1993, Berry, 
Ellingham and Corfield 1996, Thale et al. 2001, Ellingham et al. 1999). H7 viruses with avian-
like receptor properties might be able to preferentially bind α2,3-linked sialic acid expressed by 
epithelial cells on the conjunctiva and avoid capture by mucins in the ocular secretion. H5 
viruses are much less likely to infect the eye (Chan 2002), suggesting a subtle divergence in 
receptor binding preference beyond a shared α2,3-linked sialic acid preference. It has been 
documented that the balance between receptor binding protein HA and receptor destroying 
protein NA is important in viral growth (Wagner et al. 2000). It is therefore also possible that the 
balance between H7 HA and NA allows for viral replication in human conjunctiva, whereas this 
balance within the H5 subtype is suboptimal for viral growth in conjunctival cells. 
In 2008, Belser et al. (Belser et al. 2008) used glycan arrays to demonstrate that several recent 
isolates of the North American lineage of H7 were able to bind both α2,3-linked sialic acid and 
α2,6-linked sialic acid, in contrast to older H7 isolates which maintained the classic avian-like 
receptor binding to α2,3-linked sialic acid. Similar binding patterns of individual viruses 
(A/Netherlands/219/2003, A/Netherlands/230/2003, A/New York/107/2003 and 
A/Turkey/Virginia/4529/2002) were observed in a much larger screen of H7 influenza viruses 
from different sources (Gambaryan et al. 2012). In a subsequent transmission experiment in 
ferrets, one such isolate associated with human respiratory infection (A/New York/107/2003) 
which showed a particular increase in α2,6-linked sialic acid binding combined with a decrease 
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in α2,3-linked sialic acid binding, was transmitted from infected animals to sentinel animals 
placed in direct contact (3/3). RD transmission in ferrets was not detected (Belser et al. 2008).  
Additional glycosylation of HA and deletions in the NA stalk region have been identified in H7 
viruses which have crossed the species barrier from wild birds to domestic poultry (Banks et al. 
2001), however the molecular determinants for H7 infection of humans are not clear. During the 
outbreak of H7N7 in Netherlands in 2003, the avian virus was not human adapted and a typical 
non-fatal human case showed only a single amino acid difference from the avian precursor 
strain in the NS1 protein, K126R. However, the virus isolated postmortem from a veterinarian 
who was exposed to H7N7 on 2 April 2003 and succumbed to the infection of 17 April 2003 was 
shown to have adapted to the human host over 15 days. Indeed, 26 nucleotide changes were 
found resulting in 14 amino acid substitutions in comparison to the avian precursor virus 
(Fouchier et al. 2004). These substitutions include E627K in PB2, which is associated with 
higher virulence of H5N1 avian influenza virus in mice (Hatta et al. 2001), and an additional 
potential glycosylation site near the tip of HA, which is associated with higher virulence in seals 
(Naeve and Webster 1983) and chickens (Perdue, Latimer and Crawford 1995). However, even 
though the fatal human isolate had accumulated 14 amino acid substitutions (five in PB2, four in 
NA, three in HA and one each in PA and NS1) this virus did not change its receptor binding 
preference and was unable to transmit even via direct contact in ferrets (Belser et al. 2008).  
Although human-to-human transmission of H7 influenza virus is only rarely detected and so far 
has not been sustained (Koopmans et al. 2004), the ability of H7 influenza virus to transmit 
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within the ferret model (at least by direct contact) implies a molecular predisposition for human-
to-human transmission. Furthermore evidence of H7 associated conjunctivitis suggests that the 
eye can form an additional portal of entry for H7 influenza virus. Indeed, H7 positive samples 
were isolated from both the eye and throat of a human case of H7N3 infection in the UK in 2006 
(Nguyen-Van-Tam et al. 2006). There is also evidence that viral loads are higher in the eye than 
in the respiratory tract (Fouchier et al. 2004). We hypothesize that the ability of H7 viruses to 
infect humans by binding to the α2,3-linked sialic acid receptors in the eye allows the virus to 
breach the initial host species barrier permitting a window of opportunity for adaptation of the 
virus to the human host and selecting for viral mutants with human receptor binding ability, 
potentially resulting in a wider cell tropism and infection of other sites such as the throat.  
Between March and April 2006, two free range layer chicken flocks and a broiler breeder 
chicken flock were infected with LPAI H7N3 in Norfolk, England. As a precautionary measure, 
all birds on the farms were culled. Nonetheless, several poultry workers and one veterinarian 
presented with influenza-like illness, including symptoms such as conjunctivitis and fever 
(Nguyen-Van-Tam et al. 2006). Swabs were taken from all patients, but found negative by RT-
PCR with the exception of one poultry worker where samples taken from both his left eye and 
throat were found positive for H7N3.  
In this chapter, we set out to investigate whether the H7 virus that infected the above mentioned 
human patient and poultry differed from the Eurasian avian H7 virus currently circulating in the 
avian population by comparing cell tropism and replication in different models. Avian influenza 
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virus A/mallard/Sweden/105/02 (M105) was selected, as this virus was isolated in Europe and 
was readily available. Nonetheless, this virus might not be an ideal match as it is subtype H7N7, 
and not subtype H7N3. As the HA sequence of a chicken isolate (A/chicken/England/4054/06, 
E4054) from the outbreak was available, we also investigated whether specific mutations in the 
HA allowed for the zoonotic jump from chicken to a human host. Finally, we hypothesized that 
the different sites of replication in the patient (throat vs. eye) could have selected for mutations 
important in site-specific adaptations. Genotypic differences between throat or eye-H7N3 
isolates were therefore investigated using a whole genome sequencing assay and phenotypic 
differences were investigated using conjunctival cells and HAE cultures. For this purpose, H7N3 
viruses A/England/480/06 (isolated from the throat) and A/England/481/06 (isolated from the 
eye) were selected. Please refer to Table 5.2 for more details on all four viruses. 
 
 
Virus name Abbreviation Host Isolation site Subtype 
A/England/480/06 E480 Human Throat H7N3 
A/England/481/06 E481 Human Eye H7N3 
A/Chicken/England/4054/06 E4054 
Chicken (Gallus 
gallus domesticus) 
N/A H7N3 
A/Mallard/Sweden/105/02 M105 
Mallard (Anas 
platyrhynchos) 
N/A H7N7 
     
Table 5.2 List of virus strains  
List of all virus strains used in this chapter.  
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5.2 Results 
5.2.1 Molecular studies of LPAI H7N3 isolated from the eye and throat of a 
human case 
In this chapter two viruses isolated from specimens taken from different anatomical sites of a 
single human case of H7N3 infection were investigated. A/England/480/06 (E480) was isolated 
from the throat and A/England/481/06 (E481) was isolated from the left eye of a single H7N3 
infected human case. The patient was a poultry worker infected during an outbreak of H7N3 in 
the UK in 2006 (Table 5.2). Both viruses were isolated and passaged in embryonated hen‟s 
eggs. In this chapter virus obtained from egg passage 4 is studied unless stated otherwise.  
 
5.2.1.1 Development of a whole genome sequencing assay for H7N3 influenza virus 
At the Health Protection Agency Microbiology Services (HPA MS) Dr. Monica Galiano has 
developed a whole genome sequencing (WGS) assay for human influenza A based on primers 
developed by Hoffmann et al. and Rod Daniels (Hoffmann et al. 2001, Baillie et al. 2012). To 
investigate whether this assay was suitable for H7N3 whole genome sequencing, all primers 
used in Dr. Galiano‟s WGS assay (WGS primers) were aligned against the internal genes of 
A/Mallard/Netherlands/9/05 (H7N7). This virus was chosen as the reference sequence because 
all internal genes were available online(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et al. 
2008)(Cypel et al. 2008)(Cypel et al. 2008)(Cypel et al. 2008), the isolate falls into the Eurasian 
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Virus name Subtype Accession number 
A/Chicken/England/4054/2006 H7N3 EF467826 
A/Chicken/England/4266/2006 H7N3 EF467825 
A/Turkey/Italy/214845/2002 H7N3 AJ627491 
A/Chicken/Italy/267/2000 H7N1 AJ493215 
A/Chicken/Italy/1081/1999 H7N1 AF202255 
A/Turkey/Italy/3889/1999 H7N1 AJ493466 
A/Mallard/Netherlands/12/2000 H7N1 GU053030 
A/Netherlands/33/2003 H7N7 AY338457 
A/Netherlands/219/2003 H7N7 AY338459 
A/Turkey/England/1963 H7N3 CY015065 
A/African Starling/England_Q/983/1979 H7N1 AF202232 
A/Chicken/Pakistan/CR2/1995 H7N3 GU053057 
A/Avian/NY/7729-6/2000 H7N2 AY240882 
A/Avian/NY/74211-2/2000 H7N2 AY240879 
A/Avian/NY/118353-1/2000 H7N2 AY240877 
A/Chicken/NJ/608/2002 H7N2 AY240888 
A/Chicken/British Columbia/2004 H7N3 AY611524 
A/Turkey/Chile/4418/2002 H7N3 AY303635 
A/Chicken/Chile/4322/2002 H7N3 AY303631 
A/Equine/Prague/1956 H7N7 X62552 S96523 
   
Table 5.3 List of viruses used to design H7 HA primers 
A multiple sequence alignment of the haemagglutinin genes was produced using MegAlign 
(DNASTAR Lasergene 9 Core Suite software) of the listed viruses was used to design 
sequencing primers for the HA gene of E480 and E481. 
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lineage similar to the UK isolates and it was isolated within one year of E480 and E481. WGS 
primers designed by Dr. Galiano with more than 3 mismatches when compared to 
A/Mallard/Netherlands/9/05 were excluded from the assay in the first instance.  
Neuraminidase (NA) N3 primers were designed in-house at the HPA MS by Dr. Catherine 
Thompson. These primers were used to obtain part of the N3 sequence of E480. Using NCBI 
BLAST technology it was then determined that the influenza isolate closest in phylogeny to the 
E480 N3 sequence was A/Duck/Singapore/3/97 N3 NA. The WGS primers designed to 
sequence NA by Dr. Galiano were aligned against A/Duck/Singapore/3/97 NA. WGS NA 
primers designed by Dr. Galiano with more than 3 mismatches when compared to 
A/Duck/Singapore/3/97 NA were excluded from the assay in the first instance.  
The HA gene of E480 and E481 was sequenced using primers designed based on an alignment 
of 20 different H7 HA genes (Table 5.3).  
Original WGS primers that were excluded from the assay due to mismatches were replaced by 
newly designed primers based on the sequence of A/Mallard/Netherlands/9/05, 
A/Duck/Singapore/3/97 or the H7 HA alignment. Initially, 15 out of 50 primers were replaced; 
one primer used to sequence PB2, six primers used to sequence HA, two primers used to 
sequence NP, four primers used to sequence NA and two primers used to sequence NS (Table 
5.4, 1st round). The entire genome of E480 virus was then sequenced using this strategy. 
Sequence chromatographs were analyzed to determine whether the primers were suitable for 
H7 sequencing. Where primers were found unsuitable because sequencing was unsuccessful, 
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WGS primers 
MG 
WGS primers H7  
1
st
 round 
WGS primers H7  
2
nd
 round 
WGS primers H7 
3
rd
 round (Final) 
Mism. 
PB2 
Bm-PB2-1 Bm-PB2-1 Bm-PB2-1 Bm-PB2-1 N/A 
HPB2F398 HPB2F398 HPB2H7F724 HPB2H7F724 3 
HPB2R421 HPB2R421 HPB2R421 HPB2R421 2 
HPB2R960 HPB2R960 HPB2R960 HPB2R960 1 
HPB2F1441 HPB2F1441 HPB2F1441 HPB2F1441 0 
PB2-1105F PB2-1105F PB2-1105F PB2-1105F 2*
† 
 
HPB2F1785 HPB2H7F1907 HPB2H7F1907 HPB2H7F1907 3 
Bm-PB2-2341R Bm-PB2-2341R Bm-PB2-2341R Bm-PB2-2341R N/A 
PB1 
Bm-PB1-1 Bm-PB1-1 Bm-PB1-1 Bm-PB1-1 N/A 
HPB1F370 HPB1F370 HPB1F370 HPB1F370 1 
HPB1R389 HPB1R389 HPB1R389 HPB1R389 1 
PB1-1262R PB1-1262R PB1-1262R PB1-1262R 0 
PB1-1123F PB1-1123F PB1-1123F PB1-1123F 0 
HPB1F1711 HPB1F1711 HPB1F1711 HPB1F1711 4* 
HPB1R1730 HPB1R1730 HPB1R1698 HPB1R1698 1 
Bm-PB1-2341R Bm-PB1-2341R Bm-PB1-2341R Bm-PB1-2341R N/A 
PA 
Bm-PA-1 Bm-PA-1 Bm-PA-1 Bm-PA-1 N/A 
HPAR620 HPAR620 HPAR620 HPAR620 1 
HPAR984 HPAR984 HPAH7R984 HPAH7R984 0 
PA-1498R PA-1498R PA-1498R PA-1498R 3 
PA-745F PA-745F PA-745F PA-745F 2 
HPAF1435 HPAF1435 HPAF1435 HPAF1435 0 
HPAR1824 HPAR1824 HPAR1824 HPAR1824 2 
Bm-PA-2233R Bm-PA-2233R Bm-PA-2233R Bm-PA-2233R N/A 
HA 
HAFUc HAFUc HAFUc HAFUc N/A 
H1A1F1 ND_seqHAH7_F2 ND_seqHAH7_F2 ND_seqHAH7_F2 N/A 
H1HAR623 ND_seqHAH7_F4 ND_seqHAH7_F4 ND_seqHAH7_F4 N/A 
H1HAR1087 ND_seqHAH7_R1 ND_seqHAH7_R1 ND_seqHAH7_R1 N/A 
H1HAF594 ND_seqHAH7_F2 ND_seqHAH7_F2 ND_seqHAH7_F2 N/A 
H1HA2F1 ND_seqHAH7_R2 ND_seqHAH7_R2 ND_seqHAH7_R2 N/A 
     
HARUc HARUc HARUc HARUc N/A 
NP 
NPFUc NPFUc NPFUc NPFUc N/A 
NPUF645-68 NPUF645-68 HNPH7R594 HNPH7R594 2 
HNPF986 HNPH7F1017 HNPH7F1017 HNPH7F1017 0 
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WGS primers 
MG 
WGS primers H7  
1
st
 round 
WGS primers H7  
2
nd
 round 
WGS primers H7 
3
rd
 round (Final) 
Mism. 
HA 
H1A2R1 ND_seqHAH7_R3_rep ND_seqHAH7_R3_rep ND_seqHAH7_R3_rep N/A 
HARUc HARUc HARUc HARUc N/A 
NP 
NPFUc NPFUc NPFUc NPFUc N/A 
NPUF645-68 NPUF645-68 HNPH7R594 HNPH7R594 2 
HNPF986 HNPH7F1017 HNPH7F1017 HNPH7F1017 0 
NPUR664-83 NPUR664-83 NPUR664-83 NPUR664-83 1 
HNPR1010 HNPH7R1109 HNPH7R1109 HNPH7R1109 0 
NPRUc NPRUc NPRUc NPRUc N/A 
NA 
FLN1_For NAFuc Bm-N3-F NAFuc N/A 
FLN1_Rev HNAH7F736 N3-555F H7NAF615 1 
AN1-392_For HNAH7R569 N3-275R H7NAR664 3 
AN1-742_For   H7NAF1105 0 
AN1-974_Rev   H7NAR1145 1 
AN1-487_Rev NARuc Bm-N3-R NARuc N/A 
M 
MFUc MFUc MFUc MFUc N/A 
HMF581 HMF581 HMF581 HMF581 4* 
HMR400 HMR400 HMH7R366 HMH7R366 1 
MRUc MRUc MRUc MRUc N/A 
NS 
NSFUc NSFUc NSFUc NSFUc N/A 
HNSF481 HNSH7F355 HNSH7F355 HNSH7F355 7* 
HNSR504 HNSH7R474 HNSH7R474 HNSH7R474 5* 
NSRUc NSRUc NSRUc NSRUc N/A 
     
Table 5.4 List of WGS primers.  
The first column contains all WGS primers designed by Dr. Monica Galiano, HPA MS. The 
second column contains all approved WGS primers (no more than three mismatches, no 
mismatches nearby or at starting point elongation) and additional H7 specific primers (blue).  
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The third column includes additional H7 specific primers (green), designed after other primers 
were found unsuitable (no sequencing result was obtained). The fourth column contains all 
primers used for the final H7 WGS strategy. New primers are coloured red. The last column 
represents the number of mismatches between the named primers in column 4 and the 
consensus of alignments of sequences named in Table 5.5. This analysis was a theoretical 
approach to determine whether primers would be suitable for WGS of other H7 viruses. Mism. = 
Number of mismatches; * = unsuitable primer; † = last nucleotide of primer is mismatch; N/A = 
not applicable (no mismatches were found). 
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replacement primers were designed based on the sequence of A/Mallard/Netherlands/9/05 or 
A/Duck/Singapore/3/97. At this stage, nine primers were replaced; one primer used to sequence 
PB2, one primer used to sequence PB1, one primer used to sequence PA, one primer used to 
sequence NP, all four primers used to sequence NA and one primer used to sequence M (Table 
5.4, 2nd round). 
A second round of sequencing of E480 was performed using the newly designed primers, after 
which only the NA gene was not fully sequenced. Four additional primers were developed 
(Table 5.4, 3rd round), which resulted in a functioning WGS assay for both E480 and E481.  
To determine whether these primers would be suitable for WGS of other H7 viruses, 10 H7 
sequences per gene segment were aligned using Clustal W in DNASTAR Lasergene 9 Core 
suite software (Table 5.5). Virus strains from the North American and Eurasian lineages were 
compared. The final H7 WGS primers were matched to the consensus alignment for each gene. 
The number of mismatches is stated in column five of Table 5.4. Where there were more than 3 
mismatches or the last nucleotide of the primer was a mismatch, primers were deemed 
unsuitable. From 52 primers, only five were found to be unsuitable for WGS of other H7 viruses. 
This in silico investigation indicated that the H7 WGS sequencing strategy would be suitable for 
sequencing other H7 viruses of the five subtypes (H7N1, H7N2, H7N3, H7N7, H7N9) that were 
compared; however the strategy remains to be validated experimentally. 
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Virus name Subtype Gene segment 
A/Chicken/MD/MinhMA/2004 H7N2 PB2, PB1, PA, NP, M 
A/Chicken/New York/14714-9/1999 H7N3 NS 
A/Chicken/NY/12273-11/1999 H7N3 PB2, PB1, PA 
A/Chicken/NY/21665-73/1998 H7N2 NS 
A/Chicken/PA/9701524/1997 H7N2 NS 
A/Chicken/PA/9801289/1998 H7N2 PB2, PB1, PA, NP, NS 
A/Chicken/Pakistan/34669/1995 H7N3 NA 
A/Duck/Alberta/49/1976 H7 M, NS 
A/Duck/France/02166/2002 H5N3 NA 
A/Duck/Germany/1215/1973 H2N3 NA 
A/Duck/Hokkaido/Vac-2/2004 H7N7 PB1, PA, NP, M 
A/Duck/Italy/4692-9/2004 H7 PA, NP, M, NS 
A/Duck/Jiangxi/1760/2003 H7N7 PB2, NS 
A/Duck/Jiangxi/1786/2003 H7N7 PB1, NP, M 
A/Duck/New Zealand/164/1976 H11N3 NA 
A/Laughing gull/Delaware/34/1994 H2N3 NA 
A/Mallard/France/2518/2001 H9N3 NA 
A/Mallard/Italy/250/2002 H7N1 PB2, PA, M, NS 
A/Mallard/Italy/299/2005 H7N7 PB2, NP, M 
A/Pintail/Alberta/21/1979 H7 PB1 
A/Pintail/MN/423/1999 H7N3 PB2, PB1, PA 
A/Ruddy turnstone/DE/1538/2000 H7N9 PB2, PA, NP 
A/Ruddy turnstone/NJ/195/2006 H7 NP, M 
A/Shorebird/Delaware/2696/1988 H7N3 NA 
A/Teal/France/2546/2001 H1N3 NA 
A/Tern/Astrakan/775/1983 H13N3 NA 
A/Tern/South Africa/1961 H5N3 NA 
A/Tundra Swan/NC/671-058/2006 H7 NP, NS 
A/Turkey/Italy/121964/2003 H7N3 PB1 
A/Turkey/Italy/68819/2003 H7N3 PB1, M 
A/Turkey/Italy/97500/2003 H7N3 PB2, PA, M 
A/Turkey/VA/66/2002 H7N2 NS 
A/Turkey/VA/Sept67/2002 H7N2 PB2, PB1, PA, NP 
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Table 5.5 Virus strains used in multiple sequence alignment to analyze suitability of final 
H7 WGS primers for WGS of other H7 viruses  
For each gene segment, ten sequences were aligned using the ClustalW method in DNASTAR 
software (Lasergene 9 Core suite). The resulting consensus sequence was used for 
comparison with the final H7 WGS primer sequences. The numbers of mismatches are stated in 
Table 5.4, primers which were deemed unsuitable are marked (*). 
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Figure 5.1 Chromatographs of PB2 and NS1 genes of E480 and E481  
Using the H7 WGS assay, all gene segments of E480 and E481 were sequenced. Multiple 
sequence alignments using DNASTAR Lasergene 9 Core suite software revealed four 
mutational differences; three in the PB2 gene and one in the NS gene. Representative 
chromatographs of these four mutations are depicted here, stratified per gene segment.  
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Gene 
Nucleotide Amino acid 
Position E480 E481 Position E480 E481 
PB2 
650 G T 206 Methionine Isoleucine 
895 A G 288 Glutamine Arginine 
1982 G A - - - 
NS 529 G C - - - 
       
Table 5.6 Mutational differences between H7N3 isolates E480 and E481 
Nucleotide and amino acid differences are listed. Nucleotide mutation 1982 in PB2 was 
synonymous. Nucleotide mutation 529 in NS was synonymous in both the NS1 and NS2 open 
reading frame.  
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 Human isolates (%) Avian isolates (%) 
E480 (M206) 2253 (99.96) 2962 (99.80) 
E481 (I206) 0 (0) 3 (0.10) 
   
   
Table 5.7 Comparative analysis of identity of amino acid 206 in H7N3 isolates E480 and 
E481 against available avian and human PB2 sequences 
The percentages of isolates with amino acid M or I at position 206 in PB2 were calculated using 
2254 human PB2 sequences, and 2968 avian PB2 sequences. Sequences were downloaded 
from the NCBI influenza database on 23rd November 2011 using the following search criteria: 
Type A; Host Human or Avian; Region Worldwide; Full-length; Collapse identical sequences 
 
 
 Human isolates (%) Avian isolates (%) 
E480 (Q288) 2240 (99.38) 2895 (97.54) 
E481 (R288) 5 (0.22) 61 (2.06) 
   
   
Table 5.8 Comparative analysis of identity of amino acid 288 in H7N3 isolates E480 and 
E481 against available avian and human PB2 sequences 
Percentages of isolates with amino acid Q or R at position 288 in PB2 were calculated using 
2254 human PB2 sequences, and 2968 avian PB2 sequences from the NCBI Influenza Virus 
Database. Sequences were downloaded from the NCBI influenza database on 23rd November 
2011 using the following search criteria: Type A; Host Human or Avian; Region Worldwide; Full-
length; Collapse identical sequences 
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5.2.1.2 Molecular comparison of H7N3 isolates E480 and E481 
After successful whole genome sequencing of both E480 and E481, alignments were made 
using ClustalW (MegAlign, DNASTAR Lasergene 9 Core suite software) to compare the gene 
segments of the two virus isolates. In gene segment PB2, three differences were found 
(E480E481; G650T, A895G and G1982A). In gene segments NS one difference was found 
(G529C) (Figure 5.1). No differences were found in the other gene segments. Both G650T and 
A895G mutations in PB2 were non-synonymous (M206I and Q288R respectively) whereas the 
other two mutations were synonymous (Table 5.6).  
To investigate whether the non-synonymous mutations were commonly found in PB2, multiple 
protein sequence alignments were performed using MAFFT 
(http://mafft.cbrc.jp/alignment/server/) of all full-length human (2254) and all full-length avian 
(2968) PB2 sequences from the NCBI Influenza Virus Sequence database 
(http://www.ncbi.nlm.nih.gov/genomes/FLU/Database/nph-select.cgi?go=database) downloaded 
in May 2011. Identical sequences were collapsed; the earliest entry into the database was used. 
Interestingly, both amino acids found in E480 (throat isolate) were more frequently found than 
those in E481 (eye isolate). In human viruses, 2253 (99.96%) virus strains contained methionine 
at position 206, and 2240 (99.4%) virus strains contained glutamine at position 288 similar to 
E480. No human viruses contained I at position 206 and 5 (0.2%) viruses contained arginine at 
position 288 similar to E481. In avian viruses, 2962 (99.8%) virus strains contained methionine 
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Figure 5.2 Phylogenetic trees of the internal genes of H7N3 isolates E480 and E481 
compared to reference isolates of known origin 
All internal genes of E480 and E481 were found to be closely related to Eurasian avian isolates. 
Nucleotide sequences analysed were chosen from Fouchier et al. (Fouchier et al. 2004) and 
were aligned using Geneious software followed by generation of maximum likelihood trees. 
Bootstrap analyzing parameters: 1000 trials and 111 random seeds. Fs = former seasonal 
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at position 206 and 2895 (97.5%) virus strains contained glutamine at position 288 like E480. 
Only 3 (0.1%) avian viruses contained I at position 206 and 61 (2.1%) viruses contained 
arginine at position 288 like E481 (Table 5.7 and Table 5.8). 
 
5.2.1.3 Phylogenetic analysis of internal genes from E480 and E481 
Due to a segmented genome, influenza viruses are capable of gene reassortment where one or 
more gene segments from one virus are swapped for the gene segments of another virus. This 
phenomenon has been well-described and is thought to have caused the pandemics in both 
1957 and 1968 (Guan et al. 2010). A simple way to examine whether such reassortment 
occurred is by creating phylogenetic trees of all gene segments, comparing them to gene 
segments from a known source, such as different hosts and geographical origin (Suzuki 2010). 
This was done by Fouchier et al. for the H7N7 influenza virus that caused an outbreak in the 
Netherlands in 2003 (Fouchier et al. 2004). Using the same reference nucleotide sequences, 
phylogenetic trees were constructed of all internal genes of E480 (and E481) and reference 
sequences using DNASTAR software as described in Materials and Methods (Figure 5.2). As 
expected and comparable to the result by Fouchier et al. (Fouchier et al. 2004), all gene 
segments were most similar to Eurasian avian influenza, which suggests no reassortment with 
non-Eurasian avian influenza strains took place. Reassortment events are relatively rare, 
especially between different hosts and with viruses from a different geographical origin. It should 
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be noted that this analysis does not exclude reassortment between influenza viruses from 
Eurasian avian origin.  
 
5.2.1.4 Molecular comparison of HA genes of H7N3 isolates E480 and E4054 
A/Chicken/England/4054/2006 (E4054, H7N3) was isolated from poultry on 26 April 2006 in 
England as part of the same outbreak as E480 and E481 and the HA gene was partially 
sequenced (accession number EF467826). The HA protein sequence of this isolate was 
compared to the HA protein sequence of E480 using Megalign (DNASTAR Lasergene 9 Core 
Suite software). Two amino acid substitutions were found in the signal peptide of E480 HA 
compared to E4054 HA; T3I and A9V (H7 numbering). The signal peptide of H7 influenza virus, 
which is 18 amino acids long, is generally not conserved, differences are found across all amino 
acids. 826 H7 HA sequences were downloaded from the NCBI Influenza Database on 15th April 
2012 using the following search criteria: Type A; Subtype H7N*; Collapse identical sequences. 
Residue 3 was not represented in 40 out of 826 sequences, but found to be T in 66% (520/786) 
of the remaining sequences and I in 30% (237/786) of the remaining sequences. Valine (V) at 
position 9 was not found in any of the 826 H7 HA sequences, whereas A was present in 39% 
(322/826) of HA sequences. Therefore the E4054 HA signal peptide sequence was more 
representative of a typical H7 virus. To investigate whether the signal peptide of E480 was likely 
to be functional, a signal peptide prediction program for eukaryotes (SignalP 4.0) was used 
(Petersen et al. 2011) using the first 30 amino acids of both E480 and E4054. This program 
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Figure 5.3 Signal peptide analysis of avian and human H7 sequences E4054 and E480 
Signal peptide recognition program SignalP 4.0 was used to analyse the S-score of the first 30 
amino acids of avian H7N3 HA sequence E4054 and human H7N3 HA sequence E480. A high 
S-score is allocated to an amino acid that is predicted to be part of the signal peptide, whereas 
a low S-score is allocated to an amino acid that is predicted to be part of the mature protein. 
Both E4054 and E480 were predicted to contain a signal peptide (residue 1-18) with very similar 
S-scores. 
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calculates both the cleavage site and the S-score per amino acid. A high S-score is assigned to 
amino acids that are part of the predicted signal peptide, whereas low S-scores are assigned to 
amino acids that are part of the mature protein. Figure 5.3 shows a graphical representation of 
the S-score. Both proteins were predicted to be cleaved at residue 19. Furthermore, the overall 
S-scores were very similar (0.73 for E4054 vs. 0.75 for E480); suggesting the two mutations 
found in the signal peptide of E480 HA would have no effect on its function. The mutation at 
residue three (T3I) had no effect on the S-score. The mutation at residue nine (A9V) slightly 
increased the S-score starting at residue nine continuing to residue 20. This most likely does not 
have an effect on the function of the signal peptide of E480.  
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Figure 5.4 Western blot of recombinant HA proteins expressed in SF9 cells 
Protein levels of 1) E480 and 2) M105. Proteins were run on a 10% Bis/Tris gel and stained with 
anti-human Fc. Molecular protein mass was predicted to be 87.25 kDa for E480 and 87.14 for 
M105 using the Protein Molecular Weight Calculator from Molecular Gateway 
(ScienceGateway). Two lanes between the ladder and lane 1 were removed from the original 
image, causing a difference in background colour.  
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5.2.2 Cell tropism of E480 
5.2.2.1 Cell tropism of E480 in human airway epithelium 
HAE cells containing both non-ciliated and ciliated cells were used to investigate whether the 
binding characteristics of E480 HA were human- or avian-like. To achieve this E480 HA protein 
was expressed using a recombinant baculovirus expression system. First the E480 HA protein 
was codon optimized for expression in insect cells by GeneArt (Life Technologies, UK). This 
step was necessary, as the original HA sequence was found to be toxic in bacterial culture and 
cloning of this sequence was unsuccessful. The optimized HA sequence was cloned using the 
pAc3CFc His Sfi1 expression vector and HA protein was expressed in SF9 insect cells as 
described in section 3.2.2 and Figure 3.6. Detection of binding was facilitated by fusion to the 
human Fc tag (Shelton et al. 2011).  
The HA of avian H7N7 isolate A/Mallard/Sweden/105/2002 (M105, Genbank accession number 
AY999989) was expressed similarly. Protein production was confirmed with WB against the His 
tag (Figure 5.4). 
These two recombinant H7 HA proteins were used to investigate whether the cell type in HAE 
cultures used for receptor binding varied between an avian H7 isolate and the human isolate 
E480. If a differential cell tropism was found, this could indicate either that the receptor binding 
preference changed within the human host or that a slightly different receptor binding 
preference increased the chance of the initial zoonotic jump from poultry to humans. An 
equivalent amount of each HA protein, based on visual inspection of the strength of WB bands, 
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Figure 5.5 Binding of recombinant H7 HA proteins to HAE sections 
HAE culture sections obtained from Professor Ray Pickles, University of North Carolina, were 
probed with HA-Fc recombinant proteins from a) E480, an H7N3 virus isolated from a human 
case, and b) M105 avian influenza virus. Ciliated cells were identified using anti-acetylated α-
tubulin (AMS Biotechnology) (red) and HA-Fc proteins were identified using anti-human Fc 
antibody (Sigma) (green). Images are representative of multiple probed sections. Both ciliated 
(white arrow) and non-ciliated (yellow arrow) cells were found in HAE sections.  
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was used to probe HAE sections (Figure 5.4). Ciliated cells in the formalin fixed HAE sections 
were identified using anti-acetylated α-tubulin antibody (AMS Biotechnology) (red) and HA 
protein binding to specific cells was detected by anti-human Fc antibody (Sigma) (green) (Figure 
5.5). In total HA protein of E480 bound to 46.8% of available cells. HA protein of E480 did not 
show a clear preference for ciliated or non-ciliated cells, 45.1% of the bound cells were ciliated 
and 54.9% were non-ciliated. In comparison to E480 HA, the HA protein of M105 bound to a 
similar percentage of total cells (56.8%) but a higher proportion of them were ciliated cells 
(71.9% ciliated vs. 38.1% non-ciliated). Consequently, the non-ciliated/ciliated cell binding ratio 
was 1.2 for E480 and 0.6 for M105, which reflects a decreased ciliated cell binding of E480 
compared to a prominent ciliated cell binding for M105 (Figure 5.6). This result was compared to 
the ratios of cell binding obtained by HA proteins of wild type E195 and E195 E227A (Figure 
3.9). Whereas E195 HA protein showed preferential binding to non-ciliated cells (ratio 3.9), the 
ratio obtained by E195 E227A was very similar to that of E480 (1.2 in both cases). As discussed 
in section 4.2.1, E195 E227A was able to transmit between ferrets. The E480 HA protein 
binding result suggests that E480 has an increased human-like receptor binding profile, which 
could explain why this virus was able to jump the host species barrier.  
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Figure 5.6 Quantification of recombinant HA protein binding to HAE sections 
The percentages of non-ciliated and ciliated cells were quantified by blind counting >70 cells per 
sample. The non-ciliated/ciliated cell binding ratio is displayed above each bar. 
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5.2.2.2 Cell tropism of E480 in the IOBA-NHC cell line 
E481 was isolated from the left eye of a human case, whereas E480 was isolated from the 
throat of the same human case (Table 5.2). Because the initial cell tropism of influenza is 
dictated by the virus HA receptor binding preference, and no molecular differences were found 
between the HA genes of E480 and E481 (see paragraph 5.2.1), all cell tropism experiments 
were done with E480 virus only. To investigate whether E480 can infect conjunctival cells, we 
used the IOBA-NHC cell line, kindly provided by Dr. Virginia Calder (Institute of Ophthalmology, 
UCL). This cell line originates from normal human conjunctival cells and retains many important 
morphological and functional conjunctival epithelial characteristics in vitro such as CK-3 
expression (Diebold et al. 2003). Both α2,3-linked and α2,6-linked sialic acid were expressed on 
IOBA-NHC cells (Figure 5.7).  
IOBA-NHC cells were seeded on coverslips, infected with virus at an MOI of 0.1 and incubated 
at 37°C for 16 hrs. After fixation with ice-cold methanol/acetone 50:50, the cells were co-stained 
for NP protein (green) and with either MAA or SNA lectin (red). These lectins are specific for 
α2,3-linked sialic acid and α2,6-linked sialic acid respectively. Images were taken using an 
inverted fluorescence microscope (Zeiss Axiovert 200). Using ImageJ software 
(http://rsbweb.nih.gov/ij/) brightness and contrast was adjusted in exactly the same way for 
every image. NP-positive and lectin-positive images were merged. Lastly, both the red and 
green images, adjusted for brightness and contrast, were converted such that all green or red 
pixels were now white and all dark pixels were converted into black pixels. This resulted in a 
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Figure 5.7 Infection of IOBA-NHC cells with E480 
Cells were mounted on coverslips, infected with E480 (MOI 0.1) and incubated at 37°C for 16 
hrs. After fixation with acetone/methanol (50:50), the cells were probed with anti-NP protein 
antibody (green, panel 1) and either MAA or SNA lectins (red, panel 2). Using ImageJ software 
(http://rsbweb.nih.gov/ij/) NP-positive images were merged with matching lectin-positive images 
(panel 3). Lastly, co-location was visualized by converting pixels that were positive in both the 
NP-positive image and lectin-positive image to white, whereas all other pixels were converted to 
black (panel 4). N=3, representative images of all three experiments were used.  
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binary image. The NP-positive image was then „multiplied‟ by the lectin-positive image using 
ImageJ image calculator. This resulted in an image with white pixels where the primary picture 
pixels were white in both images, and black pixels where the primary picture pixels were black 
in both images or only one of the images contained white pixels. This allowed overlapping NP 
and lectin positive cells to be identified. Using these methods, it was determined that E480 had 
a preferential cell tropism for conjunctival epithelial cells positive for α2,3-linked sialic acid 
(Figure 5.7). Almost no infected cells were found to be positive for α2,6-linked sialic acid, 
whereas most cells that were infected were also α2,3-linked sialic acid positive. Although 
primary conjunctival cells are permissive for influenza virus infection (Belser et al. 2011c), to our 
knowledge this is the first time a conjunctival cell line (IOBA-NHC) has been shown to be 
infected by influenza A virus. H7 is known to have an ocular cell tropism, and it remains to be 
investigated whether other subtypes in addition to H7 are also able to infect IOBA-NHC.  
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5.2.3 Replication of E480, E481 and M105 in IOBA-NHC cell lines and HAE 
cultures 
In the previous sections (5.2.2.1 and 5.2.2.2) it was shown that E480 has an increased 
preference for non-ciliated cells, but still bound to α2,3-linked sialic acid-expressing IOBA-NHC 
cells. M105 showed a preference for binding ciliated cells in HAE cell sections, however cell 
tropism of M105 was not investigated in IOBA-NHC cells. Replication of E480, E481 and M105 
viruses in cells derived from the potential target tissues (eye and respiratory tract) was 
investigated. By examining virus replication changes in HA affecting cell tropism as well as any 
effect of differences between internal proteins could be investigated. Firstly, it was investigated 
whether the human virus isolates replicated better than the avian M105 virus in human 
conjunctival and airway epithelial cells. Secondly as differences were found in the PB2 
sequences of E480 and E481 which might affect virus replication it was investigated whether 
E480 and E481 differ in viral replication. PB2 is thought to be the second most important 
protein, after HA, in determining influenza virus host range. For example, the residue at position 
627 in PB2 has been associated with tissue cell tropism; E at position 627 is commonly found in 
avian influenza viruses whereas lysine at this position is commonly found in human influenza 
viruses. A human influenza virus reassortment with an avian PB2 gene segment was found to 
display a restricted replication profile in mammalian cells, however a single amino acid 
substitution in PB2 (E627K) fully restored replication (Subbarao, London and Murphy 1993). 
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Figure 5.8 Multi-cycle growth curve of human H7N3 isolates E480, E481 and avian 
isolate M105 in IOBA-NHC cell line 
IOBA-NHC cells were infected with E480, E481 or M105 at an MOI of 0.001 and incubated at 
37°C. Samples were taken from the supernatant at t=24, 48 and 72 h.p.i. and checked for the 
presence of influenza virus using plaque titration on MDCK cells. Data shown represent the 
mean and standard deviation of 3 wells. Statistical differences between E480 and E481 are 
represented and were determined using one-way ANOVA. ** = p<0.01, *** = p<0.001 
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Another PB2 residue at position 701 is associated with increased activity of avian origin virus 
polymerases in human cells. A mutation from D to asparagine (N) at this position was linked to 
replication of avian influenza virus H5 in mice and guinea pigs (Gao et al. 2009, Li et al. 2005). 
Combining both the E627K and D701N mutation was found to increase avian influenza virus H5 
replication in the guinea pig model (Steel et al. 2009). Interestingly, A(H1N1)pdm09 did not 
encode the human-like signatures at position 627 or 701. A third amino acid change (Q591R) in 
A(H1N1)pdm09 PB2 is linked to its ability to replicate in the human host (Yamada et al. 2010, 
Mehle and Doudna 2009).  
Therefore, it was of interest to investigate whether the two amino acid differences in PB2 
between E480 and E481 (M206I and Q288R) had an effect on viral replication in different cell 
lines, even though the mutations found in PB2 in E481 were rare and not specific for human H7 
PB2 (Table 5.7 and Table 5.8). 
 
5.2.3.1 Replication of E480, E481 and M105 in IOBA-NHC cell lines 
IOBA-NHC cells were infected with E480, E481 and M105 at an MOI of 0.001 and incubated at 
37°C and 5% CO2. Samples were taken from the supernatant at different time points post 
infection (24, 48, 72 hrs) and checked for the presence of influenza virus by plaque titration on 
MDCK cells (N=3). All viruses were capable of replication in IOBA-NHC cells, but avian 
influenza virus M105 replicated to a lower viral titre than both E480 and E481, which was 
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Figure 5.9 Multi-cycle growth curve of human H7N3 isolates E480, E481 and avian 
isolate M105 in HAE cultures at 37°C 
HAE cultures were infected with E480, E481 or M105 at an MOI of 0.01 and incubated at 37°C. 
Samples were taken from the supernatant at t=12, 24, 48, 72, 96 and 120 h.p.i. and checked for 
the presence of influenza virus using plaque titration on MDCK cells. Data shown represent the 
mean and standard deviation of 3 wells. Statistical differences between E480 and E481 or 
M105 were determined using one-way ANOVA.  
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significant in comparison to E480. Replication of M105 was delayed; there was no increase in 
viral titre between 0 and 24 h.p.i. This suggests that both E480 and E481 were better adapted to 
human IOBA-NHC cells. Interestingly, throat isolate E480 reached higher viral titres at each 
time point compared to E481 and M105, which compared to E481 was found significant at t=48 
h.p.i. (in 2 out of 3 performed growth curves) and t=72 h.p.i. (in 3 out of 3 performed growth 
curves) by one-way ANOVA (Figure 5.8).  
It should be noted that M105 was grown in a mammalian cell line (MDCKs) which could have 
positively influenced its ability to grow in mammalian cells such as IOBA-NHC cells.  
 
5.2.3.2 Replication of E480, E481 and M105 in HAE cultures 
Viral replication was then tested in HAE cultures, which are thought to represent the human 
upper respiratory tract. HAE cultures were infected with E480, E481 and M105 at an MOI of 
0.01 and incubated at 37°C. Samples were taken from the apical surface at different time points 
and checked for the presence of influenza virus using plaque titration on MDCK cells (N=1). All 
viruses were able to replicate in HAE cultures, maximum viral titres were reached rapidly at t=24 
h.p.i. Similar to the observation in IOBA-NHC, avian influenza virus M105 replication was 
delayed at early time points  compared to both human isolates of H7N3, although these 
differences were not found to be significant. No differences were observed between viral titres 
of E480 and E481 at different time points (Figure 5.9). Again, it should be taken into account 
that M105 was grown in a mammalian cell line. Sequence comparison to the original isolate will 
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Figure 5.10 Multi-cycle growth curve of human H7N3 isolates E480 and E481 in HAE 
cultures at 32°C 
HAE cultures were infected with E480 or E481 at an MOI of 0.01 and incubated at 32°C. 
Samples were taken from the apical surface at t=4, 8, 12, 16, 24 and 30 h.p.i. and checked for 
the presence of influenza virus using plaque titration on MDCK cells. Data shown represent the 
mean and standard deviation of 3 wells. Statistical differences between E480 and E481 were 
determined using Student‟s t-test. * = p<0.05 
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reveal whether the stock of M105 used in these experiments has adjusted to growth in 
mammalian systems.  
As maximum titres were found at such an early time point, the growth curve was repeated at 
32°C with E480 and E481 up to 30 h.p.i. and samples were taken at earlier time points (N=1). 
Here, viral replication was slow compared to the growth curve performed at 37°C and the 
plateau of viral replication was not yet reached at t=30 h.p.i. Moreover, at t=30 h.p.i., E481 
displayed increased viral replication compared to E480 which was found to be significant by 
Student‟s t-test (Figure 5.10). Temperature-dependent attenuation of viral replication has been 
observed previously in avian influenza viruses, and been attributed to the PB2 gene. Indeed, 
obtaining the humanizing E627K mutation in PB2 re-established viral replication at lower 
temperatures (Massin et al. 2001).  
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Virus 
Egg 
passage 
Nt at position 
650 
Nt at position 
895 
Identifier 
E480 4 G A N/A 
E480 1 G A 
E480, 0.5ml, 08-05-
2006 
E480 2 G A 
E480, 250μl, 01-05-
2006 
E480 3 G A 
E480, H0617800001, 
T/S, egg pass1 
E481 4 T G N/A 
E481 1 G A 
E481, 01-05-2006, 
500μl, E7 
E481 2.1 T G 
E481, 20-10-2006, 
0.5ml, MK+LH 
E481 2.2 G A 
E481, H0617800623, 
L/Eye, egg pass 1 
     
Table 5.9 Summary of sequence results E480 and E481 egg passage stocks 
The PB2 gene segment (nt 1-1473) of egg passage 1, 2 and 3 of E480 and E481 was 
sequenced using H7 WGS primers. A multiple sequence alignment using MegAlign (DNASTAR 
Lasergene 9 Core suite software) was performed to compare the nucleotide sequences. The 
viral stocks used throughout this chapter are displayed in green, the egg-passaged stocks used 
to grow these viral stocks are displayed in blue.  
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5.2.4 Sequencing of earlier egg passages of E480 and E481 
The E480 and E481 influenza viruses used in this study were serial-passaged through eggs four 
times. A well-known artifact of serial passage of virus in eggs is adaptive mutations in influenza 
virus to this environment (Gambaryan, Robertson and Matrosovich 1999, Robertson et al. 1987, 
Robertson et al. 1993). To ensure the mutations we found in E480 and E481 egg passage 4 
were representative of the consensus of the original isolates, the PB2 gene (nucleotide 1 to 
1473) of earlier passages was sequenced. For E480, egg passage 1, 2 and 3 was sequenced. 
In this project, egg passage 3 was passaged once in eggs to grow a high viral titre stock. For 
E481, egg passage 1 and two times an egg passage 2 (2.1 and 2.2) was sequenced. In this 
project, egg passage 2.1 was used to grow a viral stock and passaged twice in eggs to obtain a 
high viral titre stock. 
All earlier E480 egg passages contained the same nucleotide sequence as E480 egg passage 
4. However, only one of the earlier egg passages of E481 (egg passage 2.1) contained the 
same nucleotide sequence as E481 egg passage 4. Both egg passage 2.1 and egg passage 4 
were unusual compared to all other egg passages in containing the G650T and A895G 
mutations. This suggests that either the non-synonymous mutations found in PB2 were egg-
adaptive mutations, or egg passage 2 represents a quasi-species found in the original isolate 
(Table 5.9). 
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E480(/E481) versus M105 
Experiment Result Significance 
HA protein binding on HAE cultures 
E480: 45.1% ciliated, 54.9% non-ciliated 
M105: 71.9% ciliated, 38.1% non-ciliated 
N/A 
Virus replication in IOBA-NHC cells 
M105 is attenuated compared to E480 and 
E481 
p>0.01 
Virus replication in HAE cultures 
M105 is attenuated compared to E480 and 
E481 
NS 
E480 versus E4054 
Experiment Result Significance 
Multiple alignment of HA protein 
Two non-synonymous changes in signal 
peptide 
N/A 
E480 versus E481 
Experiment Result Significance 
Multiple alignment of all segments 
One synonymous mutation in PB2 
One synonymous mutation in NS 
Two non-synonymous mutations in PB2 
N/A 
Virus replication in IOBA-NHC cells E481 is attenuated compared to E480  p>0.01 
Virus replication in HAE cultures at 37°C No difference NS 
Virus replication in HAE cultures at 32°C E480 is attenuated compared to E481 p>0.05 
E480 
Experiment Result Significance 
Cell tropism in IOBA-NHC cells 
Clear preference for α2,3-linked sialic acid 
expressing cells 
N/A 
   
Table 5.10 List of all experimental results 
All experimental results were summarized in above table. N/A = Not applicable; NS = Not 
significant 
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5.3 Discussion 
In this chapter, we showed that HA protein from E480 bound more non-ciliated cells in HAE 
cultures than HA protein from M105. Furthermore, replication of M105 in both IOBA-NHC and 
HAE cultures was attenuated compared to E480 and E481, although this difference was not 
significant in HAE cultures. These small differences could explain the ability of the virus to make 
the zoonotic jump. The HA protein of E480 and chicken virus E4054 differed only in the signal 
peptide, which was not thought to have an effect on cell tropism. Finally, two non-synonymous 
mutations were found in the PB2 protein of E480 compared to E481, which potentially 
accounted for a difference in replication in HAE cultures and IOBA-NHC cells. Unfortunately due 
to a lack of materials it was not possible to confirm whether these mutations were genuine. 
After successful whole genome sequencing of both E480 and E481 using a newly developed 
WGS assay, the HA gene segment of E480 was compared to poultry isolate E4054. Two amino 
acid substitutions, T3I and A9V, were found in the HA signal peptide of E480. These mutations 
are not thought to have an effect on receptor binding properties, as the signal peptide is absent 
from the mature protein. Using a signal peptide prediction program, it was shown that the „new‟ 
E480 signal peptide is still recognized as such, and the mutations are not thought to have an 
effect on expression of the HA protein in eukaryotic cells. Multiple sequence alignment using H7 
HA sequences, showed that I at position 3 was common (30% of sequences), but valine at 
position 9 was not observed in any H7 HA sequences. In the signal peptide prediction outcome 
however, this mutation had no effect other than elevating the S-score, which in any case is high 
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for signal peptide linked amino acids. It is unclear whether this would affect the expression 
levels of HA in the eukaryotic cell.  
Next, all gene segments of E480 and E481 were compared. As only the HA sequence of E4054 
was known, no further comparison could be made between the poultry and human viruses. Two 
synonymous changes (one in NS, one in PB2) and two non-synonymous changes (both in PB2) 
were identified. None of the other gene segments had any differences. 
Both HA and PB2 are thought to be key proteins in influenza virus that need to adapt to the host 
to allow replication of the virus and transmission between hosts. As the receptor binding protein, 
the HA protein is mostly important in the selection of which cells will be entered by influenza 
virus and thereby dictates initial cell tropism. Avian influenza viruses bind preferentially to α2,3-
linked sialic acid, whereas human influenza viruses preferentially bind α2,6-linked sialic acid and 
this differential receptor binding preference is reflected in a divergence in cell tropism; avian 
influenza virus infects mostly ciliated cells, whereas human influenza virus infects non-ciliated 
cells in the HAE cell model (Matrosovich et al. 2007, Matrosovich et al. 2000, Matrosovich et al. 
1997, Matrosovich et al. 2004a, Thompson et al. 2006, Ayora-Talavera et al. 2009, Shelton et 
al. 2011).  
Together with PB1 and PA, PB2 forms the RdRp. Host-specific adaptations in this protein are 
thought to be mostly important for the replication of influenza virus in either avian or mammalian 
cells. Several changes in PB2 have been identified that result in such an adaptation and have 
been discussed previous. A mutation at position 627 from E to lysine (E627K) is known to 
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facilitate adaptation to the mammalian host (Hatta et al. 2001, Subbarao et al. 1993). A second 
mutation (D701N), which was identified in a natural H5N1 isolate, caused high pathogenicity in 
a mouse model (Li et al. 2005). Both of these mutations were found to contribute to efficient 
propagation in the human upper respiratory tract (Le et al. 2009) and be a factor in transmission 
in mammalian models (Van Hoeven et al. 2009b, Steel et al. 2009). A recently identified 
mutation is thought to have played a major role in the adaptation of A(H1N1)pdm09 to the 
human host, which has the avian signature amino acids at position 627 and 701. Here residue 
590 and 591, which are closely located to residue 627 on the surface of PB2, are mutated from 
G to serine and glutamine to arginine respectively (Yamada et al. 2010).  
Two possible scenarios would explain the adaptive effect of the PB2 mutations; either it is 
possible that a stimulatory host-specific co-factor is necessary for efficient replication of 
influenza virus, or alternatively a host-specific inhibitory factor in human cells is dysfunctional 
when these mutations occur. Recent research in our laboratory using heterokaryons formed by 
avian and human cells suggests a stimulatory host-specific co-factor is necessary for efficient 
replication in human cells, such as importin  (Moncorge, Mura and Barclay 2010).  
The identification of the two amino acid mutations in PB2 is a potential adaptation of H7N3 to 
the human host. The influenza polymerase does not have any proofreading activity, and 
therefore tens of thousands of new viral mutants (quasispecies) are produced during replication 
of the virus (Drake 1993). Neither of the amino acids found in E481 (isolated from the eye) are 
regularly found in avian or human PB2 gene segment sequences. This could suggest that E480 
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represents an earlier consensus of H7N3, whereas E481 represents a quasispecies with a 
favorable fitness in the human host, allowing increased replication of this „mutant virus‟.  
The mutations found in PB2 in earlier research linked to host adaptation are localised in the C-
terminal part of the protein and are found adjacent in the crystal structure of PB2 (Yamada et al. 
2010) at what is very likely to be the interaction point of PB2 and the (stimulatory or inhibitory) 
host-specific co-factor. In fact, the area in which the two mutations found in this study are 
located have so far not been linked to any function of PB2. It is therefore difficult to predict 
whether they are likely to affect viral replication.  
The growth curves performed in IOBA-NHC cells and HAE cultures did show a difference; 
whereas E480 grew better in conjunctival epithelial cell line IOBA-NHC, E481 outgrew E480 in 
HAE cultures when incubated at 32°C, the temperature of the human upper respiratory tract, 
which is slightly lower than the temperature of the eye at 34°C (Fujishima et al. 1996). This 
suggests that amino acids 206I and 288R in PB2 result in increased replication in the human 
URT. However the molecular analysis does not support this, as these mutations are found in 
2.06% and 0.22% of avian PB2 sequences respectively versus 0.1% and 0% in human PB2 
sequences. It is possible that cells in the URT express co-factors important for influenza virus 
replication which are expressed to a lesser extent in conjunctival epithelial cells and that the 
presence of 206I and 288R result in a better exploitation of these factors. To further explore the 
adaptive formation of E481 over E480, growth curves should be performed in avian cells and 
compared to replication in human cells, although it should be noted that any potential adaptation 
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advantage to the human host does not necessarily come at a cost for the avian host. It would 
also be informative to increase the length of growth curves in HAE cultures performed at 32°C; 
a greater difference could potentially be found at later time points.  
Development of the H7 WGS strategy during this project allowed retrospective analysis of 
earlier passages of E480 and E481 which had not been selected for study previously due to 
limited volumes. WGS of earlier passages of E481 revealed a different consensus in two out of 
three earlier egg passages. It is therefore possible that the mutations M206I and Q288R 
described in this chapter are the result of egg adaptations, a well-known artifact of egg passage 
(Gambaryan et al. 1999, Robertson et al. 1987, Robertson et al. 1993, Matrosovich et al. 1997, 
Lugovtsev, Vodeiko and Levandowski 2005). An alternative possibility is that the original clinical 
isolate of E481 contained a range of quasispecies, including E481 206M/288R as well as E481 
206I/288R. As a consequence, in two egg passages the former quasispecies dominated, 
whereas in one egg passage the latter quasispecies dominated. To resolve this question next-
generation sequencing of the original clinical isolates could be used, which will not just give the 
consensus of E480 and E481, but also allow analysis of the quasispecies content. This 
experiment would reveal whether E481 (and possibly E480) naturally contain virus with the 
206I/288R combination or whether these mutations are purely egg-adaptations. 
Cell tropism experiments performed with E480 revealed a very avian-like binding profile. In 
IOBA-NHC cells, the virus displayed a preferential infection pattern for α2,3-linked sialic acid 
expressing cells. This preference for α2,3-linked sialic acid was also reflected in its HA protein 
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binding profile on HAE cells; almost 50% of bound cells were ciliated. Compared to M105 
recombinant HA protein binding a slight decrease in ciliated cell binding was found. This could 
potentially explain the ability of E480 to jump the zoonotic barrier. However, when this binding 
profile is compared to the A(H1N1)pdm09 E195 recombinant HA protein binding profile on HAE, 
there is still much more ciliated cell binding than would be expected with an influenza virus able 
to transmit between humans. E480 was able to infect a human but there was no evidence of 
human-to-human transmission during this outbreak. This binding profile suggests further 
adaptation to a more human-like non-ciliated cell binding profile would be required before this 
could happen. 
Finally, phylogenetic trees were created to investigate whether reassortment of E480/E481 had 
occurred with non-Eurasian avian gene segments. However, all internal genes were found to be 
closely related to Eurasian avian lineages and therefore it was concluded that no reassortment 
occurred prior to the zoonotic jump. 
 Future research should focus on the „missing link‟, by investigating replication and cell tropism 
of the chicken virus E4054. This will reveal whether differences between M105 and E4054, or 
between E4054 and E480 where responsible for the zoonotic jump. Importantly, cell tropism of 
M105 in IOBA-NHC was not yet investigated. It is possible that this virus is attenuated in initial 
infection of human conjunctival cells compared to E480, as suggested by the delay in viral 
replication as observed in Figure 5.8. Furthermore, the effect of single mutations in the PB2 of 
H7 as revealed via WGS assay should be investigated using a reverse genetic system. Finally, 
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although no virus was recovered from samples taken from patients presenting with influenza-
like illness after exposure to H7-infected poultry, it should be attempted to isolate RNA and 
sequence the entire genome. This will provide us with a much larger spectrum of H7 viruses 
which are able to infect the human host and might provide more information on which amino 
acids are of particular importance in H7 influenza virus zoonosis.  
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6 Infection of ex-vivo whole porcine lungs with A(H1N1)pdm09 
6.1 Introduction 
In the middle of 2011, the opportunity arose to investigate a new model of influenza infection via 
collaboration with the Royal Brompton Hospital, London. The possibilities of ex-vivo lung 
perfusion (EVLP), a method developed by Steen et al. (Steen et al. 2003) to assess the quality 
and facilitate the reconditioning of rejected human donor lungs to increase the donor pool 
available for transplantation, have been further investigated by Dr. Mark Griffiths and Dr. 
Alastair Proudfoot at the Royal Brompton Hospital. Here, whole lungs are ventilated and 
perfused using an albumin-based medium, potentially with red blood cells (Figure 6.1). Applying 
this methodology, lung function and histology have been preserved for up to twelve hours 
(Cypel et al. 2008). While developed for clinical transplant, increasingly investigators are 
realising the application of this system as a tractable model in respiratory research; EVLP 
combines the 3D dimensions of a real lung with the physical factors involved in breathing. 
Furthermore, the immune system could potentially be included in this model, as it might be 
possible to include immune cells in the perfusate. However, EVLP experiments require a very 
specific expertise, are relatively challenging and expensive. As a pilot study, we investigated 
whether porcine lungs used in an EVLP experiment were able to support influenza replication. 
Within this chapter, several different readouts of influenza-infected porcine lungs in the EVLP 
setup are assessed, and uncontrolled factors are revealed.  
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A(H1N1)pdm09 was a very interesting candidate for the pilot study, as the first pandemic of the 
21st century did not originate from birds, as was expected by many scientists in the field since 
1997 when H5N1 directly infected humans, but from a swine-origin. Traditionally, the swine host 
has been seen as a possible mixing vessel for avian and human influenza, allowing for 
reassortment between these viruses and subsequent release of a potentially pandemic virus. 
This hypothesis was based on findings that the pig exhibits a relatively low species barrier 
towards infection with avian and human influenza viruses. Indeed, isolation of human influenza 
virus (Ottis et al. 1982, Katsuda et al. 1995) and avian influenza virus (Guan et al. 1996, Karasin 
et al. 2000) from pigs as well as documented reassortment events involving avian and human 
influenza viruses within pigs  (Brown et al. 1998, Castrucci et al. 1993, Zhou et al. 1999) 
underline the possibility of the pig as a mixing vessel. Furthermore, phylogenetic analyses of the 
NP gene of avian, human and swine influenza viruses showed that swine influenza NP 
sequences were scattered across the phylogenetic tree, whereas avian and human influenza 
NP sequences were found to form two distinct branches (Scholtissek 1994), suggesting NP 
genes of swine influenza viruses have both avian and human origin. As discussed previously, 
avian influenza virus has HA that preferentially binds to α2,3-linked sialic acid, whereas human 
influenza HA prefers α2,6-linked sialic acid as its receptor. Interestingly, expression of both of 
these terminal sugars is found in the porcine trachea (Ito et al. 1998) although recent data 
suggests the distribution of α2,3-linked sialic acid is restricted to lower LRT (bronchioles and 
alveoli) whereas α2,6-linked sialic acid is found abundantly throughout the respiratory tract (Van 
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Poucke et al. 2010, Nelli et al. 2010). After circulation in the swine host, the HA of swine 
influenza viruses of avian origin have acquired a more human-like receptor binding profile, 
potentially preparing them for a zoonotic jump (Ito et al. 1998, Bradley et al. 2011). Finally, pigs 
are similar to the human host in regards of the physiology of the respiratory tract. To sum up, 
the hypothesis of the pig serving as a mixing vessel for generation of viruses with human 
pandemic potential has a thorough factual grounding. Nonetheless, for decades no such 
reassortant virus emerged from the swine population and hence people focused on H5N1 
zoonoses which have occurred relatively frequently since 1997. Although A(H1N1)pdm09 is not 
a reassortant between an avian and human influenza virus but rather between two distinct 
swine lineages (Garten et al. 2009), the recent pandemic has again put pigs in the spotlight as a 
possible source for pandemic influenza. Therefore, porcine in vitro, ex vivo and in vivo models 
to investigate influenza pathogenesis, replication and transmission are vital research tools. 
Furthermore, swine influenza virus infections cause significant economic losses within the pig 
industry (Bennett, Christiansen and Clifton-Hadley 1999), illustrating the importance of research 
on this subject. 
Other porcine infection models have been developed over the years. Primary porcine cells, 
developed either from alveolar epithelial cells (Daidoji et al. 2008) or respiratory epithelial cells 
derived from distal tracheal/proximal primary bronchial airway (Busch et al. 2008), were able to 
support replication of avian, human and swine influenza virus. In earlier published research, 
Busch et al. showed an H3N2 virus pair of either swine or human-lineage to have different 
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infectivity and replication kinetics in swine; swine-lineage H3N2 infected more cells and showed 
higher viral replication than human-linage H3N2 in 7-week-old pigs (Landolt et al. 2003). 
Interestingly, this was mirrored in their primary cell model where increased infection of cells by 
the swine-lineage H3N2 isolate was found compared to the human-lineage H3N2. This 
suggests this particular model could have a good predictive value of infection in the host. The 
different infection profile was shown to depend on amino acids in the HA protein (Busch et al. 
2008). However, cell lines usually lack several important physiological characteristics of the 
respiratory tract, such as cell polarization and the mucociliary escalator system.  
Porcine and human ex vivo organ explants have been used extensively to investigate infectious 
disease such as Bordetella bronchiseptica and Bordetella pertussis as these tissue sections do 
reproduce the physiological characteristics and cellular complexity of the respiratory tract 
(Dugal, Girard and Jacques 1990, Soane et al. 2000). Not surprisingly, similar models using 
porcine explants to investigate influenza infection have been developed. Nunes et al. (Nunes et 
al. 2010) maintained porcine tracheal explants with an air-liquid interface and showed the 
cellular architecture of these explants was intact for 7 days during which time mucus was 
produced and cilia stayed active. Furthermore, this model was able to support viral replication of 
a swine H1N1 virus. A second group developed methods to culture ex vivo organ explants 
extracted from porcine nasal, tracheal, bronchial and lung sites. All of these tissue explants 
could support influenza replication, and interestingly showed limited growth of avian influenza in 
nasal and tracheal explants compared to swine and human influenza viruses. This result 
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correlated with the sialic acid expression in the different explants (Van Poucke et al. 2010, 
Glorieux et al. 2007). These models represent an interesting application, but unlike in vivo 
models exclude the involvement of the immune system (more specifically immune cells) in 
infection kinetics due to an absence of blood supply, and lack the physical complexity of the 
whole organ or the involvement of dynamic mechanic forces created by continuous breathing. 
In contrast, in vivo models allow for investigation of numerous infection kinetics parameters 
within the host, such as cytokine expression, vaccine efficacy and transmission. Pigs have been 
proven useful in in vivo experiments to study replication of influenza virus and subsequent 
pathogenesis (Van Reeth et al. 2002, Hinshaw et al. 1981, Kida et al. 1994, Shortridge et al. 
1998, Landolt et al. 2003, Weingartl et al. 2009) or influenza transmission between pigs and 
occasionally from pigs to ferrets (Choi et al. 2005, De Vleeschauwer et al. 2009, Brown et al. 
1994, Zhu et al. 2011). Transmission experiments using pigs are challenging, as pigs are 
relatively large animals and difficult to handle. Furthermore, the price of experiments is 
significantly increased when sourcing „high health status herd‟ pigs, which are extensively tested 
to ensure they are free of certain pathogens, including swine influenza. Accidental infection of 
laboratory workers after collecting nasal swabs from pigs experimentally infected with swine 
H1N1 has been reported, even though experiments were carried out using BSL3 containment 
level practices (Wentworth et al. 1997). Furthermore, outcome of disease is not always similar 
to that found in humans; pigs found to be infected with avian influenza virus H5N1 did not 
display clinical symptoms (Nidom et al. 2010) and swine experimentally infected with highly 
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Figure 6.1 The ex-vivo lung perfusion model 
The lungs were perfused with Steen solution circulated via a centrifugal pump. The trachea is 
attached to a ventilator protected by a filter. This closed system allows for ventilation of the 
lungs and is expected to maintain them for approximately 12-18 hrs. The lungs were kept in an 
unsealed dome to provide an environment with a high humidity a), connected to the centrifugal 
pump by cannulae placed in the pulmonary artery and vein and connected to the ventilator by a 
cannula placed in the trachea b). A schematic overview of the EVLP system is displayed in 
panel c (Scheme modified from Proudfoot et al. (Proudfoot et al. 2011)). PAP = pulmonary 
artery pressure, LAP = left atrial pressure 
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pathogenic H5N1 avian influenza virus typically develop mild disease compared to mouse and 
ferret animal models (Lipatov et al. 2008, Shortridge et al. 1998). 
A new high-tech model, a biomimetic microsystem that reconstitutes the alveolar-capillary 
interface of the human lung measuring just 1-2 cm in length, has been described recently by 
Huh et al. (Huh et al. 2010). This model was able to reproduce the host immune response to 
Escherichia coli including inflammatory cytokines such as TNF-However, although this model 
might represent an option for future experiments, the current availability does not yet allow us to 
investigate influenza infection. 
In this chapter, the possibility of infecting porcine lungs in the EVLP setup with influenza virus 
A(H1N1)pdm09 was investigated. Several virological and physiological parameters were 
examined, such as viral replication and Pmax. In the experiments described here lungs of 
porcine origin were used as a proof of principle prior to future study in whole human lungs.  
Please refer to the supplied CD or DVD to view the set-up of the EVLP experiments on video. 
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6.2 Results 
6.2.1 Infection of ex vivo porcine lung tissue sections 
Prior to infection of an entire porcine lung, the ability to grow influenza virus in tissue sections 
obtained from porcine lungs routinely used by Dr. Alastair Proudfoot, Royal Brompton Hospital, 
for EVLP was investigated. To this end, two viruses with an expected differential lung tropism 
were used to infect ex vivo porcine lung tissue sections; E195 is a prototypic A(H1N1)pdm09 
virus which has been discussed before, E195 D225G was constructed using the reverse 
genetics system. The D225G mutation in the HA protein of A(H1N1)pdm09 was first described 
by Kilander et al. They investigated the amino acid distribution at residue 225 in 205 mild and 61 
severe/fatal cases and detected the 225G mutation in 11/61 severe cases, but none of the mild 
cases. This led to the hypothesis that the 225G mutation increased pneumotropism (Kilander et 
al. 2010) via suspected increased α2,3-linked sialic acid binding (Stevens et al. 2006a) 
subsequently resulting in severe outcome of disease. Indeed, successive research showed that 
the 225G mutation in A(H1N1)pdm09 greatly increases infection of ciliated cells and results in 
an increase in HA binding to α2,3-linked sialic acids (Liu et al. 2010). Interestingly, in pigs 
inoculated with a mixture of 225D/G A(H1N1)pdm09 both mutations were found in influenza 
virus obtained from the nasal wash, but influenza virus obtained from 2/4 middle lung lobe 
sections contained only A(H1N1)pdm09 with mutation 225G whereas the other 2 middle lung 
lobe sections contained a mixture (Brookes et al. 2010). Therefore, it was hypothesized 
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Figure 6.2 Infection of ex vivo porcine lung tissue sections with influenza virus 
Each section was infected with 106 PFU of either wild type E195 or E195 D225G. Medium 
samples were taken every 24 hrs after infection and infectious viral titre was detected on a 
monolayer of MDCK cells. Viral titres of ex-vivo porcine lung tissue sections (EVPLTS) infected 
with wild type E195 are depicted in different shades of red, viral titres of EVPLTS infected with 
E195 D225G are depicted in different shades of blue. 
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that E195 D225G might have an advantage over wild type E195 to grow in lung tissue.  
Ex vivo porcine lung tissue sections (EVPLTS) were divided into different sections of equal size 
(approximately 5 by 5 mm) and washed with DMEM (Gibco). Hereafter, EVPLTS were 
incubated in triplicate at 37°C for 1 hr in 250 µl DMEM containing 106 PFU of either E195 or 
E195 D225G. After inoculum was removed, the EVPLTS were washed thrice with PBS, and 
incubated at 37°C in DMEM with 50 U/ml penicillin and 50 µg/ml streptomycin. No trypsin was 
added throughout the experiment and media was replaced every 24 hr followed by titration on 
MDCK cells to detect infectious virus.  
Directly after infection, a high viral titre was observed despite the wash step after removal of the 
inoculum. Due to the complex three-dimensional structure of the EVPLTS, it is deemed 
impossible to remove all virions that did not infect cells during the incubation step. Hence, using 
a lower viral titre as inoculum might be recommended. E195 D225G was detected at a higher 
viral titre than E195 at 0 h.p.i., but backtitration of the inoculum showed a similar viral input for 
both strains (106 PFU). This may suggest that less E195 D225G was bound and internalized 
than wild type E195. Such early time point differences were also noted by Scull et al. when 
titrating avian and human influenza virus in HAE cultures (Scull et al. 2009).  
Twenty-four hrs after infection, no infectious virus was detected in EVPLTS infected with wild 
type E195. However, at this time point all three EVPLTS infected with E195 D225G were 
positive for influenza virus; the average detected viral titre was 450 PFU/ml. It should be noted 
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Figure 6.3 Photographs of ex-vivo lung perfusion experiment 
Throughout the experiment, photographs were taken at -1, 7, 11 and 18 h.p.i. The air bubbles 
observed at 18 h.p.i. are caused by air leaks. On the posterior side of the lungs, tissue samples 
were taken. Photographs courtesy of Dr. Alastair Proudfoot. 
 
273 
 
 
that this titre is lower than the viral titre found at 0 h.p.i. suggesting that the virus detected here 
might be partly the remains of input that has not yet decayed. However, wild type E195 has 
decreased by 4 logs at this time whereas E195 D225G has decreased with only 2 logs. It is 
possible that virus detected at this time point is newly generated virus. Indeed, hereafter 2/3 
EVPLTS infected with E195 D225G continued to increase in infectious viral titre over time. 
Likewise, 3/3 EVPLTS were able to support replication of wild type E195. It is unclear why one 
EVPLTS was unable to support viral replication. Division into the EVPLTS was done randomly 
and it is possible that there was a difference in the number of cells susceptible to influenza 
infection available in each section (Figure 6.2).  
This pilot experiment proved that EVPLTS were susceptible to influenza infection and increases 
the likelihood that EVLP could be used as a model to study influenza virus infection. 
 
6.2.2 First infection of whole porcine lungs with E195 
The following experiments were only performed with clinical E195, and not with mutant E195 
D225G. En bloc lungs were extracted from a 5-month old large white pig by Dr. Alastair 
Proudfoot according to published protocols and transported on wet ice. The lungs were coupled 
to the EVLP circuit as described in Proudfoot et al. (Proudfoot et al. 2011). In short, cannulae 
were placed in the pulmonary artery and left atrial cuff after which the lungs were perfused with 
two litres of albumin-based perfusate called Steen solution (Steen et al. 2003) combined with 
200 ml of autologous porcine red blood cells to increase oncotic pressure and buffer the 
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Figure 6.4 Influenza virus detection in porcine lung tissue samples obtained from first 
EVLP experiment 
Presence of infectious virus was detected by standard plaque assay on a confluent monolayer 
of MDCK cells in PFU per gram of lung tissue or millilitre (perfusate).  
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inevitable lactic acidosis as the lung anaerobically metabolises over time. The perfusate was 
circulated via a centrifugal pump at a fixed flow rate of 1 litre/minute. Lastly, the trachea was 
attached to a standard clinical-grade ventilator protected by a filter which ventilates the porcine 
lungs. This closed system allows for ventilation of the lungs and was expected to maintain them 
for approximately 12-18 hrs (Figure 6.1). Following rewarming of the lungs to 37°C via a heat-
cooler device, 50 ml of 107 E195 isolate/ml was introduced into the right lower lobe via a 
bronchoscope. The other lung was left uninfected and was termed the mock-infected lung. 
Physiological parameters were measured throughout the experiment. Tissue samples were 
taken at -1, 1, 8, 12 and 18 h.p.i. of the infected lung and -1, 1, 8 and 18 but not 12 h.p.i of the 
mock-infected lung from the distal parts of the lower lobes, which were thought to be the tissue 
sites most likely to be infected with influenza virus. Perfusate samples were taken at 4, 8, 12 
and 18 h.p.i. Air leaks developed after 14 h.p.i in both lungs and the experiment was terminated 
at 18 h.p.i. Images were taken at different time points by Dr. Alastair Proudfoot to illustrate the 
appearance of the porcine lungs over time (Figure 6.3).  
Viral titres in homogenised porcine lung tissue samples were measured by standard plaque 
assay on a confluent MDCK cell monolayer. In samples obtained from the lung infected with the 
E195 isolate, high viral titres were found immediately after inoculation (105 PFU/g lung tissue). 
Unlike when a confluent cell monolayer is infected with influenza virus, the lungs could not be 
washed after infection. Therefore, the detected virus is most likely virus originating from the 
inoculum which had not entered cells. No increase in viral titre was observed in tissue samples 
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Figure 6.5 Physiological parameters of the porcine whole lung after infection 
The pulmonary vascular resistance was calculated by extraction of the mean pulmonary arterial 
wedge pressure (LAP, mmHg) of the mean pulmonary arterial pressure (PAP, mmHg) divided 
by the perfusate flow (L/min) x 80. The PaO2:FiO2 ratio was calculated by multiplying the flow of 
inhaled oxygen (FiO2) with the mean airway pressure (MAP), which is divided by the arterial 
partial pressure of oxygen (PaO2). Lastly, the peak inspiratory pressure (Pmax) was measured 
directly from the ventilator.  
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taken from the E195 inoculated lung at 8 and 12 h.p.i., but at 18 h.p.i. an increase in viral titre of 
2.5 logs over the original titre was observed, which likely represents viral replication and 
release. No infectious virus was detected in the mock-infected lung at 1 and 8 h.p.i., but at 18 
h.p.i. a viral titre of 104 PFU/g was present. This increase in viral titre likely represents viral 
replication and release.  
Interestingly, infectious virus could also be detected in the perfusate from 12 h.p.i. onwards. As 
the perfusate was circulated throughout the entire pair of lungs and as such does not 
discriminate between the mock-infected and E195 infected lung, this could be a potential source 
of infection of the mock-infected lung. However, the fact that the increase in viral titre in the 
mock-infected lung occurs at the same time and with a similar increase to that found in the 
E195-infected lung (2.5 logs and 4 logs between 8-12 and 18 h.p.i.), may suggest viral 
replication started at the same time in both lungs. It is therefore thought to be most likely that 
the infection of the mock-infected lung started with a low viral titre which entered the mock-
infected lung at 0 h.p.i., either during infection of the other lung with E195 isolate or via 
aerosolized E195 virus mobilized via ventilation. It can however not be excluded that the 
perceived stagnation in growth between 1 and 12 h.p.i. is in fact decay of virus that did not 
initially infect cells in the lung in combination with progeny virions. In that case, the infected 
perfusate might be the source of infection of the mock-infected lung (Figure 6.4).   
Functional assessment of porcine lungs was performed in accordance with techniques applied 
clinically in human ex-vivo lung transplantation (Cypel et al. 2011). Three physiological variables 
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Figure 6.6 Hematoxylin and eosin staining of tissue sections extracted from the E195- 
and mock-infected porcine lung  
Staining of different tissue sections at different time points was performed to score the 
pathology, as in Table 6.1. One image is annotated to show the bronchioli, alveoli and arteries. 
The black arrows point out apoptotic cells. All images are courtesy of Dr. Alexandra Rice.  
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were measured hourly; pulmonary vascular resistance (PVR), PaO2:FiO2 ratio and peak 
inspiratory pressure (Pmax). Pulmonary vascular resistance (dyn·s·cm-5) as a marker of 
pulmonary vascular endothelial function was calculated:  
 
 
No consistent changes in PVR were observed during the experiment. PaO2:FiO2 ratio provides 
an assessment of the ability of the lungs to diffuse oxygen across the alveolar capillary 
membrane and was calculated as follows: 
 
 
 In which the concentration of inhaled oxygen is FiO2, the mean airway pressure is MAP and the 
arterial partial pressure of oxygen is PaO2, measured in the circulating perfusate. Again no 
consistent changes in this parameter were observed during the experiment. Pmax reflects the 
driving pressure required to inflate the lungs to a given volume and is therefore a surrogate 
measure of parenchymal lung injury for example secondary to interstitial oedema due to acute 
lung injury. In this setting, the deterioration in lung compliance at 13 h.p.i. (Figure 6.5c) could 
reflect virus-induced injury to the alveolar capillary membrane albeit that this was not associated  
with any deterioration in PVR or the PaO2:FiO2 ratio. This hypothesis is supported by an 
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increase in viral titre observed by standard plaque assay from 12 h.p.i. to 18 h.p.i. Assessment 
of regional interstitial oedema in the virus-injured lobe could have been undertaken by x-ray 
imaging however, this was logistically challenging for our model system (Figure 6.5). 
Lastly, pathogenesis caused by influenza infection in porcine lungs was scored unblinded by 
pulmonary pathologist Dr. Alexandra Rice, Royal Brompton Hospital. Lung tissue samples were 
fixed in 10% formalin for 24 hrs and then embedded in wax. Sections cut at 5 µm were stained 
with haematoxylin and eosin and then examined by light microscope for pathological changes 
(Figure 6.6). Semi–quantitive assessment of acute lung injury was performed using interstitial, 
alveolar and septal oedema and interstitial and alveolar inflammation. Each parameter was 
scored for severity using a 4 point scale; 0 = absent, 1 = mild, 2 = moderate, 3 = severe. The 
sum of scores for each parameter gave the Total Lung Injury Score (TLIS) with a value of 0 to 
24. Bronchial damage was divided into epithelial damage and cellular influx driven by 
inflammation. No differences were observed in the TLIS between the mock-infected or E195-
infected lungs and the inflammatory cell influx is similar at all time points between both lungs. 
However, alveolar epithelial cell and neutrophil apoptosis was evident at 18 h.p.i. in the E195-
infected lung combined with an indurated epithelium, which was absent at 1 and 8 h.p.i. and the 
mock-infected lung. Furthermore, the general appearance of the E195-infected lung at 18 h.p.i. 
was described as resembling an acute bronchiolitis. In conclusion, at 18 h.p.i. the E195-infected 
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E195-infected lung 
  Oedema Inflammation TLIS Bronchial 
I A S I A 
 
E F 
Pre-infection 0 0 2 0 0 2 0 1 
1 h.p.i. 0 1 2 1 0 4 0 1 
8 h.p.i. 0 0 2 0 0 2 0 1 
12 h.p.i. 1 0 2 1 0 4 0 1 
18 h.p.i. 1 0 1 1 0 3 
2-3 
apoptosis++ 2 
 
 
Mock-infected lung 
  Oedema Inflammation TLIS Bronchial 
I A S I A 
 
E F 
Pre-infection 0 0 2 0 0 2 0 1 
1 h.p.i. 0 0 2 1 0 3 0 1 
8 h.p.i. 1 0 2 1 0 4 0 1 
18 h.p.i. 1 0 2 1 0 4 0 2 
         
         Table 6.1 Pathogenesis score of ex vivo porcine lung infected with E195, experiment 1 
Oedema and inflammation were scored for the interstitium (I) and alveoli (A), oedema was also 
scored for the septum (S). Each parameter was scored for severity using a 4 point scale; 0 = 
absent, 1 = mild, 2 = moderate, 3 = severe. The sum of scores for each parameter gave the 
Total Lung Injury Score (TLIS) with a value of 0 to 24. No differences were observed in TLIS 
over time or between the E195-infected and mock-infected lungs. Overall bronchial damage 
was divided into epithelial damage (E) and cellular influx driven by inflammation (F). Although 
no differences were found in cellular influx during the experiment or between the E195-infected 
and mock-infected lungs, an increased apoptosis of epithelial cells and neutrophils was 
observed in the E195-infected lung at 18 h.p.i. 
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lung showed clinical symptoms of infection, whereas this was not found in the mock-infected 
lung (Table 6.1). 
 
6.2.3 Second infection of whole porcine lungs with E195 
In the previous experiment porcine whole lungs were infected with a high dose of E195; the 
lungs were inoculated with 5 x 108 PFU/lung. Consequently, a high viral load was found in this 
lung at 1 h.p.i. Hypothetically, this could have been the cause of virus replication in the 
neighbouring mock-infected lung; aerosolised virus potentially could have gained access to the 
mock-infected lung via recirculation of air. Therefore to prevent cross-infection and a high viral 
titre at earlier time points, the experiment was repeated with a much lower dose of the E195 
inoculum, namely 4 x 106 PFU/lung (virus titre was 2 x 105, four lobe segments were infected 
with five ml each). Both lungs were again extracted from a 5-month old large white pig by Dr. 
Alastair Proudfoot and transported on wet ice, after which the lungs were coupled to the EVLP 
system as described in section 6.2.2. After one hr to allow the lungs to warm-up to 
approximately 37°C, one lung was mock-infected with serum-free medium and one lung was 
infected with 20 ml of 2 x 105 PFU of clinical E195/ml. Physiological parameters were measured 
throughout the experiment. Tissue samples were taken at -1, 1, 4, 8, 12 and 18 h.p.i. of the 
infected lung and -1, 1, 4, 8, 12 and 18 h.p.i. of the mock-infected lung at the distal part of the 
lower lobe. This site was argued to be most likely to be infected by influenza virus, as virus 
inoculum was targeted at this tissue.  
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Figure 6.7 Influenza virus detection in porcine lung tissue samples obtained from 
second EVLP experiment 
Presence of virus was detected by standard plaque assay on a confluent monolayer of MDCK 
cells in PFU per gram of lung tissue.  
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Figure 6.8 Wet/dry ratio of E195- and mock-infected ex-vivo porcine lungs 
a) Samples taken at 18 h.p.i. from the E195- and mock-infected porcine lung were weighed. 
After incubation at 65°C for two hrs on a hot plate, the tissue samples were weighed again. The 
ratio was calculated by dividing the weight before heating by the weight after heating of the 
samples. All samples were performed in triplicate and statistical analysis was done on Excel by 
Student‟s t-test. b/c) Heating of the whole lung samples on a hot plate in a CL2 safety cabinet. 
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Figure 6.9 Physiological parameters of the porcine whole lung after infection 
The pulmonary vascular resistance was calculated by extraction of the mean pulmonary arterial 
wedge pressure (LAP, mmHg) of the mean pulmonary arterial pressure (PAP, mmHg) divided 
by the perfusate flow (L/min) x 80. The PaO2:FiO2 ratio was calculated by multiplying the flow of 
inhaled oxygen (FiO2) with the mean airway pressure (MAP), which is divided by the arterial 
partial pressure of oxygen (PaO2). Lastly, the peak inspiratory pressure (Pmax) was measured 
directly from the ventilator.  
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Viral titres in homogenised porcine lung tissue samples were measured using standard plaque 
assay on a confluent MDCK cell monolayer. In samples obtained from the lung infected with 
E195, viral titres were not found until 18 h.p.i. (2.7 x 105 PFU/g lung tissue). No infectious virus 
was detected in the mock-infected lung at any time point throughout the experiment (Figure 
6.7).  
In the clinical setting, injured lungs contain a higher proportion of water than healthy lungs. To 
measure lung injury after influenza infection, the wet/dry ratio of tissue samples obtained from 
the E195- and mock-infected lungs at 18 h.p.i. was investigated by homogenization in sterile 
PBS followed by heating the samples at 65°C for two hrs. Indeed, the mean wet/dry ratio of 
samples from the E195-infected lung was 3.79, whereas this was 1.99 for samples from the 
mock-infected lung. However, this difference was not significant as calculated by Student‟s t-test 
(p=0.14) (Figure 6.8). 
Functional assessment of porcine lungs was performed as in section 6.2.2 in accordance with 
techniques applied clinically in human ex-vivo lung transplantation (Cypel et al. 2011); PVR, 
PaO2:FiO2 ratio and Pmax were calculated. No consistent changes in either of these  
parameters were observed during the experiment (Figure 6.9). This is in line with the lack of 
infectious virus as detected by plaque assay until 18 h.p.i.  
Lastly, pathogenesis caused by influenza infection in porcine lungs was scored again by 
pulmonary pathologist Dr. Alexandra Rice as described in section 6.2.2. In line with the other 
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E195-infected lung 
  Oedema Inflammation TLIS Bronchial 
I A S I A 
 
E F 
Pre-infection 0 0 3 1 0 4 0 0 
1 h.p.i 0 0 1 1 0 2 0 0 
8 h.p.i 0 0 1 0 0 1 0 0 
13 h.p.i 0 0 1 1 1 3 0 0 
14.5 h.p.i 0 0 1 1 0 2 0 0 
18 h.p.i 0 0 2 1 0 3 0 0 
 
 
Mock-infected lung 
  Oedema Inflammation TLIS Bronchial 
I A S I A 
 
E F 
Pre-infection 0 0 3 1 0 4 0 0 
1 h.p.i 0 0 2 1 0 3 0 0 
8 h.p.i 0 0 2 1 0 3 0 0 
13 h.p.i 0 0 2 0 0 2 0 0 
14.5 h.p.i 0 0 1 0 0 1 N/A N/A 
18 h.p.i 0 0 1 0 0 1 0 0 
 
 
        
         Table 6.2 Pathogenesis score of ex vivo porcine lung infected with E195, experiment 2 
Oedema and inflammation were scored for the interstitium (I) and alveoli (A), oedema was also 
scored for the septum (S). Each parameter was scored for severity using a 4 point scale; 0 = 
absent, 1 = mild, 2 = moderate, 3 = severe. The sum of scores for each parameter gave the 
Total Lung Injury Score (TLIS) with a value of 0 to 24. Overall bronchial damage was divided 
into epithelial damage (E) and cellular influx driven by inflammation (F). No differences were 
observed over time or between the E195-infected and mock-infected lungs. 
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experimental outcomes of the second infectious experiment, no differences were observed 
between the mock-infected and E195-infected lungs at any time point (Table 6.2). 
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6.3 Discussion 
In this chapter, the possibility of using EVLP as a porcine infection model was investigated. It 
was shown that whole porcine ex vivo lungs were able to support viral replication, which 
resulted in measurable viral and pathological parameters. It seems therefore feasible to use this 
model to study influenza infection in the context of a whole organ. 
It should be noted that the investigated virus (A(H1N1)pdm09) is known to replicate in pigs 
(Brookes et al. 2010); indeed A(H1N1)pdm09 has a porcine origin. It is not clear whether this 
model would also be suitable for the study of other influenza viruses such as seasonal H3N2 of 
human origin or H5N1 of avian origin. It would be of interest to investigate whether EVLP of a 
porcine lung is suitable for these influenza A viruses, as well as influenza B viruses, or whether 
the use of a human lung would be required to extend the model for this purpose. Both human 
and avian influenza viruses have been shown to be able to grow in ex vivo porcine tissue 
section originating from the respiratory tract (Van Poucke et al. 2010, Punyadarsaniya et al. 
2011) suggesting it is likely that viruses from both origins will be able to replicate in EVLP of a 
porcine lung. However, avian influenza replication was generally delayed in ex vivo cultures, 
and might be too slow to be investigated using EVLP of porcine lungs.  
No increase in viral titre was observed until 18 h.p.i. in two independent experiments. Even 
though it was noted which lobes were inoculated with influenza virus, translating that to the right 
location for biopsies is complex, due to the three-dimensional structure of the whole lung. It is 
therefore possible that the viral replication cycle within this model took the expected 8 hours, but 
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that this occurred at sites that were not used to take biopsies. The increase in viral titre 
observed at 18 h.p.i. is most likely caused by multi-cycle events, and the growth curves (Figure 
6.4 and Figure 6.7) are not thought to represent a single cycle of replication. However, it cannot 
be excluded that viral replication is slightly delayed. Before the lungs were attached to medium 
and oxygen supply, the tissue was transported on ice to increase preservation. Although warm-
up time of one hour was allowed, it is possible that the cell machinery was still relatively slow. 
Unfortunately, it is not possible to increase the length of the warm-up phase, as the life 
expectancy of the lungs is relatively short (Cypel et al. 2008) and already restricts the length of 
the experiment. Interestingly, viral growth does seem slow in the ex vivo porcine tissue sections; 
no increase in viral titre is observed until 48 h.p.i. This does not mean however that viral 
replication did not take place until 48 h.p.i., a high viral titre at 0 h.p.i. might hide viral replication 
at time points before 48 h.p.i.   
The interpretation of data on viral titre is relatively difficult, as the current model includes some 
variables. Firstly, the isolated tissue will vary between time points and contains an unknown 
mixture of different cell types. It is therefore possible that one sample contains a large portion of 
cells that support replication of influenza, whereas another sample contains a small portion of 
these cells potentially resulting in differences in detected infectious virus titre. Secondly, the 
porcine lungs are relatively large organs and it is not clear where influenza replication is taking 
place, potentially leading to under- or overestimation of viral titre per lung due to sampling at the 
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wrong location. Finally, as the number of cells is not known, it is not possible to calculate a MOI. 
This can lead to variation between experiments. 
Future experiments using this model should be done to refine the methodology. Ideally, the 
length of the experiment should be increased to 48 or 72 h.p.i. However, the condition of the 
lungs at the end of both experiments was poor and perceived as a potential safety hazard due 
to air leaks. Therefore, to increase the length of the experiment either the quality of the lung 
needs to be improved or the rate of decay needs to be decreased. The porcine lungs used were 
directly isolated from a pig, time between isolation and start of the experiment was minimized 
where possible. During this time, the lungs were kept on ice to minimize decay. It seems 
therefore improbable that the quality of the lungs can be improved. To decrease the rate of 
decay, maintenance variables such as medium should be improved, however the current state 
of knowledge does not allow for further improvement. An interesting alternative way to increase 
the length of the experiment would be to move to the use of so-called precision-cut lung slices 
(PCLS). Initial infection would then occur in the context of the whole lung, thereby taking 
advantage of the whole three-dimensional physiology of the lung as well as mimicking the 
dynamic mechanical forces normally experienced in the lung, which are potentially important in 
the enhancement of the inflammatory response (Huh et al. 2010). Physiological parameters can 
be measured during this part of the experiment, followed by wet/dry ratios when proceeding to 
the second part of the experiment. In the PCLS extension, the (mock-)infected porcine lungs 
would be filled with warm (37°C) low-melting agarose, followed by extracting cylindrical portions 
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of tissue of interest (e.g. where the lung was inoculated), which is subsequently cut into slices 
with a thickness of approximately 250 µm as described in Punyadarsaniya et al. 
(Punyadarsaniya et al. 2011). PCLS slides can be maintained in medium for up to seven days, 
which significantly increases the time span of growth curves.  
An ideal viral inoculum titre needs to be defined by infecting lungs with serially diluted virus. In 
the first experiment performed, the viral inoculum titre was perhaps too high, in the second 
experiment the viral inoculum titre was perhaps too low. 
It would be interesting to investigate viral growth of mutant E195 D225G in the porcine lungs. 
This virus has been found to be selected for in vivo in pigs (Brookes et al. 2010) and grew better 
in EVPLTS. Hypothetically, this virus would grow better in the porcine lung than wild type E195 
and could therefore present a relatively simple method to test the tissue-specificity of the EVLP 
model.  
Finally, other measurement such as x-ray imaging and electron microscopy would greatly 
improve the output of each experiment.  
Naturally, this model is too complex and expensive to simply look at how influenza viruses grow 
within the porcine lung. It is therefore important to think of niche experiments that this model is 
ideally suited for. One such example would be to test a novel antiviral therapy; simultaneously 
antiviral efficacy and toxicity to lung physiology would be tested. Alternatively, the effect of 
blood-borne immune cells on influenza infection could be investigated via addition to the media. 
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Moreover, the effect of therapies that target the immune response could be tested in that 
context.  
Initially, EVLP was developed for the maintenance of human lungs. These experiments could be 
extended to the human model, enabling performance of such antiviral testing in human lungs. It 
can even be envisioned to study the effect of avian influenza virus such as H5 and H7 in a 
human lung.    
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7 General Discussion 
There is no doubt that there will be another influenza pandemic, but the timing and nature of the 
emerging virus is still difficult to predict. Very recent work looking at the H5N1 avian influenza 
virus described genetic changes the avian virus would need to undergo before acquiring 
transmissibility between mammals. These changes occurred in two genes, the receptor-binding 
protein HA and polymerase complex unit PB2 protein (Herfst et al. 2012, Imai et al. 2012). The 
mutations described for H5N1 adaptation are not necessarily predictive of the amino acid 
substitutions that will be found in the next pandemic virus. Instead, it is more likely that certain 
properties of the virus, such as receptor binding and stability of the HA protein and efficiency of 
the polymerases need to change in order to produce a pandemic virus (Sorrell et al. 2011). 
The work presented in this thesis aimed to identify adaptations in the HA protein primarily but 
also in the PB2 protein that had an effect on the zoonotic and pandemic potential of influenza A 
virus. The viruses studied in this thesis included the recently emerged A(H1N1)pdm09 virus that 
caused the 2009 swine flu pandemic, and an H7N3 virus associated with zoonotic infections in 
the UK. 
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7.1 Why did the A(H1N1)pdm09 virus that emerged in 2009 cause a human 
pandemic? 
It remains unclear why the particular virus that emerged in 2009 in Mexico from pigs caused a 
pandemic whereas other swine viruses did not. One hypothesis was that this virus was more 
able to bind human forms of the sialic acid receptor. Using in vitro methods, it was shown in this 
thesis that residue 227, which was unique to A(H1N1)pdm09 had a significant effect on cell 
tropism. Whereas A(H1N1)pdm09 with the original residue 227E in HA preferentially bound and 
infected non-ciliated cells in human airway epithelium cultures, this profile is shifted to include 
more ciliated cells when the HA gene is mutated at this position to contain 227A, the amino acid 
found in swine-origin isolates. Nonetheless, this mutation did not abrogate transmission in a RD 
transmission experiment in ferrets; four out of four sentinel animals were infected with E195 
E227A. Interestingly, when comparing the virus shedding patterns of the RD sentinels of the 
E195 E227A transmission experiment with those of the wild type E195 transmission experiment, 
subtle differences were observed. The average duration of shedding was considerably shorter 
for E195 E227A compared to E195 (3.5 days vs. 5.3 days). Furthermore, for two out of four 
animals peak titre as well as the total number of plaque forming units shed during the 
experiment was considerably lower, whereas this was relatively uniform for animals infected 
with E195 (Table 4.1). If such characteristics were to be reflected in the human host, it is 
possible that the E227A mutant virus would have increased difficulty initiating a chain of 
transmission, as both the period and amount of shedding are decreased. In fact, the basic 
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reproduction number R0, which defines the number of secondary cases produced by a single 
infection, is based on three variables; the average rate of contact between a susceptible and 
infected person (c), the transmissibility of the agent (t) and the duration of contagiousness (d): 
R0 = t * c * d. As the A227E mutation decreased both variables t and d in the ferret transmission 
experiment and assuming transmissibility depends on amount of virus shed, the R0 number will 
decrease accordingly. Simplistically, if the value of R0 were to drop below 1 no sustained 
transmission pattern will be reached. Different studies to provide an estimate of the R0 of 
A(H1N1)pdm09 based on early epidemic growth data determined an array of different 
outcomes, ranging from 1.25 to 3.1 (Roberts and Nishiura 2011, Boelle, Bernillon and 
Desenclos 2009, Fraser et al. 2009). If indeed the true R0 value of the earlier isolates of 
A(H1N1)pdm09 is found in the lower range, it is possible that the presence of the E227A 
mutation would lower its value sufficiently to prevent a transmission chain. Experiments to 
investigate transmission chains in ferrets have not yet been described in the literature, but could 
provide the key to the effect of residue 227 on the pandemic potential of A(H1N1)pdm09.  
It should be noted that ferret transmission experiments are designed in such a way that aerosol 
transmission of influenza virus is more likely to occur than in a natural situation. Sentinel ferrets 
are continuously exposed to infected animals under permissive conditions, for example the air 
flow is directed from the infected ferret to the sentinel ferret thereby increasing the chance of 
transmission. Furthermore, in general viral doses used to infect ferrets (104-106) are much 
higher than the viral dose expected to naturally infect a human. This can significantly alter the 
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shedding profile as shown by Roberts et al. (Roberts et al. 2011). It is possible that when 
investigating less restricted influenza viruses, such as E195 E227A, the unnatural shedding 
profile caused by a high viral inoculum pushes the equilibrium towards transmission. Lastly, due 
to the scale of ferret transmission experiments the number of ferrets per experiment is always 
relatively small. Therefore, no statistical analysis can be performed on the results and the 
outcome is presented in a very black and white fashion: aerosol transmission occurred or did 
not occur. If it would be possible to use larger numbers of ferrets, properties such as „total 
amount of virus shed‟, „days of shedding‟ and „time to infection‟ could be more reliably compared 
between different influenza viruses and might alter the current conclusions on the transmission 
potential of E195 E227A. 
It should be noted that it is likely that the A227E mutation has occurred on several occasions in 
other swine influenza viruses, however none of these viruses went on to cause a pandemic. The 
start of the A(H1N1)pdm09 chain of transmission in humans was most likely a chance 
encounter between one swine host and one human host. Furthermore, it was not investigated 
whether the A227E mutation increases viral fitness in the porcine host, but if this is not the case 
it is unlikely the mutant virus would outgrow other quasispecies variants.  
A second role the A227E mutation might have played in starting the A(H1N1)pdm09 pandemic 
involved the avidity of the HA protein for sialic acid. In Figure 3.8 it can be observed that the 
E227A mutation seemed to increase recombinant HA protein binding to HAE sections whereas 
in comparison E195 showed weaker binding. A similar effect of this mutation was found in 
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glycan assay studies by de Vries et al. and recently by Xu et al. (de Vries et al. 2011, Xu et al. 
2012). Xu et al. relate the relative weak binding of A(H1N1)pdm09 HA to the equally weak 
receptor-destroying activity of A(H1N1)pdm09 NA and find that the HA and NA of all earlier 
pandemic strains were equally balanced (1918 H1N1, 1957 H2N2 and 1968 H3N2); both 1957 
H2N2 and 1968 H3N2 have strong HA and NA activity, whereas 1918 H1N1 displays an 
intermediate HA and NA activity. In contrast, 2 out of 3 swine progenitor viruses tested show a 
clear mismatched HA/NA. The balance between HA and NA therefore seems to represent 
another prerequisite of human influenza, but not necessarily swine influenza. The importance of 
the HA NA balance for transmission of A(H1N1)pdm09 in ferrets was also described by Yen et 
al. (Yen et al. 2011b). 
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Figure 7.1 Human H5N1 virus infection cases in Egypt 
Absolute number of human H5N1 virus infections in Egypt (solid line, left Y axis) and relative 
number of human H5N1 virus infections in Egypt compared to the number of worldwide 
infections (dashed line, right Y axis) is displayed. The year in which the H5N1 influenza virus 
sublineage with increased α2,6-linked sialic acid binding emerged is marked with a star (*). 
Information obtained from WHO website (WHO Accessed 26-01-2012). 
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7.2 Why have some avian influenza viruses jumped into the human host, 
whereas others have not (yet) done so? 
Transmission of an avian influenza virus to a human host is in most cases associated with direct 
contact with infected animals and hence exposure to a relative high quantity of virus and this is 
suspected to be the direct cause of most human cases. Nonetheless, some properties of the 
virus seem to increase the chance to make a zoonotic jump. A pertinent example is the 
emergence of new sub-lineages of H5N1 genotype Z (for example clade 2.2.1) in birds in Egypt 
in 2008 which display an enhanced binding affinity for α2,6-linked sialic acid in combination with 
residual binding affinity for α2,3-linked sialic acid (Watanabe et al. 2011). Interestingly, the 
emergence of these sub-lineages coincided with an increase in the number of human H5N1 
infection cases in Egypt and consequently since 2009, Egypt has seen much higher numbers of 
human H5N1 infections than other affected countries (Figure 7.1). These findings suggest that 
the altered receptor binding affinity of H5N1 contributed to the increased number of bird-to-
human zoonotic events. In addition, clade 2.2.1 contains the E627K mutation in PB2 (Chen et 
al. 2005), which is characterised as a mammalian adaptation and could help increase the host 
range of influenza A virus (Subbarao et al. 1993), thereby further increasing the chances of this 
specific subtype to cause a successful infection in a human host. 
Using an alternative initial site of infection might also help a virus make a zoonotic jump. Many 
human H7 influenza infection cases are associated with conjunctivitis (Belser et al. 2009a), 
whereas this outcome has only been found in a few H5N1 and A(H1N1)pdm09 influenza cases 
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(Dubnov-Raz et al. 2011, Chan 2002). Access to the respiratory tract via the eye has been 
shown for infection with respiratory syncytial virus (RSV) in both the human and murine host 
under experimental conditions (Hall et al. 1981, Bitko, Musiyenko and Barik 2007) and RSV has 
been isolated from the eye of paediatric patients with respiratory infection and conjunctivitis 
(Bitko et al. 2004). It is assumed that migration of the virus occurs via the lacrimal duct, which 
connects the eye to the respiratory tract in a wide variety of animals, including ferrets 
(Lewington 2007), pigs and humans. It is possible that H7 influenza virus can use a similar 
route, initially infecting the eye, followed by migration into the respiratory tract. Supporting that 
hypothesis, recent work has shown that ferrets infected with seasonal and avian influenza virus 
(H1, H3, H5 and H7) via the ocular route shed virus in the nasal and conjunctival wash (Belser 
et al. 2012). Likewise, mice infected via the ocular route were found to be positive for influenza 
virus in ocular tissue (H5 and H7), lung tissue (H1, H3, H5 and H7) and nasal tissue (H5 and 
H7) at 6 d.p.i. (Belser et al. 2009c). Bischoff et al. investigated the importance of the ocular 
portal of entry for influenza virus by exposing human volunteers wearing varying degrees of 
protective clothing to aerosolised 106.5-7.5 fluorescent forming units of live attenuated influenza 
virus H1N1, H3N2 and influenza B. They found that even in the nasal wash of volunteers 
wearing a fit-tested N95 respirator, but no eye protection, influenza virus could be detected 
using RT-PCR in 3/5 volunteers. However, when eye protection was worn in combination with 
the fit-tested N95 respirator, influenza virus was detected in only 1/5 volunteers (Bischoff et al. 
2011). These investigations suggest that the ocular route is a possible mechanism for viral entry 
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for influenza virus when the human host is exposed to a high enough viral titre. Combined with 
the relative ease of human ocular infection with H7 influenza virus compared to other subtypes, 
this route could form an alternative gateway to creating a pandemic virus of avian origin. 
An outbreak of low pathogenicity H7N3 in poultry in the UK led to one confirmed human 
infection associated with conjunctivitis in a poultry worker, and virus was isolated from both the 
throat and the eye. Due to the nature of his work, this patient was most likely exposed to 
infected birds and potentially received a high dose of virus which facilitated this zoonotic event. 
Nonetheless, we were interested in why this H7N3 isolate was able to jump the zoonotic barrier, 
and compared the virus to an avian H7N7 virus that was not associated with human infections. 
It was shown that the human H7N3 isolate (E480) bound more non-ciliated cells in a human 
airway epithelium culture than an avian H7N7 isolate (M105). Furthermore, M105 displayed a 
delayed growth in both differentiated human airway epithelium cultures and conjunctival 
epithelial cells compared to E480. We hypothesise that due to the changed receptor binding 
preference, E480 was more likely to infect the human eye than M105. Further work with these 
viruses using glycan arrays might help elucidate the nature of the receptor change (Liu, Palma 
and Feizi 2009).  
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7.3 Viral adaptations within the human host, to the human host 
In conjunction with one of the recent controversial papers on molecular determinants of H5N1 
mammalian transmission (Herfst et al. 2012), Russell et al. published a mathematical model to 
estimate the possibility of an avian H5N1 influenza virus acquiring the remaining mutations to 
obtain a identical profile to the transmissible virus of Herfst et al. (Herfst et al. 2012) or Imai et 
al. (Imai et al. 2012) within a mammalian host. Several different scenarios were investigated that 
could improve the possibility of such a mutant arising, such as the duration of infection and the 
positive selection of mutations. Both of these variables (and others) were found to increase the 
chances of such mutations evolving within a single host (Russell et al. 2012). 
It can be hypothesised that using the eye as an initial infection site prolongs the infectious 
period. Efficient viral replication in the eye close to a more restricted site, which can potentially 
positively select for mammalian–adapted influenza virus mutants, may facilitate movement from 
the eye to the respiratory tract. Both of those scenarios should increase the potential of 
obtaining a more mammalian-adapted H7 influenza virus (Russell et al. 2012). We investigated 
whether any such adaptation to the new host could be seen in the H7 infected individual by 
comparing the viruses isolated at different sites. No differences were found in the HA 
sequences of E480 (throat isolate) and E481 (eye isolate), but two non-synonymous changes 
were found in the PB2 sequence, namely M206I and Q288R. It cannot yet be excluded that 
these changes were not caused by serial egg-passage, but it was found that E481 containing 
the two unique mutations in PB2 displayed a small growth advantage over E480 in human 
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airway epithelial cultures at the temperature of the upper airway tract. The M201I mutation is 
found in a domain with an unknown function, but the Q288R mutation is found close to a 
functional domain associated with cap-snatching. Nonetheless, amino acid 288 was not found to 
be necessary for cap-snatching (Guilligay et al. 2008). Due to the relative uncertainty 
surrounding functional domains in PB2, it is difficult to predict what effect these mutations have. 
Avian polymerases are thought to be inefficient in mammalian cells, and adaptive mutations 
such as 627K and 701N are thought to increase the viral replication of the polymerase in 
mammalian cells (de Jong et al. 2006, Tarendeau et al. 2008, Hudjetz and Gabriel 2012). More 
work is needed to establish the origin and full effect of these mutations, but it is possible that 
they also represent an adaptive mechanism towards the human host. 
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7.4 Receptor binding assays, an essential tool to predict pandemic potential 
Interestingly, when comparing HA binding profiles of E195 and E480, it was noticeable that 
E195 E227A had the same non-ciliated/ciliated cell binding ratio as E480 (both 1.2) whereas the 
ratio for M105 was much lower (0.6) and the ratio for wild type E195 was much higher (3.9). Do 
these two isolates represent viruses that are approaching human-like receptor binding? 
Receptor binding assays are an essential tool in determining whether changes in the viral HA 
protein increase the pandemic potential of influenza virus isolates.  
Traditional receptor binding assays use red blood cells treated with sialidase followed by re-
sialylation using specific sialyltransferases (Rogers and Paulson 1983, Glaser et al. 2005). 
Although this assay is relatively easy to use, it is perceived as inadequate to detect subtle 
changes in receptor binding preference as complex branched glycans are lacking. Alternatively, 
avian and human glycan receptor analogues can be synthesized or isolated from natural 
sources and receptor binding assays can be performed using solid-phase enzyme-linked 
immunosorbent assays (Gambaryan and Matrosovich 1992, Barclay et al. 2007), thin-layer 
chromatography (Masuda et al. 1999, Suzuki et al. 1992) or lipid-linked glycan probes 
(neoglycolipid (NGL) technology), which converts isolated oligosaccharides into multivalent 
probes, thereby increasing sensitivity for detection of low affinity protein-carbohydrate 
interactions (Childs et al. 2009, Liu et al. 2010, Feizi et al. 2003, Feizi et al. 1994, Feizi and Chai 
2004). Development of printed covalent glycan arrays by the Consortium for Functional 
Glycomics allowed for differentiation between 611 glycan targets resulting in a detailed receptor 
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binding profile of HA proteins (Stevens et al. 2006a, Stevens et al. 2006b, Blixt et al. 2004, 
Dyukova et al. 2006, Ratner et al. 2004). These last methods have provided us with a much 
more detailed insight into the subtle changes in receptor binding preferences. However, critics 
of these methods argue that the involvement of these 611 specific sugars in HA receptor 
binding is unproven and that the complex types of glycans found in the URT are 
underrepresented (Xu et al. 2009).  
A rapid glycan assay suitable for use in routine influenza virus surveillance containing just one 
α2,3-linked sialic acid and one α2,6-linked sialic acid would undoubtedly be unable to tease out 
small differences in receptor binding preference and choosing one glycan representing 
respiratory tract sialic acid expression is impossible. Furthermore, producing or obtaining 
sufficient quantities of quality controlled glycans suitable for use in a high throughput assay 
within a surveillance laboratory is challenging (Liu et al. 2009). 
We and others have shown the differential preference of human and avian influenza virus or HA 
protein for non-ciliated and ciliated cells within HAE cultures (Ayora-Talavera et al. 2009, 
Shelton et al. 2011, Thompson et al. 2006, Liu et al. 2010, Matrosovich et al. 2004a). Recently, 
Shelton et al. investigated the feasibility of using paraffin-embedded HAE culture sections to 
examine the pandemic potential of different avian influenza virus subtypes (Shelton et al. 2011). 
Well-differentiated human airway epithelium (HAE) cells are available from commercial sources 
such as Epithelix Sàrl (Geneva, Switserland). Using A(H1N1)pdm09 virus, we were able to 
show that these cultures are indeed infected by influenza virus, and a differentiation between 
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Figure 7.2 Receptor binding assay in HAE cultures using E331 
HAE cultures were infected with E331 (A(H1N1)pdm09) at an MOI of 1 and incubated at 37°C 
for 16 hrs. After fixation with paraformaldehyde, the cells were probed with anti-NP protein 
antibody (green, panel 1) and anti-tubulin (red, data not shown). Using ImageJ software 
(http://rsbweb.nih.gov/ij/) co-location was visualized by converting pixels that were positive in 
both the NP-positive image (panel 2) and tubulin-positive image to white, whereas all other 
pixels were converted to black (panel 3). All infected cells were counted and termed ciliated or 
non-ciliated (panel 4), e.g. if 10 cells were infected of which 3 were non-ciliated panel 4 would 
indicate 3/10. N=1, all five images shown.  
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ciliated and non-ciliated cells could be made (Figure 7.2). Infection of HAE cells and differential 
quantification of infected ciliated and non-ciliated cells could potentially be developed into a 
receptor-binding assay, arguably utilizing „relevant‟ sialic acids naturally found in the respiratory 
tract. Van Riel et al. have developed a different method of looking at receptor binding of 
influenza viruses; formalin-fixed, paraffin-embedded relevant tissue sections such as human 
trachea and alveoli were incubated with formalin-inactivated fluorescein isothiocyanate (FITC)-
labelled virus using a two-step signal-amplification system (van Riel et al. 2006). The 
functionality of this assay has been proven using tissue sections from different sources. For 
example, A/Vietnam/1194/2005 (H5N1) virus was able to bind abundantly to epithelial cells in 
the duck intestine but bind rarely to human trachea tissue sections, whereas 
A/Netherlands/213/2003 (H3N2) was found to bind abundantly to cells in the human trachea but 
bound poorly to cells in the duck intestine (van Riel et al. 2006). This assay is an interesting 
alternative to the HAE receptor binding assay described above. However, if the object of 
investigation is clinical isolates, passaging the initial isolates to provide sufficient virus for 
labelling has the potential to introduce mutations in HA which might change receptor-binding 
preference. Furthermore, there may be difficulties in providing a reliable tissue source, 
especially with human-origin tissue. Finally, very subtle changes in receptor-binding preference 
might only be observed using HAE cultures; in our hands non-ciliated/ciliated HA binding ratios 
were more discriminative on HAE culture cells than on human trachea tissue (Table 3.5). 
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7.5 Which influenza virus subtype will cause the next pandemic? 
The experiments described above suggest that relatively small differences in viral fitness have 
the potential to tip the balance and create a pandemic influenza virus. So, what influenza 
viruses are out there, infecting both avian and swine hosts, that need only a small change to 
cause the next human influenza pandemic?  
Avian influenza virus H5N1 continues to circulate in wild bird and poultry populations and has 
caused hundreds of human infections since 1997. However, none of these infections have yet 
led to sustained human-to-human transmission. Recently published studies investigating the RD 
transmission in ferrets of a mutated recombinant H5N1 virus based on a human isolate by 
groups led by Dr. Yoshihiro Kawaoka and Dr. Ron Fouchier show that H5 is capable of 
transmission between mammals (Herfst et al. 2012, Imai et al. 2012). Herfst et al. achieved 
airborne transmission of complete A/Indonesia/5/2005 H5N1 virus between ferrets on six 
different occasions with a minimum of nine amino acid mutations (mutations Q226L, G228S 
(HA) and E627K (PB2) were introduced, mutations H103Y, T156A (HA), H99Y, I368V (PB1), 
R99K and S345N (NP) were found after serial passage within the ferret host, virus F5). The 
mutations that were introduced into the virus by mutagenesis before serial passage (Q226L, 
G228S (HA) and E627K (PB2)) were found in all six progeny airborne-transmissible viruses, but 
only two additional mutations were consistently detected; H103Y and T156A (HA), which 
removes a potential N-linked glycosylation site (Herfst et al. 2012). Imai et al. achieved 
transmission of their recombinant H5N1 virus (HA of A/Vietnam/1203/2004 on a backbone of 
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A(H1N1)pdm09) by mutating four amino acids in the HA protein (mutations N224K and Q226L 
were introduced by mutagenesis, mutations N158D and T318I were found after serial passage 
within the ferret host). It is particularly interesting that transmission of H5 occurred on a 
A(H1N1)pdm09 backbone, and the reassortment event leading to such a viral variant is not 
inconceivable; both A(H1N1)pdm09 and H5N1 can be found in swine populations in Asia 
(Nidom et al. 2010, Lee et al. 2009a, Zhou et al. 2011, Kim et al. 2011). It is not clear whether 
the complete H5N1 virus discussed in Herfst et al. would be transmitted through the air with just 
the three engineered and two consistently found additional mutations or whether the additional 
four mutations found in virus F5 are necessary to cause transmission. In the latter case, the 
chances of such a virus arising in nature are severely decreased and it seems more likely that a 
reassortment event with for example A(H1N1)pdm09 such as that discussed in Imai et al. is 
morel likely to give rise to a future pandemic virus. 
Another potential pandemic candidate that was the subject of Chapter 5 is influenza subtype 
H7. This virus has a distinct ocular tropism and although infection can lead to severe respiratory 
distress and even death (Fouchier et al. 2004) it is often associated with self-limiting 
conjunctivitis. This relatively mild symptomatic display could contribute to undetected viral 
infections. So far, there have been more than 100 detected cases of human infection with H7 
including a H7N7 outbreak in the Netherlands causing 89 human infections (Belser et al. 2009a, 
Fouchier et al. 2004), but only limited human-to-human transmission has been reported 
(Koopmans et al. 2004). Recent North American H7 isolates display a more human-like receptor 
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binding profile and can be transmitted to contact sentinels in a ferret model (Belser et al. 2008), 
theoretically increasing its chances of causing a pandemic. Lastly, as discussed above H7 
influenza virus has the potential to use eye tissue as an alternative infection site and move 
down into the respiratory tract via the tear ducts, potentially gathering adaptive mutations in the 
process.   
Another avian influenza virus that forms a potential pandemic threat is of the H9N2 subtype. 
This virus has been prevalent among domestic poultry in Asia since the early 1990s (Choi et al. 
2004) and has since reached other parts of the world (Tombari et al. 2011). H9N2 has caused 
repeated human infections in Asia (Peiris et al. 1999, Butt et al. 2005). Patients usually present 
with mild clinical symptoms and no fatal cases have been reported. As with H5 and H7, no 
sustained human-to-human transmission has yet occurred. However, H9N2 displays a more 
human-like receptor binding preference (Wan et al. 2008) and both contact transmission and 
aerosol transmission (after repeated passage in ferrets) of viruses reassorted with H3N2 or 
A(H1N1)pdm09 viruses in a ferret model has been reported (Sorrell et al. 2009, Kimble et al. 
2011, Wan et al. 2008). Interestingly, H9N2 has been detected in pigs (Peiris et al. 2001) 
increasing the risk of such a reassortant virus arising in nature. 
Another potential candidate for the next pandemic is swine-origin H3. Recent events in North 
America have demonstrated the potential of this virus to be introduced into the human 
population. Transmission of both A(H1N1)pdm09 and H3N2 in the swine population has 
resulted in a reassortment virus (H3N2v) containing all genes of swine H3N2 but for the M gene, 
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which originated from A(H1N1)pdm09. Thirteen human infections with H3N2v have been 
detected between July 2011 and April 2012, of which six cases had no history of exposure to 
swine suggesting that human-to-human transmission had occurred (ProMED 12-04-2012). 
These viruses are able to transmit through the air in the ferret transmission model, although this 
was not linked to the introduction of the M gene from A(H1N1)pdm09 (Pearce et al. 2012). 
H3N2 was introduced into the American swine population in 1998 from a human source (Zhou 
et al. 2000) and consequently people born before 1998 are expected to have been exposed to 
an antigenically similar virus. This is reflected in the age of the H3N2v-infected patients; eleven 
of the thirteen cases occurred in children aged below ten years. Therefore, although H3N2v is 
possibly able to transmit between humans (although this is not yet confirmed) its pool of 
susceptible cases is limited compared to that of for example H5N1. H3 influenza virus does not 
only circulate in pigs and humans, but can also be found in the avian population. Until the recent 
A(H1N1)pdm09 many scientists assumed that the human population would be sufficiently 
immune to H3, and other subtypes like H1 and H2 due to previous exposure and no pandemic 
preparedness aimed at these three subtypes was undertaken. Capua et al. however 
hypothesised that due to antigenic drift, contemporary avian influenza viruses would not be 
cross-reactive with contemporary human influenza viruses.  Indeed, antibodies present in 
human sera obtained 3-5 weeks after vaccination using the seasonal 2006-2007 vaccine did not 
cross-react with Eurasian avian H1 and H3 viruses, and limited H2 cross-reactivity was found in 
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people >40 years of age (Capua et al. 2009), highlighting a potential large pool of susceptible 
subjects.  
In my personal opinion, the influenza A subtype most likely to cause the next pandemic is H2. 
H2N2 has already proven its ability to cause a pandemic in 1957, something that H5, H7 and H9 
might never be able to do. This virus continues to circulate in the avian host and has been 
isolated from birds in geographically distinct locations such as Norway, Australia, North America 
and Germany (Jonassen and Handeland 2007, Kishida et al. 2008, Makarova et al. 1999, Suss 
et al. 1994) as well as in pigs (Ma et al. 2007). Moreover, earlier isolates of H2 had the potential 
to bind α2,6-linked sialic acid (Viswanathan et al. 2010) and H2N3 which has been isolated from 
swine in the United States was able to transmit to contact sentinels in both the ferret and swine 
model (Ma et al. 2007). Finally, everyone born after 1968, the last year in which H2N2 was 
detected in the human host, has no protective immunity against H2N2 influenza virus (Nabel, 
Wei and Ledgerwood 2011, Capua et al. 2009). This includes me, and an estimated 
1,833,255,876 others (number based on google data as of 2010, www.google.co.uk/publicdata).  
During a standard worldwide proficiency panel testing in 2004-2005, A/Japan/305/1957 H2N2 
influenza virus was accidentally sent out to approximately 4,000 laboratories. As this virus 
should be handled under biological containment level 3 conditions, and the proficiency panel is 
regularly handled under biological containment level 2 conditions, CDC immediately took 
precautions to prevent a laboratory-origin influenza pandemic. All laboratories and organisations 
responsible for delivery of the panels were urged to destroy the H2N2 samples, and laboratory 
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workers exposed to the proficiency panel were closely followed up. Although this particular 
incident did not cause an outbreak (Schrauder et al. 2006), the significant response of the CDC 
further underlines the possibility of an influenza pandemic caused by H2N2 (EditorialTeam et al. 
2005). 
Whichever subtype will cause the next influenza pandemic, it is vital that good global 
surveillance of avian, swine and human hosts is in place. Although A(H1N1)pdm09 was first 
detected in Mexico, Eurasian swine flu (which provided the NA and M gene of A(H1N1)pdm09) 
has still not been detected in this continent. Therefore, it would be more logical to conclude the 
actual reassortant arose in Asia, where all genetic elements are currently circulating in the 
swine host. If this reassortment had been detected at an earlier stage, the influenza community 
might have been better prepared, by for example starting vaccine development. In the future, 
this information can potentially save thousands of lives. 
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